View Filing Data

Print Document View Excel Document

Document and Entity Information - USD ($) $ in Billions	12 Months Ended
Document and Entity Information - USD ($) $ in Billions	Dec. 31, 2014	Feb. 27, 2015	Jun. 30, 2014
Document And Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Trading Symbol	ACHC
Entity Registrant Name	Acadia Healthcare Company, Inc.
Entity Central Index Key	0001520697
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		66,452,931
Entity Public Float			$ 2.1

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 94,040	$ 4,569
Accounts receivable, net of allowance for doubtful accounts of $22,449 and $18,345, respectively	118,378	95,885
Deferred tax assets	20,155	15,703
Other current assets	41,570	28,969
Total current assets	274,143	145,126
Property and equipment:
Land	132,406	58,947
Building and improvements	858,055	259,523
Equipment	73,584	36,742
Construction in progress	66,268	44,186
Less accumulated depreciation	(60,613)	(29,289)
Property and equipment, net	1,069,700	370,109
Goodwill	802,986	661,549
Intangible assets, net	21,636	20,568
Deferred tax assets - noncurrent	13,141
Other assets	41,984	27,307
Total assets	2,223,590	1,224,659
Current liabilities:
Current portion of long-term debt	26,965	15,195
Accounts payable	48,696	36,026
Accrued salaries and benefits	59,317	37,721
Other accrued liabilities	30,956	25,748
Total current liabilities	165,934	114,690
Long-term debt	1,069,305	601,941
Deferred tax liabilities - noncurrent	63,880	7,971
Other liabilities	43,506	19,347
Total liabilities	1,342,625	743,949
Equity:
Preferred stock, $0.01 par value; 10,000,000 shares authorized, no shares issued
Common stock, $0.01 par value; 90,000,000 shares authorized; 59,211,859 and 50,070,980 issued and outstanding as of December 31, 2013 and 2012, respectively	592	501
Additional paid-in capital	847,301	461,807
Accumulated other comprehensive loss	(68,370)
Retained earnings	101,442	18,402
Total equity	880,965	480,710
Total liabilities and equity	$ 2,223,590	$ 1,224,659

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]
Receivable, allowance for doubtful accounts	$ 22,449	$ 18,345
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized	10,000,000	10,000,000
Preferred stock, issued	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	90,000,000	90,000,000
Common stock, shares issued	59,211,859	50,070,980
Common stock, shares outstanding	59,211,859	50,070,980

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]
Revenue before provision for doubtful accounts	$ 294,901	$ 294,479	$ 213,803	$ 201,418	$ 189,999	$ 184,702	$ 177,494	$ 161,213	$ 1,030,784	$ 735,109	$ 413,850
Provision for doubtful accounts									(26,183)	(21,701)	(6,389)
Revenue									1,004,601	713,408	407,461
Salaries, wages and benefits (including equity-based compensation expense of $10,058, $5,249 and $2,267, respectively)									575,412	407,962	239,639
Professional fees									52,482	37,171	19,019
Supplies									48,422	37,569	19,496
Rents and leases									12,201	10,049	7,838
Other operating expenses									110,654	80,572	42,777
Depreciation and amortization									32,667	17,090	7,982
Interest expense, net									48,221	37,250	29,769
Debt extinguishment costs										9,350
Gain on foreign currency derivatives									(15,262)
Transaction-related expenses									13,650	7,150	8,112
Total expenses									878,447	644,163	374,632
Income (loss) from continuing operations before income taxes	34,840	33,156	37,362	20,796	19,935	22,287	20,291	6,732	126,154	69,245	32,829
Provision for income taxes									42,922	25,975	12,325
Income (loss) from continuing operations									83,232	43,270	20,504
Loss from discontinued operations, net of income taxes									(192)	(691)	(101)
Net income	$ 22,129	$ 25,402	$ 22,451	$ 13,058	$ 12,280	$ 14,364	$ 12,197	$ 3,738	$ 83,040	$ 42,579	$ 20,403
Basic earnings per share:
Income from continuing operations									$ 1.51	$ 0.87	$ 0.53
Loss from discontinued operations										(0.02)
Net income	$ 0.38	$ 0.43	$ 0.43	$ 0.26	$ 0.25	$ 0.29	$ 0.24	$ 0.07	1.51	0.85	0.53
Diluted earnings per share:
Income from continuing operations									1.50	0.86	0.53
Loss from discontinued operations										(0.01)
Net income	$ 0.37	$ 0.43	$ 0.43	$ 0.26	$ 0.24	$ 0.29	$ 0.24	$ 0.07	$ 1.50	$ 0.85	$ 0.53
Weighted-average shares outstanding:
Basic									55,063	50,004	38,477
Diluted									55,327	50,261	38,696

Consolidated Statements of Income (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]
Equity-based compensation expense	$ 10,058	$ 5,249	$ 2,267

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Statement of Comprehensive Income [Abstract]
Net income	$ 22,129	$ 25,402	$ 22,451	$ 13,058	$ 12,280	$ 14,364	$ 12,197	$ 3,738	$ 83,040	$ 42,579	$ 20,403
Other comprehensive loss:
Foreign currency translation loss									(66,206)
Pension liability adjustment, net of tax of $0.6 million, $0 and $0, respectively									(2,164)
Other comprehensive loss									(68,370)
Comprehensive income									$ 14,670	$ 42,579	$ 20,403

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Statement of Comprehensive Income [Abstract]
Pension liability adjustment, tax	$ 0.6	$ 0.0	$ 0.0

Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings (Accumulated Deficit) [Member]	Retained Earnings [Member]
Balance at Dec. 31, 2011	$ 96,365	$ 321	$ 140,624		$ (44,580)
Balance, shares at Dec. 31, 2011		32,116,000
Issuance of common stock, net	311,841	$ 176	311,665
Issuance of common stock, net, shares		17,538,000
Common stock issued under stock incentive plans	960	$ 2	958
Common stock issued under stock incentive plans, shares		233,000
Equity-based compensation expense	2,267		2,267
Excess tax benefit from equity awards	714		714
Net income	20,403				20,403
Balance at Dec. 31, 2012	432,550	$ 499	456,228		(24,177)
Balance, shares at Dec. 31, 2012		49,887,000
Issuance of common stock, net	205		205
Common stock issued under stock incentive plans	$ 313	$ 2	311
Common stock issued under stock incentive plans, shares	126,662	184,000
Common stock withheld for minimum statutory taxes	$ (1,555)		(1,555)
Equity-based compensation expense	5,249		5,249
Excess tax benefit from equity awards	1,779		1,779
Net income	42,579				42,579
Balance at Dec. 31, 2013	480,710	$ 501	461,807		18,402
Balance, shares at Dec. 31, 2013		50,071,000
Issuance of common stock, net	374,431	$ 89	374,342
Issuance of common stock, net, shares		8,882,000
Common stock issued under stock incentive plans	$ 570	$ 2	568
Common stock issued under stock incentive plans, shares	210,199	259,000
Common stock withheld for minimum statutory taxes	$ (4,669)		(4,669)
Equity-based compensation expense	10,058		10,058
Excess tax benefit from equity awards	4,617		4,617
Other	578		578
Other comprehensive loss	(68,370)			$ (68,370)
Net income	83,040				83,040
Balance at Dec. 31, 2014	$ 880,965	$ 592	$ 847,301	$ (68,370)	$ 101,442
Balance, shares at Dec. 31, 2014		59,212,000

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Operating activities:
Net income	$ 83,040	$ 42,579	$ 20,403
Adjustments to reconcile net income to net cash provided by continuing operating activities:
Depreciation and amortization	32,667	17,090	7,982
Amortization of debt issuance costs	3,198	2,264	2,507
Equity-based compensation expense	10,058	5,249	2,267
Deferred income tax expense	7,215	10,083	2,847
Loss from discontinued operations, net of taxes	192	691	101
Debt extinguishment costs		9,350
Gain on foreign currency derivatives	(15,262)
Other	488	21	(3)
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net	(15,110)	(21,242)	(10,344)
Other current assets	(2,011)	(3,652)	1,583
Other assets	(6,513)	(2,239)	637
Accounts payable and other accrued liabilities	2,793	(848)	485
Accrued salaries and benefits	11,980	2,803	5,142
Other liabilities	2,749	3,181	702
Net cash (used in) provided by continuing operating activities	115,484	65,330	34,309
Net cash (used in) provided by discontinued operating activities	(198)	232	(411)
Net cash provided by operating activities	115,286	65,562	33,898
Investing activities:
Cash paid for acquisitions, net of cash acquired	(738,702)	(164,019)	(443,473)
Cash paid for capital expenditures	(113,244)	(68,941)	(27,595)
Cash paid for real estate acquisitions	(23,177)	(8,092)	(53,159)
Settlement of foreign currency derivatives	15,262
Other	(913)	(1,926)	(417)
Net cash used in investing activities	(860,774)	(242,978)	(524,644)
Financing activities:
Borrowings on long-term debt	542,500	150,000	176,063
Borrowings on revolving credit facility	230,500	61,500	16,000
Principal payments on revolving credit facility	(284,000)	(8,000)	(16,000)
Principal payments on long-term debt	(7,695)	(7,680)	(6,000)
Repayment of long-term debt		(52,500)
Payment of debt issuance costs	(12,993)	(4,307)	(4,551)
Payment of premium on note redemption		(6,759)
Issuances of common stock, net	374,431	(205)	311,841
Common stock withheld for minimum statutory taxes, net	(4,099)	(1,242)	960
Excess tax benefit from equity awards	4,617	1,779	714
Cash paid for contingent consideration	(5,000)
Other	(289)
Net cash provided by financing activities	837,972	132,586	479,027
Effect of exchange rate changes on cash	(3,013)
Net increase (decrease) in cash and cash equivalents	89,471	(44,830)	(11,719)
Cash and cash equivalents at beginning of the period	4,569	49,399	61,118
Cash and cash equivalents at end of the period	94,040	4,569	49,399
Supplemental Cash Flow Information:
Cash paid for interest	36,776	33,270	27,238
Cash paid for income taxes	32,257	16,960	3,928
Significant Non-Cash Transactions:
Contingent consideration issued in connection with acquisition	1,467		6,120
Effect of acquisitions:
Assets acquired, excluding cash	819,518	192,928	482,891
Liabilities assumed	(78,849)	(17,725)	(44,982)
Deposits paid for acquisitions		500	11,684
Prior year deposits paid for acquisitions	(500)	(11,684)
Contingent consideration issued in connection with acquisition	(1,467)		(6,120)
Cash paid for acquisitions, net of cash acquired	$ 738,702	$ 164,019	$ 443,473

Description of Business and Basis of Presentation	12 Months Ended
Description of Business and Basis of Presentation	Dec. 31, 2014
Accounting Policies [Abstract]
Description of Business and Basis of Presentation	1. Description of Business and Basis of Presentation *Description of Business* Acadia Healthcare Company, Inc. (the “Company”) develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico. At December 31, 2014, the Company operated 78 behavioral healthcare facilities with over 5,800 beds in 24 states, the United Kingdom and Puerto Rico. On February 11, 2015, the Company completed its acquisition of CRC Health Group, Inc. (“CRC”) for total consideration of approximately $1.3 billion. CRC is a leading provider of treatment services related to substance abuse and other addiction and behavioral disorders. At December 31, 2014, CRC operated 35 inpatient facilities with over 2,400 beds and 81 comprehensive treatment centers located in 30 states. *Basis of Presentation* The business of the Company is conducted through limited liability companies and C-corporations, each of which is a direct or indirect wholly owned subsidiary of the Company. The Company’s consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, all of which are 100% owned. All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. The majority of the Company’s expenses are “cost of revenue” items. Costs that could be classified as general and administrative expenses include the Company’s corporate office costs, which were $36.9 million, $29.0 million and $21.6 million for the years ended December 31, 2014, 2013 and 2012, respectively. Certain reclassifications have been made to prior years to conform to the current year presentation.

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. At times, cash and cash equivalent balances may exceed federally insured limits. Management believes that the Company mitigates any risks by depositing cash and investing in cash equivalents with major financial institutions.

Revenue and Accounts Receivable

Revenue is primarily derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care and adolescent residential treatment. The Company receives payments from the following sources for services rendered in our facilities: (i) state governments under their respective Medicaid and other programs; (ii) commercial insurers; (iii) the federal government under the Medicare program administered by CMS; (iv) NHS in the United Kingdom; and (v) individual patients and clients. Revenue is recorded in the period in which services are provided at established billing rates less contractual adjustments based on amounts reimbursable by Medicare or Medicaid under provisions of cost or prospective reimbursement formulas or amounts due from other third-party payors at contractually determined rates.

The following table presents revenue by payor type as a percentage of revenue before provision for doubtful accounts:


	Year Ended December 31,
	2014			2013			2012
Commercial		23.0	%		24.9	%		20.1	%
Medicare		19.4			21.5			11.8
Medicaid		38.3			48.0			63.6
NHS		14.5			—			—
Self-Pay		2.5			3.4			2.5
Other		2.3			2.2			2.0

Revenue		100	%		100	%		100	%

On a combined basis, revenue related to the Medicare and Medicaid programs were 58%, 70% and 75% of all revenue before provision for doubtful accounts for the years ended December 31, 2014, 2013 and 2012, respectively. The Company’s concentration of credit risk from other payors is reduced by the large number of payors and their geographic dispersion. The Company generated approximately 15% and 12% of its revenue for the year ended December 31, 2014 from facilities located in the United Kingdom and Arkansas, respectively, and approximately 17% and 8% of its revenue from facilities located in Arkansas and Mississippi for the year ended December 31, 2013.

Allowance for Contractual Discounts

The Company derives a significant portion of its revenues from Medicare, Medicaid and other payors that receive discounts from established billing rates. The Medicare and Medicaid regulations and various managed care contracts under which these discounts must be calculated are complex, subject to interpretation and adjustment, and may include multiple reimbursement mechanisms for different types of services provided in the Company’s inpatient facilities and cost settlement provisions. Management estimates the allowance for contractual discounts on a payor-specific basis given its interpretation of the applicable regulations or contract terms. The services authorized and provided and related reimbursement are often subject to interpretation that could result in payments that differ from the Company’s estimates. Additionally, updated regulations and contract renegotiations occur frequently, necessitating regular review and assessment of the estimation process by management.

Settlements under cost reimbursement agreements with third-party payors are estimated and recorded in the period in which the related services are rendered and are adjusted in future periods as final settlements are determined. Final determination of amounts earned under the Medicare and Medicaid programs often occurs in subsequent years because of audits by such programs, rights of appeal and the application of numerous technical provisions. In the opinion of management, adequate provision has been made for any adjustments and final settlements. However, there can be no assurance that any such adjustments and final settlements will not have a material effect on the Company’s financial condition or results of operations. The Company’s cost report receivables were $1.9 million at December 31, 2014 and were included in other current assets in the consolidated balance sheets. The Company’s cost report liabilities were $0.8 million at December 31, 2013 and were included in other accrued liabilities in the consolidated balance sheets. Management believes that these receivables and liabilities are properly stated and are not likely to be settled for a significantly different amount. The net adjustments to estimated cost report settlements resulted in increases to revenue of $0.3 million and $0.2 million for the years ended December 31, 2014 and 2013, respectively.

Management believes that it is in compliance with all applicable laws and regulations and is not aware of any pending or threatened investigations involving allegations of wrongdoing. While no such regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties and exclusion from the Medicare and Medicaid programs.

Allowance for Doubtful Accounts

The Company’s ability to collect outstanding patient receivables from third party payors is critical to its operating performance and cash flows. The primary collection risk with regard to patient receivables relates to uninsured patient accounts or patient accounts for which primary insurance has paid, but the portion owed by the patient remains outstanding. The Company estimates uncollectible accounts and establish an allowance for doubtful accounts in order to adjust accounts receivable to estimated net realizable value. In evaluating the collectability of accounts receivable, the Company considers a number of factors, including the age of the accounts, historical collection experience, current economic conditions, and other relevant factors. Accounts receivable that are determined to be uncollectible based on the Company’s policies are written off to the allowance for doubtful accounts. Significant changes in payor mix or business office operations could have a significant impact on the Company’s results of operations and cash flows.

A summary of activity in the Company’s allowance for doubtful accounts is as follows (in thousands):


	Balance at Beginning of Period		Additions Charged to Costs and Expenses		Accounts Written Off, Net of Recoveries			Balance at End of Period
Year ended December 31, 2012	$	2,424	$	6,389	$	(1,329	)	$	7,484
Year ended December 31, 2013		7,484		21,701		(10,840	)		18,345
Year ended December 31, 2014		18,345		26,183		(22,079	)		22,449

Charity Care

The Company provides care without charge to patients who are financially unable to pay for the healthcare services they receive based on Company policies and federal and state poverty thresholds. The costs of providing charity care services were $2.5 million, $2.6 million and $1.2 million for the years ended December 31, 2014, 2013 and 2012, respectively. The estimated cost of charity care services was determined using a ratio of cost to gross charges determined from our most recently filed Medicare cost reports and applying that ratio to the gross charges associated with providing charity care for the period.

Insurance

The Company is subject to medical malpractice and other lawsuits due to the nature of the services the Company provides. The Company’s operations have professional and general liability insurance for claims in excess of a $250,000 deductible with an insured excess limit of $36 million. The reserve for professional and general liability risks was estimated based on historical claims, demographic factors, industry trends, severity factors, and other actuarial assumptions calculated by an independent third-party actuary. The estimated accrual for professional and general liabilities could be significantly affected should current and future occurrences differ from historical claim trends and expectations. While claims are monitored closely when estimating professional and general liability accruals, the complexity of the claims and wide range of potential outcomes often hampers timely adjustments to the assumptions used in these estimates. The professional and general liability reserve was $16.3 million as of December 31, 2014, of which $4.2 million was included in other accrued liabilities and $12.1 million was included in other long-term liabilities. The professional and general liability reserve was $14.0 million as of December 31, 2013, of which $4.1 million was included in other accrued liabilities and $9.9 million was included in other long-term liabilities. The Company estimates receivables for the portion of professional and general liability reserves that are recoverable under the Company’s insurance policies based on an independent actuarial evaluation. Such receivable was $12.0 million as of December 31, 2014, of which $3.5 million was included in other current assets and $8.5 million was included in other assets, and such receivable was $11.2 million as of December 31, 2013, of which $3.4 million was included in other current assets and $7.8 million was included in other assets.

The Company’s statutory workers’ compensation program is fully insured with a $500,000 deductible per accident. The workers’ compensation liability was $8.4 million as of December 31, 2014, of which $4.8 million was included in accrued salaries and benefits and $3.6 million was included in other long-term liabilities, and such liability was $6.2 million as of December 31, 2013, of which $4.1 million was included in accrued salaries and benefits and $2.1 million was included in other long-term liabilities. The reserve for workers compensation claims was based upon independent actuarial estimates of future amounts that will be paid to claimants. Management believes that adequate provisions have been made for workers’ compensation and professional and general liability risk exposures.

Property and Equipment and Other Long-Lived Assets

Property and equipment are recorded at cost. Depreciation is calculated on the straight-line basis over the estimated useful lives of the assets, which typically range from 10 to 40 years for buildings and improvements, three to seven years for equipment and the shorter of the lease term or estimated useful lives for leasehold improvements. When assets are sold or retired, the corresponding cost and accumulated depreciation are removed from the related accounts and any gain or loss is recorded in the period of sale or retirement. Repair and maintenance costs are expensed as incurred. Depreciation expense was $32.1 million, $16.3 million and $7.4 million for the years ended December 31, 2014, 2013 and 2012, respectively.

The carrying values of long-lived assets are reviewed for possible impairment whenever events, circumstances or operating results indicate that the carrying amount of an asset may not be recoverable. If this review indicates that the asset will not be recoverable, as determined based upon the undiscounted cash flows of the operating asset over the remaining useful lives, the carrying value of the asset will be reduced to its estimated fair value. Fair value estimates are based on independent appraisals, market values of comparable assets or internal evaluations of future net cash flows.

Goodwill and Indefinite-Lived Intangible Assets

The Company’s goodwill and other indefinite-lived intangible assets, which consist of licenses and accreditations and certificates of need intangible assets that are not amortized, are evaluated for impairment annually during the fourth quarter or more frequently if events indicate that the carrying value of a reporting unit may not be recoverable. The Company has two operating segments, U.S. Facilities and U.K. Facilities, for segment reporting purposes, each of which represents a reporting unit for purposes of the Company’s goodwill impairment test. Potential impairment is noted for a reporting unit if its carrying value exceeds the fair value of the reporting unit. For a reporting unit with potential impairment of goodwill, the Company determines the implied fair value of goodwill. If the carrying value of goodwill exceeds its implied fair value, an impairment loss is recorded. The Company’s annual impairment tests of goodwill and other indefinite-lived intangibles in 2014, 2013 and 2012 resulted in no impairment charges.

Other Current Assets

Other current assets consisted of the following (in thousands):


	As of December 31,
	2014		2013

Other receivables	$	12,713	$	6,833
Prepaid expenses		11,746		6,397
Insurance receivable – current portion		3,500		3,400
Workers’ compensation deposits – current portion		4,800		4,100
Income taxes receivable		3,399		4,005
Other		5,412		4,234

Other current assets	$	41,570	$	28,969

Debt Issuance Costs

Debt issuance costs are deferred and amortized to interest expense over the term of the related debt. Debt issuance costs at December 31, 2014 were $20.9 million, net of accumulated amortization of $9.5 million. Debt issuance costs at December 31, 2013 were $13.3 million, net of accumulated amortization of $6.1 million. Amortization expense related to debt issuance costs, which is reported as interest expense, was $3.2 million and $2.3 million, respectively, for the years ended December 31, 2014 and 2013. Estimated amortization of debt issuance costs for the years ending December 31, 2015, 2016, 2017, 2018 and 2019 is $4.5 million, $4.6 million, $4.7 million, $4.5 million and $1.6 million, respectively.

Other Accrued Liabilities

Other accrued liabilities consisted of the following (in thousands):


	As of December 31,
	2014		2013

Accrued interest	$	13,013	$	5,065
Insurance liability – current portion		4,239		4,139
Contingent consideration		3,000		4,891
Accrued property taxes		2,069		1,819
Other		8,635		9,834

Other accrued liabilities	$	30,956	$	25,748

Stock Compensation

The Company measures and recognizes the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718, “Compensation—Stock Compensation.” The Company uses the Black-Scholes valuation model to determine grant-date fair value for equity awards and uses straight-line amortization of share-based compensation expense over the requisite service period of the respective awards.

Earnings Per Share

Basic and diluted earnings per share are calculated in accordance with FASB ASC 260, “Earnings Per Share,” based on the weighted-average number of shares outstanding in each period and dilutive stock options, nonvested shares and warrants, to the extent such securities have a dilutive effect on earnings per share.

Income Taxes

The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and net operating loss and tax credit carryforwards. The amount of deferred taxes on these temporary differences is determined using the tax rates that are expected to apply to the period when the asset is realized or the liability is settled, as applicable, based on tax rates and laws in the respective tax jurisdiction enacted as of the balance sheet date.

The Company reviews its deferred tax assets for recoverability and establishes a valuation allowance based on historical taxable income, projected future taxable income, applicable tax strategies, and the expected timing of the reversals of existing temporary differences. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The Company records a liability for unrecognized tax benefits resulting from uncertain tax positions taken or expected to be taken in a tax return. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits in income tax expense.

Recent Accounting Pronouncements

In April 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-08, “Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity” (“ASU 2014-08”). ASU 2014-08 raises the threshold for a disposal to qualify as a discontinued operation and requires new disclosures of both discontinued operations and certain other disposals that do not meet the definition of a discontinued operation. ASU 2014-08 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2014. Early adoption is permitted. Management is evaluating the impact of ASU 2014-08 on the Company’s consolidated financial statements and does not expect ASU 2014-08 to have a significant impact on the Company’s consolidated financial statements.

In May 2014, the FASB and the International Accounting Standards Board issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)” (“ASU 2014-09”). ASU 2014-09’s core principal is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016. Early adoption is not permitted. Management is evaluating the impact of ASU 2014-09 on the Company’s consolidated financial statements.

Earnings Per Share

12 Months Ended

Dec. 31, 2014

Earnings Per Share [Abstract]

Earnings Per Share

3. Earnings Per Share

The following table sets forth the computation of basic and diluted earnings (loss) per share for the years ended December 31, 2014, 2013 and 2012 (in thousands except per share amounts):


	Year Ended December 31,
	2014			2013			2012
Numerator:
Basic and diluted earnings (loss) per share:
Income (loss) from continuing operations	$	83,232		$	43,270		$	20,504
(Loss) from discontinued operations		(192	)		(691	)		(101	)

Net income (loss)	$	83,040		$	42,579		$	20,403

Denominator:
Weighted average shares outstanding for basic earnings per share		55,063			50,004			38,477
Effects of dilutive instruments		264			257			219

Shares used in computing diluted earnings per common share		55,327			50,261			38,696

Basic net earnings (loss) per share:
Income (loss) from continuing operations	$	1.51		$	0.87		$	0.53
Loss from discontinued operations		—			(0.02	)		—

Net income (loss)	$	1.51		$	0.85		$	0.53

Diluted net earnings (loss) per share:
Income (loss) from continuing operations	$	1.50		$	0.86		$	0.53
Loss from discontinued operations		—			(0.01	)		—

Net income (loss)	$	1.50		$	0.85		$	0.53

Approximately 0.7 million, 0.6 million and 0.4 million shares of common stock issuable upon exercise of outstanding stock options were excluded from the calculation of diluted earnings per share for the year ended December 31, 2014, 2013 and 2012, respectively, because their effect would have been anti-dilutive.

Acquisitions

12 Months Ended

Dec. 31, 2014

Business Combinations [Abstract]

Acquisitions

4. Acquisitions

Croxton

On December 1, 2014, the Company acquired the assets of Croxton Warwick Lodge (“Croxton”), an inpatient psychiatric facility with 24 beds located in Melton Mowbray, Leicestershire, England, for cash consideration of $15.6 million.

Skyway

On December 31, 2014, the Company completed the acquisition of Skyway House (“Skyway”), a substance abuse facility with 28 beds located in Chico, California, for $0.3 million.

McCallum

On September 3, 2014, the Company acquired for $37.4 million the assets of McCallum Place (“McCallum”), an eating disorder treatment facility with 85 beds offering residential, partial hospitalization and intensive outpatient treatment programs located in St. Louis, Missouri, and Austin, Texas. The Company may make a cash payment under an earn-out agreement of up to $6.0 million, contingent upon achievement by McCallum of certain operating performance targets for the one-year period ending October 31, 2015.

Partnerships in Care

On July 1, 2014, the Company acquired Partnerships in Care for cash consideration of $661.7 million, which is net of cash acquired of $12.0 million and the gain on settlement of the foreign currency derivatives of $15.3 million. The Company used $300.0 million of proceeds from the July 1, 2014 sale of 5.125% Senior Notes due 2022 (the “5.125% Senior Notes”) (described in Note 7), $374.4 million of proceeds from the June 2014 sale of Acadia common stock (described in Note 8) and borrowings under the Company’s Amended and Restated Senior Secured Credit Facility to fund the acquisition. Partnerships in Care is the second largest independent provider of inpatient behavioral healthcare services in the United Kingdom, operating 23 inpatient behavioral healthcare facilities with over 1,200 beds at the acquisition date.

Pacific Grove

On January 1, 2014, the Company acquired the assets of Pacific Grove Hospital (“Pacific Grove”), an inpatient psychiatric facility with 68 beds located in Riverside, California, for cash consideration of $10.5 million.

2013 Acquisitions

On December 1, 2013, the Company acquired the assets of Cascade Behavioral Hospital (“Cascade”). On October 1, 2013, the Company acquired the assets of Longleaf Hospital (“Longleaf”). On August 1, 2013, the Company acquired The Refuge, a Healing Place (“The Refuge”). On May 1, 2013, the Company acquired two facilities from United Medical Corporation (the “UMC Facilities”). On January 31, 2013, the Company acquired DMC-Memphis, Inc. d/b/a Delta Medical Center (“Delta”). On January 1, 2013, the Company acquired the assets of Greenleaf Center (“Greenleaf”).

Summary of Acquisitions

The Company selectively seeks opportunities to expand and diversify its base of operations by acquiring additional facilities. The majority of the goodwill associated with domestic acquisitions completed in 2014 and 2013 is deductible for federal income tax purposes. The fair values assigned to certain assets and liabilities assumed by the Company have been estimated on a preliminary basis and are subject to change as new facts and circumstances emerge that were present at the date of acquisition. Specifically, the Company is further assessing the valuation of certain tax matters as well as certain receivables and assumed liabilities of McCallum and Partnerships in Care.

The preliminary fair values of assets acquired and liabilities assumed, at the corresponding acquisition dates, during the year ended December 31, 2014 in connection with the Partnerships in Care and other 2014 acquisitions were as follows (in thousands):


	Partnerships in Care		Other		Total
Cash	$	11,674	$	—	$	11,674
Accounts receivable		7,684		1,849		9,533
Prepaid expenses and other current assets		8,828		186		9,014
Property and equipment		610,477		27,203		637,680
Goodwill		120,364		31,951		152,315
Intangible assets		651		204		855
Other assets		6,897		3,224		10,121

Total assets acquired		766,575		64,617		831,192
Accounts payable		3,958		93		4,051
Accrued salaries and benefits		10,422		—		10,422
Other accrued expenses		6,690		732		7,422
Deferred tax liabilities – noncurrent		49,250		—		49,250
Other liabilities		7,704		—		7,704

Total liabilities assumed		78,024		825		78,849

Net assets acquired	$	688,551	$	63,792	$	752,343

The fair values of assets acquired and liabilities assumed during 2013, at the corresponding acquisition dates, were as follows (in thousands):


	UMC Facilities		Other		Total
Cash	$	52	$	873	$	925
Accounts receivable		4,961		5,840		10,801
Prepaid expenses and other current assets		691		3,039		3,730
Property and equipment		22,347		42,672		65,019
Goodwill		67,589		37,651		105,240
Intangible assets		1,505		1,910		3,415
Other assets		4,712		29		4,741

Total assets acquired		101,857		92,014		193,871
Accounts payable		1,535		7,487		9,022
Accrued salaries and benefits		588		3,079		3,667
Other accrued expenses		315		2,298		2,613
Other liabilities		—		2,360		2,360

Total liabilities assumed		2,438		15,224		17,662

Net assets acquired	$	99,419	$	76,790	$	176,209

Other

The qualitative factors comprising the goodwill acquired in the Greenleaf, Delta, the UMC Facilities, The Refuge, Longleaf, Cascade, Pacific Grove, Partnerships in Care, McCallum, Croxton and Skyway acquisitions (collectively the “2013 and 2014 Acquisitions”) include efficiencies derived through synergies expected by the elimination of certain redundant corporate functions and expenses, the ability to leverage call center referrals to a broader provider base, coordination of services provided across the combined network of facilities, achievement of operating efficiencies by benchmarking performance, and applying best practices throughout the combined companies.

Transaction-related expenses comprised the following costs for the years ended December 31, 2014, 2013 and 2012 (in thousands):


	Year Ended December 31,
	2014		2013		2012
Legal, accounting and other fees	$	12,836	$	5,535	$	4,161
Severance and contract termination costs		814		1,615		3,951

	$	13,650	$	7,150	$	8,112

CRC Acquisition

On February 11, 2015, the Company completed its acquisition of CRC for total consideration of approximately $1.3 billion. As consideration for the acquisition, the Company issued 5,975,326 shares of its common stock to certain holders of CRC common stock and repaid CRC’s outstanding indebtedness. CRC is a leading provider of treatment services related to substance abuse and other addiction and behavioral disorders. At the acquisition date, CRC operated 35 inpatient facilities with over 2,400 beds and 81 comprehensive treatment centers located in 30 states.

The preliminary fair values of assets acquired and liabilities assumed in connection with the CRC acquisition are estimated as follows (in thousands). As the acquisition was recently completed on February 11, 2015, these amounts have been estimated on a preliminary basis from historical financial information and are subject to change as acquisition method of accounting is finalized.


Cash	$	15,000
Accounts receivable		50,000
Prepaid expenses and other current assets		16,000
Property and equipment		130,000
Goodwill		1,050,500
Intangible assets		15,000
Deferred tax assets - noncurrent		94,000

Total assets acquired		1,370,500
Accounts payable		6,000
Accrued salaries and benefits		23,000
Other accrued expenses		32,500
Long-term debt		895,467
Other liabilities		25,000

Total liabilities assumed		981,967

Net assets acquired	$	388,533

Pro Forma Information

The consolidated statements of income for the year ended December 31, 2014 included revenue of $300.4 million and income from continuing operations before income taxes of $23.9 million for acquisitions completed in 2013 and 2014. The consolidated statements of income for the year ended December 31, 2013 included revenue of $80.8 million and loss from continuing operations before income taxes of $0.3 million for acquisitions completed in 2013.

The following table provides certain pro forma financial information for the Company as if the 2013 and 2014 Acquisitions and the CRC acquisition occurred as of January 1, 2013 (in thousands):


	Year Ended December 31,
	2014		2013
Revenue	$	1,569,877	$	1,480,631

Income from continuing operations, before income taxes	$	126,263	$	18,652

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6996-128479

+ Details

Other Intangible Assets

12 Months Ended

Dec. 31, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Other Intangible Assets

5. Other Intangible Assets

Other identifiable intangible assets and related accumulated amortization consisted of the following as of December 31, 2014 and 2013 (in thousands):


	Gross Carrying Amount				Accumulated Amortization
	December 31, 2014		December 31, 2013		December 31, 2014			December 31, 2013
Intangible assets subject to amortization:
Contract intangible assets	$	2,100	$	2,100	$	(1,330	)	$	(910	)
Non-compete agreements		1,247		1,247		(1,155	)		(1,021	)

		3,347		3,347		(2,485	)		(1,931	)
Intangible assets not subject to amortization:
Licenses and accreditations		9,184		8,391		—			—
Trade names		3,000		3,000		—			—
Certificates of need		8,590		7,761		—			—

		20,774		19,152		—			—

Total	$	24,121	$	22,499	$	(2,485	)	$	(1,931	)

Amortization expense related to definite-lived intangible assets was $0.6 million, $0.8 million and $0.6 million for the years ended December 31, 2014, 2013 and 2012, respectively. Estimated amortization expense for the years ending December 31, 2014, 2015, 2016, 2017 and 2018 is $0.5 million, $0.4 million, $0 million, $0 and $0, respectively. The Company’s licenses and accreditations, trade names and certificate of need intangible assets have indefinite lives and are, therefore, not subject to amortization.

Discontinued Operations

12 Months Ended

Dec. 31, 2014

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

6. Discontinued Operations

In 2012, the Company disposed of a facility located in Miami, Florida and recognized a pretax loss on disposal of $0.2 million, which had been included in loss from discontinued operations on the consolidated statements of income. The results of operations of this facility, in addition to certain terminated management contracts, have been reported as discontinued operations in the accompanying consolidated financial statements.

A summary of results from discontinued operations is as follows (in thousands):


	Year Ended December 31,
	2014			2013			2012
Revenue	$	—		$	—		$	3,576

Net loss from discontinued operations, net of income taxes	$	(192	)	$	(691	)	$	(101	)

- Definition

The entire disclosure for the facts and circumstances leading to the completed or expected disposal, manner and timing of disposal, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the segment in which the disposal group was reported, and the classification (whether sold or classified as held for sale) and carrying value of the assets and liabilities comprising the disposal group. Includes all disposal groups, including those classified as components of the entity (discontinued operations).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1436-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1474-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1510-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1020-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1012-107759

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2443-110228

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

+ Details

Long-Term Debt

12 Months Ended

Dec. 31, 2014

Debt Disclosure [Abstract]

Long-Term Debt

7. Long-Term Debt

Long-term debt consisted of the following (in thousands):


	December 31, 2014			December 31, 2013
Amended and Restated Senior Credit Facility:
Senior Secured Term A Loans (net of discount of $1,924 and $0, respectively)	$	525,576		$	292,500
Senior Secured Revolving Line of Credit		—			53,500
12.875% Senior Notes due 2018 (net of discount of $1,080 and $1,283, respectively)		96,420			96,216
6.125% Senior Notes due 2021		150,000			150,000
5.125% Senior Notes due 2022		300,000			—
9.0% and 9.5% Revenue Bonds (net of premium of $1,649 and $2,100, respectively)		24,274			24,920

		1,096,270			617,136
Less: current portion		(26,965	)		(15,195	)

Long-term debt	$	1,069,305		$	601,941

Amended and Restated Senior Credit Facility

The Company entered into a senior secured credit facility (the “Senior Secured Credit Facility”) on April 1, 2011. On December 31, 2012, the Company entered into an Amended and Restated Credit Agreement (the “Amended and Restated Credit Agreement”) which amended and restated the Senior Secured Credit Facility (“Amended and Restated Senior Credit Facility”).

On February 13, 2014, the Company entered into a Fourth Amendment (the “Fourth Amendment”) to the Amended and Restated Credit Agreement, to increase the size of the Amended and Restated Senior Credit Facility and extend the maturity date thereof, which resulted in the Company having a revolving line of credit of up to $300.0 million and term loans of $300.0 million. The Fourth Amendment also reduced the interest rates applicable to the Amended and Restated Senior Credit Facility and provided increased flexibility to the Company in terms of the financial and other restrictive covenants. The Fourth Amendment also provides for a $150.0 million incremental credit facility, with the potential for unlimited additional incremental amounts, provided the Company meets certain financial ratios, in each case subject to customary conditions precedent to borrowing.

On June 16, 2014, the Company entered into a Fifth Amendment (the “Fifth Amendment”) to the Amended and Restated Credit Agreement. The Fifth Amendment specifically permitted the Company’s acquisition of Partnerships in Care, gave the Company the ability to incur a tranche of term loan B debt in the future through its incremental credit facility, and modified certain of the restrictive covenants on miscellaneous investments and incurrence of miscellaneous liens. The restrictive covenants on investments in joint ventures and foreign subsidiaries were also amended such that the Company may now invest, in any given fiscal year, up to five percent (5%) of its total assets in both joint ventures and foreign subsidiaries, respectively; provided that the aggregate amount of investments in both joint ventures and foreign subsidiaries, respectively, may not exceed ten percent (10%) of its total assets over the life of the Amended and Restated Senior Credit Facility; provided further that the aggregate amount of investments made in both joint ventures and foreign subsidiaries collectively pursuant to the foregoing may not exceed fifteen percent (15%) of its total assets. Finally, the Fifth Amendment provided increased flexibility to the Company in terms of its financial covenants.

On December 15, 2014, the Company entered into a Sixth Amendment (the “Sixth Amendment”) to our Amended and Restated Credit Agreement. Pursuant to the Sixth Amendment, we incurred $235.0 million of additional term loans. A portion of the additional term loan advance was used to prepay our outstanding revolving loans, and a portion of the additional term loan advance is being held as cash on the consolidated balance sheet. The Sixth Amendment also specifically permitted the acquisition of CRC. In connection with the acquisition of CRC, the Sixth Amendment (i) imposed a temporary reserve on the Company’s revolving credit facility in the amount of $110.0 million in order to preserve such reserved amounts for later borrowings to partially fund the consideration for the acquisition of CRC (subject to limited conditionality provisions) (the reserve is no longer in effect due to the acquisition of CRC), (ii) permitted the incurrence of an additional incremental term loan facility under the Amended and Restated Credit Agreement partially to fund the consideration for the acquisition of CRC (subject to limited conditionality provisions) and (iii) permitted the issuance of additional senior unsecured indebtedness or senior unsecured bridge indebtedness partially to fund the consideration for the acquisition of CRC.

On February 6, 2015, the Company entered into a Seventh Amendment (the “Seventh Amendment”) to our Amended and Restated Credit Agreement. The Seventh Amendment added Citibank, N.A. as an “L/C Issuer” under the Amended and Restated Credit Agreement in order to permit the rollover of CRC’s existing letters of credit into the Amended and Restated Credit Agreement and increased both the Company’s Letter of Credit Sublimit and Swing Line Sublimit to $20.0 million.

On February 11, 2015, the Company entered into a First Incremental Facility Amendment (the “First Incremental Amendment”) to our Amended and Restated Credit Agreement. The First Incremental Amendment activated a new $500.0 million incremental Term Loan B facility (the “TLB Facility”) that was added to our Amended and Restated Senior Credit Facility, subject to limited conditionality provisions. Borrowings under the TLB Facility were used to fund a portion of the purchase price for our acquisition of CRC.

The Company had $299.6 million of availability under the revolving line of credit as of December 31, 2014. Borrowings under the revolving line of credit are subject to customary conditions precedent to borrowing. The Amended and Restated Credit Agreement requires quarterly term loan principal repayments of our outstanding term loan A loans (“TLA Facility”) of $6.7 million for March 31, 2015 to December 31, 2015, $10.0 million for March 31, 2016 to December 31, 2016, $13.4 million for March 31, 2017 to December 31, 2017, and $16.7 million for March 31, 2018 to December 31, 2018, with the remaining principal balance of the TLA Facility due on the maturity date of February 13, 2019. On December 15, 2014, prior to the execution of the Sixth Amendment, the Company prepaid the December 31, 2014 quarterly term loan principal payment of $1.9 million. The Company is required to repay the TLB Facility in equal quarterly installments of $1.3 million on the last business day of each March, June, September and December, with the outstanding principal balance of the TLB Facility due on February 11, 2022.

Borrowings under the Amended and Restated Senior Credit Facility are guaranteed by each of the Company’s wholly-owned domestic subsidiaries (other than certain excluded subsidiaries) and are secured by a lien on substantially all of the assets of the Company and such subsidiaries. Borrowings with respect to the TLA Facility and the Company’s revolving credit facility (collectively, “Pro Rata Facilities”) under the Amended and Restated Credit Agreement bear interest at a rate tied to Acadia’s Consolidated Leverage Ratio (defined as consolidated funded debt net of up to $40.0 million of unrestricted and unencumbered cash to consolidated EBITDA, in each case as defined in the Amended and Restated Credit Agreement). The Applicable Rate (as defined in the Amended and Restated Credit Agreement) for the Pro Rata Facilities was 2.75% for Eurodollar Rate Loans (as defined in the Amended and Restated Credit Agreement) and 1.75% for Base Rate Loans (as defined in the Amended and Restated Credit Agreement) at December 31, 2014. Eurodollar Rate Loans with respect to the Pro Rata Facilities bear interest at the Applicable Rate plus the Eurodollar Rate (as defined in the Amended and Restated Credit Agreement) (based upon the LIBOR Rate (as defined in the Amended and Restated Credit Agreement) prior to commencement of the interest rate period). Base Rate Loans with respect to the Pro Rata Facilities bear interest at the Applicable Rate plus the highest of (i) the federal funds rate plus 0.50%, (ii) the prime rate and (iii) the Eurodollar Rate plus 1.0%. As of December 31, 2014, the Pro Rata Facilities bore interest at a rate of LIBOR plus 2.75%. In addition, we are required to pay a commitment fee on undrawn amounts under the revolving line of credit. We paid a commitment fee of 0.50% for undrawn amounts for the period from January 1, 2013 through February 12, 2014 and 0.40% for undrawn amounts for the period from February 13, 2014 through the date of the Sixth Amendment. Borrowings under the Pro Rata Facilities mature on February 13, 2019.

The Amended and Restated Credit Agreement requires the Company and its subsidiaries to comply with customary affirmative, negative and financial covenants, including a fixed charge coverage ratio, consolidated leverage ratio and senior secured leverage ratio. The Company may be required to pay all of its indebtedness immediately if it defaults on any of the numerous financial or other restrictive covenants contained in any of its material debt agreements. As of December 31, 2014, the Company was in compliance with such covenants.

12.875% Senior Notes due 2018

On November 1, 2011, the Company issued $150.0 million of 12.875% Senior Notes due 2018 (the “12.875% Senior Notes”) at 98.323% of the aggregate principal amount of $150.0 million, a discount of $2.5 million. The notes bear interest at a rate of 12.875% per annum. The Company pays interest on the notes semi-annually, in arrears, on November 1 and May 1 of each year.

The indenture governing the 12.875% Senior Notes contains covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to: (i) pay dividends, redeem stock or make other distributions or investments; (ii) incur additional debt or issue certain preferred stock; (iii) transfer or sell assets; (iv) engage in certain transactions with affiliates; (v) create restrictions on dividends or other payments by the restricted subsidiaries; (vi) merge, consolidate or sell substantially all of the Company’s assets; and (vii) create liens on assets.

The 12.875% Senior Notes issued by the Company are guaranteed by each of the Company’s subsidiaries that guarantee the Company’s obligations under the Amended and Restated Senior Credit Facility. The guarantees are full and unconditional and joint and several.

On March 12, 2013, the Company redeemed $52.5 million in principal amount of the 12.875% Senior Notes using a portion of the net proceeds of its December 2012 equity offering pursuant to the provision in the indenture permitting an optional redemption with equity proceeds of up to 35% of the principal amount of 12.875% Senior Notes. The 12.875% Senior Notes were redeemed at a redemption price of 112.875% of the principal amount thereof plus accrued and unpaid interest to, but not including, the redemption date in accordance with the provisions of the indenture governing the 12.875% Senior Notes. As part of the redemption of 35% of the 12.875% Senior Notes, the Company recorded a debt extinguishment charge of $9.4 million, including the premium and write-off of deferred financing costs, which was recorded in debt extinguishment costs in the consolidated statements of income.

6.125% Senior Notes due 2021

On March 12, 2013, the Company issued $150.0 million of 6.125% Senior Notes due 2021 (the “6.125% Senior Notes”). The 6.125% Senior Notes mature on March 15, 2021 and bear interest at a rate of 6.125% per annum, payable semi-annually in arrears on March 15 and September 15 of each year.

The indenture governing the 6.125% Senior Notes contains covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to: (i) pay dividends, redeem stock or make other distributions or investments; (ii) incur additional debt or issue certain preferred stock; (iii) transfer or sell assets; (iv) engage in certain transactions with affiliates; (v) create restrictions on dividends or other payments by the restricted subsidiaries; (vi) merge, consolidate or sell substantially all of the Company’s assets; and (vii) create liens on assets.

The 6.125% Senior Notes issued by the Company are guaranteed by each of the Company’s subsidiaries that guarantee the Company’s obligations under the Amended and Restated Senior Credit Facility. The guarantees are full and unconditional and joint and several.

The Company may redeem the 6.125% Senior Notes at its option, in whole or part, at any time prior to March 15, 2016, at a price equal to 100% of the principal amount of the 6.125% Senior Notes redeemed, plus accrued and unpaid interest to the redemption date and plus an applicable premium. The Company may redeem the 6.125% Senior Notes, in whole or in part, on or after March 15, 2016, at the redemption prices set forth in the indenture governing the 6.125% Senior Notes plus accrued and unpaid interest to the redemption date. At any time on or before March 15, 2016, the Company may elect to redeem up to 35% of the aggregate principal amount of the 6.125% Senior Notes at a redemption price equal to 106.125% of the principal amount thereof, plus accrued and unpaid interest to the redemption date, with the net proceeds of one or more equity offerings.

5.125% Senior Notes due 2022

On July 1, 2014, the Company issued $300.0 million of 5.125% Senior Notes. The 5.125% Senior Notes mature on July 1, 2022 and bear interest at a rate of 5.125% per annum, payable semi-annually in arrears on January 1 and July 1 of each year, beginning on January 1, 2015.

The indenture governing the 5.125% Senior Notes contains covenants that limit, among other things, the Company’s ability and the ability of its restricted subsidiaries to: (i) pay dividends, redeem stock or make other distributions or investments; (ii) incur additional debt or issue certain preferred stock; (iii) transfer or sell assets; (iv) engage in certain transactions with affiliates; (v) create restrictions on dividends or other payments by the restricted subsidiaries; (vi) merge, consolidate or sell substantially all of the Company’s assets and (vii) create liens on assets.

The 5.125% Senior Notes issued by the Company are guaranteed by each of the Company’s subsidiaries that guarantee the Company’s obligations under the Amended and Restated Senior Credit Facility. The guarantees are full and unconditional and joint and several.

The Company may redeem the 5.125% Senior Notes at its option, in whole or part, at any time prior to July 1, 2017, at a price equal to 100% of the principal amount of the 5.125% Senior Notes redeemed, plus accrued and unpaid interest to the redemption date and plus an applicable premium. The Company may redeem the 5.125% Senior Notes, in whole or in part, on or after July 1, 2017, at the redemption prices set forth in the indenture governing the 5.125% Senior Notes plus accrued and unpaid interest to the redemption date. At any time on or before July 1, 2017, the Company may elect to redeem up to 35% of the aggregate principal amount of the 5.125% Senior Notes at a redemption price equal to 105.125% of the principal amount thereof, plus accrued and unpaid interest to the redemption date, with the net proceeds of one or more equity offerings.

5.625% Senior Notes due 2023

On February 11, 2015, the Company issued $375.0 million of 5.625% Senior Notes due 2023. The 5.625% Senior Notes mature on February 15, 2023 and bear interest at a rate of 5.625% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on August 15, 2015.

The indenture governing the 5.625% Senior Notes contains covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to: (i) pay dividends, redeem stock or make other distributions or investments; (ii) incur additional debt or issue certain preferred stock; (iii) transfer or sell assets; (iv) engage in certain transactions with affiliates; (v) create restrictions on dividends or other payments by the restricted subsidiaries; (vi) merge, consolidate or sell substantially all of the Company’s assets and (vii) create liens on assets.

The 5.625% Senior Notes issued by the Company are guaranteed by each of the Company’s subsidiaries that guarantee the Company’s obligations under the Amended and Restated Senior Credit Facility. The guarantees are full and unconditional and joint and several.

The Company may redeem the 5.625% Senior Notes at its option, in whole or part, at any time prior to February 15, 2018, at a price equal to 100% of the principal amount of the 5.625% Senior Notes redeemed, plus accrued and unpaid interest to the redemption date and plus an applicable premium. We may redeem the 5.625% Senior Notes, in whole or in part, on or after February 15, 2018, at the redemption prices set forth in the indenture governing the 5.625% Senior Notes plus accrued and unpaid interest to the redemption date. At any time on or before February 15, 2018, the Company may elect to redeem up to 35% of the aggregate principal amount of the 5.625% Senior Notes at a redemption price equal to 105.625% of the principal amount thereof, plus accrued and unpaid interest to the redemption date, with the net proceeds of one or more equity offerings.

9.0% and 9.5% Revenue Bonds

On November 11, 2012, in connection with the acquisition of Park Royal, the Company assumed debt of $23.0 million. The fair market value of the debt assumed was $25.6 million and resulted in a debt premium balance being recorded as of the acquisition date. The debt consisted of $7.5 million and $15.5 million of Lee County (Florida) Industrial Development Authority Healthcare Facilities Revenue Bonds, Series 2010 with stated interest rates of 9.0% and 9.5% (“9.0% and 9.5% Revenue Bonds”), respectively. The 9.0% bonds in the amount of $7.5 million have a maturity date of December 1, 2030 and require yearly principal payments beginning in 2013. The 9.5% bonds in the amount of $15.5 million have a maturity date of December 1, 2040 and require yearly principal payments beginning in 2031. The principal payments establish a bond sinking fund to be held with the trustee and shall be sufficient to redeem the principal amounts of the 9.0% and 9.5% Revenue Bonds on their respective maturity dates. As of December 31, 2014 and December 31, 2013, $2.3 million was recorded within other assets on the balance sheet related to the debt service reserve fund requirements. The yearly principal payments, which establish a bond sinking fund, will increase the debt service reserve fund requirements. The bond premium amount of $2.6 million is amortized as a reduction of interest expense over the life of the revenue bonds using the effective interest method.

Other

The aggregate maturities of long-term debt as of December 31, 2014 were as follows (in thousands):


2015	$	26,965
2016		40,360
2017		53,755
2018		67,155
2019		340,555
Thereafter		568,835

Total	$	1,097,625

Equity	12 Months Ended
Equity	Dec. 31, 2014
Equity [Abstract]
Equity	8. Equity *Preferred Stock* The Company’s amended and restated certificate of incorporation provides that up to 10,000,000 shares of preferred stock may be issued. The Board of Directors has the authority to issue preferred stock in one or more series and to fix for each series the voting powers (full, limited or none), and the designations, preferences and relative participating, optional or other special rights and qualifications, limitations or restrictions on the stock and the number of shares constituting any series and the designations of this series, without any further vote or action by the stockholders. *Common Stock* The Company’s amended and restated certificate of incorporation provides that up to 90,000,000 shares of common stock may be issued. Holders of the Company’s common stock are entitled to one vote for each share held of record on all matters on which stockholders may vote. There are no preemptive, conversion, redemption or sinking fund provisions applicable to shares of the Company’s common stock. In the event of liquidation, dissolution or winding up, holders of the Company’s common stock are entitled to share ratably in the assets available for distribution, subject to any prior rights of any holders of preferred stock then outstanding. Delaware law prohibits the Company from paying any dividends unless it has capital surplus or net profits available for this purpose. In addition, the Amended and Restated Senior Credit Facility imposes restrictions on the Company’s ability to pay dividends. *Equity Offerings* On June 17, 2014, the Company completed the offering of 8,881,794 shares of common stock (including shares sold pursuant to the exercise of the over-allotment option that the Company granted to the underwriters as part of the offering) at a price of $44.00 per share. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discount of $15.6 million and additional offering-related expenses of $0.8 million, were $374.4 million. The Company used the net offering proceeds to fund a portion of the consideration for the acquisition of Partnerships in Care. On February 11, 2015, the Company completed its acquisition of CRC for total consideration of approximately $1.3 billion. As consideration for the acquisition, the Company issued 5,975,326 shares of its common stock to certain holders of CRC common stock and repaid CRC’s outstanding indebtedness.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph d
-Article 4

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Article 4

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

+ Details

Equity-Based Compensation

12 Months Ended

Dec. 31, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Equity-Based Compensation

9. Equity-Based Compensation

Equity Incentive Plans

The Company issues stock-based awards, including stock options, restricted stock and restricted stock units, to certain officers, employees and non-employee directors under the Acadia Healthcare Company, Inc. Incentive Compensation Plan (the “Equity Incentive Plan”). As of December 31, 2014, a maximum of 4,700,000 shares of the Company’s common stock were authorized for issuance as stock options, restricted stock and restricted stock units or other share-based compensation under the Equity Incentive Plan, of which 2,671,030 were available for future grant. Stock options may be granted for terms of up to ten years. The Company recognizes expense on all share-based awards on a straight-line basis over the requisite service period of the entire award. Grants to employees generally vest in annual increments of 25% each year, commencing one year after the date of grant. The exercise prices of stock options are equal to the most recent closing price of the Company’s common stock on the date of grant.

The Company recognized $10.1 million, $5.2 million and $2.3 million in equity-based compensation expense for the years ended December 31, 2014, 2013 and 2012, respectively. As of December 31, 2014, there was $31.3 million of unrecognized compensation expense related to unvested options, restricted stock and restricted stock units, which is expected to be recognized over the remaining weighted average vesting period of 1.5 years.

As of December 31, 2014, there were no warrants outstanding and exercisable. The Company recognized a deferred income tax benefit of $4.1 million and $2.1 million for the years ended December 31, 2014 and 2013, respectively, related to equity-based compensation expense. The actual tax benefit realized from stock options exercised during the years ended December 31, 2014 and 2013 was $4.6 million and $1.8 million, respectively. No tax benefits were recognized or realized during the year ended December 31, 2012.

Stock option activity during 2013 and 2014 was as follows (aggregate intrinsic value in thousands):


	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value
Options outstanding at January 1, 2013		555,097		$	13.13		7.53	$	5,632
Options granted		411,800			30.55		9.30		2,059
Options exercised		(126,662	)		9.36		N/A		2,803
Options cancelled		(41,426	)		23.50		N/A		N/A

Options outstanding at December 31, 2013		798,809			21.93		8.20		10,700
Options granted		226,663			49.80		9.25		209
Options exercised		(210,199	)		14.93		N/A		4,994
Options cancelled		(77,851	)		27.85		N/A		N/A

Options outstanding at December 31, 2014		737,422		$	32.19		8.09	$	14,512

Options exercisable at December 31, 2013		133,647		$	11.15		4.81	$	3,472

Options exercisable at December 31, 2014		91,947		$	28.87		6.30	$	3,326

Restricted stock activity during 2013 and 2014 was as follows:


	Number of Shares			Weighted Average Grant-Date Fair Value
Unvested at January 1, 2013		318,063		$	15.73
Granted		290,845			31.31
Cancelled		(53,056	)		21.27
Vested		(94,155	)		15.52

Unvested at December 31, 2013		461,697		$	24.96
Granted		468,484			48.99
Cancelled		(75,369	)		36.36
Vested		(132,784	)		22.81

Unvested at December 31, 2014		722,028		$	39.77

Restricted stock unit activity during 2013 and 2014 was as follows:


	Number of Units			Weighted Average Grant-Date Fair Value
Unvested at January 1, 2013		68,628		$	16.11
Granted		72,876			29.39
Cancelled		—			—
Vested		(45,753	)		16.11

Unvested at December 31, 2013		95,751		$	23.05
Granted		108,449			50.75
Cancelled		—			—
Vested		(79,087	)		21.81

Unvested at December 31, 2014		125,113		$	38.73

The grant-date fair value of the Company’s stock options is estimated using the Black-Scholes option pricing model. The following table summarizes the grant-date fair value of options and the assumptions used to develop the fair value estimates for options granted during the year ended December 31, 2014 and 2013:


	December 31, 2014			December 31, 2013

Weighted average grant-date fair value of options	$	17.14		$	11.62
Risk-free interest rate		1.7	%		1.0	%
Expected volatility		36	%		40	%
Expected life (in years)		5.5			5.5

The Company’s estimate of expected volatility for stock options is based upon the volatility of guideline companies given the lack of sufficient historical trading experience of the Company’s common stock. The risk-free interest rate is the approximate yield on United States Treasury Strips having a life equal to the expected option life on the date of grant. The expected life is an estimate of the number of years an option will be held before it is exercised.

Income Taxes

12 Months Ended

Dec. 31, 2014

Income Tax Disclosure [Abstract]

Income Taxes

10. Income Taxes

Income tax expense (benefit) from continuing operations consists of the following for the periods presented (in thousands):


	Year Ended December 31,
	2014		2013		2012
Current:
Federal	$	30,834	$	13,202	$	7,045
State		3,959		2,513		2,553
Foreign		914		177		—

Total current		35,707		15,892		9,598
Deferred:
Federal		2,667		7,802		3,144
State		353		1,786		(417	)
Foreign		4,195		495		—

Total deferred provision		7,215		10,083		2,727

Provision for (benefit from) income taxes	$	42,922	$	25,975	$	12,325

The following table presents the income taxes associated with continuing operations and discontinued operations as reflected in the consolidated statements of income (in thousands):


	Year Ended December 31,
	2014			2013			2012
Continuing operations	$	42,922		$	25,975		$	12,325
Discontinued operations		(22	)		(544	)		(197	)

Total	$	42,900		$	25,431		$	12,128

A reconciliation of the U.S. federal statutory rate, from continuing operations, to the effective tax rate is as follows for the periods presented:


	Year Ended December 31,
	2014			2013			2012
U.S. federal statutory rate on income before income taxes		35.0	%		35.0	%		35.0	%
Impact of foreign operations (1)		(4.2	)		(0.3	)		—
State income taxes, net of federal tax effect		2.3			4.9			3.8
Permanent differences		1.1			0.8			0.8
Change in valuation allowance		(0.1	)		(0.3	)		(0.9	)
Other		(0.1	)		(2.6	)		(1.2	)

Effective income tax rate		34.0	%		37.5	%		37.5	%

(1)

Our effective tax rate reflects the benefit of having a portion of our operations outside the U.S., most of which are taxed at statutory rates lower than the statutory U.S. rate of 35%, and the benefit of some income being partially exempt from income taxes due to various operating and financing activities.

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities of the Company at December 31, 2014 and December 31, 2013 were as follows (in thousands):


	December 31,
	2014			2013
Deferred tax assets:
Net operating losses and tax credit carryforwards – federal and state	$	5,082		$	905
Fixed asset basis difference		—			1,141
Bad debt allowance		9,028			7,490
Accrued compensation and severance		11,517			7,669
Pension reserves		1,975			—
Insurance reserves		4,621			2,680
Leases		850			1,083
Accrued expenses		41			91
Other assets		1,989			1,553

Total gross deferred tax assets		35,103			22,612
Less: valuation allowance		(4,734	)		(124	)

Deferred tax assets		30,369			22,488

Deferred tax liabilities:
Fixed asset basis difference		(38,147	)		—
Prepaid items		(1,705	)		(1,560	)
Intangible assets		(21,094	)		(13,196	)
Other liabilities		(7	)		—

Total deferred tax liabilities		(60,953	)		(14,756	)

Total net deferred tax (liability) asset	$	(30,584	)	$	7,732

The above amounts are classified as current or long-term in the consolidated balance sheets in accordance with the asset or liability to which they relate or, when applicable, based on the expected timing of the reversals of existing temporary differences. Current deferred tax assets at December 31, 2014 and 2013 were $20.2 million and $15.7 million, respectively. Non-current deferred tax assets at December 31, 2014 were $13.1 million. Non-current deferred tax liabilities at December 31, 2014 and 2013 were $63.9 million and $8.0 million, respectively.

The Company records a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized. As of December 31, 2014 and 2013, the Company carried a valuation allowance against deferred tax assets of $4.7 million and $0.1 million, respectively.

The Company fully utilized all federal net operating loss carryforwards as of the period ended December 31, 2012. The foreign net operating loss carryforward as of December 31, 2014 is approximately $23.7 million and has no expiration. In addition, the Company has certain foreign tax credits which do not have an expiration date.

The Company has state net operating loss carryfowards at December 31, 2014 and 2013 of approximately $7.1 million and $18.5 million, respectively. These net operating loss carryforwards, if not used to offset future taxable income, will expire from 2031 to 2033. In addition, the Company has certain state tax credits which will begin to expire in 2026 if not utilized.

Income taxes receivable was $3.4 million and $4.0 million at December 31, 2014 and 2013, respectively, and was included in other current assets in the consolidated balance sheet. Income taxes payable of $0.1 million at December 31, 2014 was included in other accrued liabilities in the consolidated balance sheet. In addition, income taxes payable of $2.4 million and $1.3 million at December 31, 2014 and 2013, respectively, were included in other liabilities in the consolidated balance sheet. The balance in other liabilities relates to certain unrecognized tax benefits.

A reconciliation of the beginning and ending amount of unrecognized income tax benefits is as follows (in thousands):


	2014		2013		2012
Balance at January 1	$	1,893	$	1,195	$	1,050
Additions based on tax positions related to the current year		—		321		262
Additions for tax positions of prior years		1,030		377		—
Reductions as a result of the lapse of applicable statutes of limitations		—		—		(117	)

Balance at December 31	$	2,923	$	1,893	$	1,195

The Company’s continuing accounting policy is to recognize interest and penalties related to income tax matters as a component of tax expense in the consolidated statements of income. The Company recognized interest and penalties relative to uncertain tax positions of $0.3 million and $0.1 million for the period ending December 31, 2014 and 2013, respectively. No interest or penalties were recognized relative to uncertain tax positions during the year ended December 31, 2012. It is possible the amount of unrecognized tax benefit could change in the next twelve months as a result of a lapse of the statute of limitations and settlements with taxing authorities; however, management does not anticipate the change will have a material impact on the Company’s consolidated financial statements.

The Company’s uncertain tax positions are related to tax years that remain subject to examination by the relevant taxing authorities. The Company and its subsidiaries file income tax returns in federal and in many state and local jurisdictions as well as foreign jurisdictions. The Company may be subject to examination by the Internal Revenue Service (“IRS”) for calendar year 2011 through 2014. Additionally, any net operating losses that were generated in prior years and utilized in these years may also be subject to examination by the IRS. In foreign jurisdictions, the Company may be subject to examination for calendar years 2010 through 2014. Generally, for state tax purposes, the Company’s 2010 through 2014 tax years remain open for examination by the tax authorities. At the date of this report there were no audits or inquires that had progressed sufficiently to predict their ultimate outcome.

One of the Company’s Puerto Rico subsidiaries was granted a tax exemption for which a tax credit of up to 15% of eligible payroll expenses is available to offset up to 50% of the income taxes attributed to that entity. The tax exemption will expire on December 31, 2017.

The Company does not provide for U.S. income taxes on the undistributed earnings of its foreign subsidiaries as it is the Company’s intention to utilize those earnings in the foreign operations for an indefinite period of time. At December 31, 2014, undistributed earnings of the foreign subsidiaries amounted to approximately $20.7 million. The amount of unrecognized deferred tax liability related to these temporary differences is not practicable at this time as this could be significantly impacted by the source location and amount of the distribution, the underlying tax rate already paid on the earnings, foreign withholding taxes, and the opportunity to use foreign tax credits.

Derivatives	12 Months Ended
Derivatives	Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	11. Derivatives The Company entered into two foreign currency forward contracts in June 2014 in connection with the Partnerships in Care acquisition. The foreign currency forward contracts limited the economic risk of changes in the foreign exchange rate between US Dollars (“USD”) and British Pounds (“GBP”) associated with the payment of the purchase price in GBP on July 1, 2014. These foreign currency forward contracts did not meet the hedge accounting criteria under Accounting Standards Codification 815, Derivatives and Hedging. As such, gains associated with changes in fair value of $15.3 million for the year ended December 31, 2014 have been recorded in the consolidated statements of income. The final fair value of the foreign currency forward contracts settled on July 1, 2014.

- Definition

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35706170&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=35706170&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=35706170&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Fair Value Measurements

12 Months Ended

Dec. 31, 2014

Fair Value Disclosures [Abstract]

Fair Value Measurements

12. Fair Value Measurements

The carrying amounts reported for cash and cash equivalents, accounts receivable, other current assets, accounts payable and other current liabilities approximate fair value because of the short-term maturity of these instruments.

The carrying amounts and fair values of the Company’s Amended and Restated Senior Credit Facility, 12.875% Senior Notes, 6.125% Senior Notes, 5.125% Senior Notes, 9.0% and 9.5% Revenue Bonds and contingent consideration liability as of December 31, 2014 and 2013 were as follows (in thousands):


	Carrying Amount				Fair Value
	December 31,				December 31,
	2014		2013		2014		2013
Amended and Restated Senior Credit Facility	$	525,576	$	346,000	$	525,576	$	346,000

12.875% Senior Notes due 2018	$	96,420	$	96,216	$	109,688	$	118,706

6.125% Senior Notes due 2021	$	150,000	$	150,000	$	153,000	$	155,625

5.125% Senior Notes due 2022	$	300,000		—	$	295,500		—

9.0% and 9.5% Revenue Bonds	$	24,274	$	24,920	$	24,274	$	24,920

Contingent consideration liabilities	$	3,000	$	6,500	$	3,000	$	6,500

The Company’s Amended and Restated Senior Credit Facility, 12.875% Senior Notes, 6.125% Senior Notes, 5.125% Senior Notes and 9.0% and 9.5% Revenue Bonds were categorized as Level 2 in the GAAP fair value hierarchy. Fair values were based on trading activity among the Company’s lenders and the average bid and ask price as determined using published rates.

The fair value of the contingent consideration liabilities were categorized as Level 3 in the GAAP fair value hierarchy. The contingent consideration liabilities were valued using a probability-weighted discounted cash flow method. This analysis reflected the contractual terms of the purchase agreements and utilized assumptions with regard to future earnings, probabilities of achieving such future earnings and a discount rate. Significant increases with respect to assumptions as to future earnings and probabilities of achieving such future earnings would result in higher fair value measurement while an increase in the discount rate would result in a lower fair value measurement. During the year ended December 31, 2014, the Company changed its projections of the timing of future payments for the Park Royal contingent consideration liability. This change resulted in a $0.5 million increase in the fair value of the contingent consideration liability, which was recorded in transaction-related expenses in the consolidated statements of income. During the year ended December 31, 2014, the Company paid $5.0 million of the estimated $7.0 million Park Royal contingent consideration liability as a result of the facility achieving certain earnings targets. The Company may make an earn-out payment of up to $6.0 million, contingent upon achievement by McCallum of certain operating performance targets for the one-year period ending October 31, 2015. During the year ended December 31, 2014, the Company changed its probability of achieving future earnings for the McCallum contingent consideration liability. This change resulted in a $0.5 million decrease in the fair value of the contingent consideration liability, which was recorded in transaction-related expenses in the consolidated statements of income.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Leases

12 Months Ended

Dec. 31, 2014

Leases [Abstract]

Leases

13. Leases

The Company is obligated under certain operating leases to rent space for its facilities and other office space. The original terms of the leases typically range from five to ten years, with optional renewal periods.

Aggregate minimum lease payments under non-cancelable operating leases with original or remaining lease terms in excess of one year were as follows as of December 31, 2014 (in thousands):


2015	$	9,951
2016		8,976
2017		6,439
2018		4,118
2019		2,678
Thereafter		18,551

Total minimum rental obligations	$	50,713

During the years ended December 31, 2014, 2013 and 2012, rent expense was $12.2 million, $10.0 million and $7.8 million, respectively.

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	14. Commitments and Contingencies The Company is, from time to time, subject to various claims and legal actions that arise in the ordinary course of the Company’s business, including claims for damages for personal injuries, medical malpractice, breach of contract, tort and employment related claims. In these actions, plaintiffs request a variety of damages, including, in some instances, punitive and other types of damages that may not be covered by insurance. In the opinion of management, the Company is not currently a party to any proceeding that would individually or in the aggregate have a material adverse effect on the Company’s business, financial condition or results of operations.

Segment Information

12 Months Ended

Dec. 31, 2014

Segment Reporting [Abstract]

Segment Information

15. Segment Information

The Company operates in one line of business, which is operating acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers and facilities providing outpatient behavioral healthcare services. As management reviews the operating results of its facilities in the United States (the U.S. Facilities) and its facilities in the United Kingdom (the U.K. Facilities) separately to assess performance and make decisions, the Company’s operating segments include its U.S. Facilities and U.K. Facilities. At December 31, 2014, the U.S. Facilities included 54 behavioral healthcare facilities with approximately 4,600 beds in 24 states and Puerto Rico, and the U.K. Facilities included 24 behavioral healthcare facilities with approximately 1,300 beds in the United Kingdom.

The following tables set forth the financial information by operating segment, including a reconciliation of Segment EBITDA to income from continuing operations before income taxes (in thousands):


	Year Ended December 31,
	2014			2013			2012

Revenue:
U.S. Facilities	$	850,625		$	710,695		$	406,718
U.K. Facilities		151,127			—			—
Corporate and Other		2,849			2,713			743

	$	1,004,601		$	713,408		$	407,461


Segment EBITDA (1):
U.S. Facilities	$	209,668		$	172,625		$	102,443
U.K. Facilities		39,832			—			—
Corporate and Other		(34,012	)		(27,291	)		(21,484	)

	$	215,488		$	145,334		$	80,959


	Year Ended December 31,
	2014			2013			2012

Segment EBITDA (1)	$	215,488		$	145,334		$	80,959
Plus (less):
Equity-based compensation expense		(10,058	)		(5,249	)		(2,267	)
Gain on foreign currency derivatives		15,262			—			—
Debt extinguishment costs		—			(9,350	)		—
Transaction-related expenses		(13,650	)		(7,150	)		(8,112	)
Interest expense, net		(48,221	)		(37,250	)		(29,769	)
Depreciation and amortization		(32,667	)		(17,090	)		(7,982	)

Income (loss) from continuing operations before income taxes	$	126,154		$	69,245		$	32,829


	U.S. Facilities		U.K. Facilities			Corporate and Other		Consolidated
Goodwill:
Balance at January 1, 2014	$	661,549	$	—		$	—	$	661,549
Increase from 2014 acquisitions		31,951		120,364			—		152,315
Foreign currency translation loss		—		(11,323	)		—		(11,323	)
Other		445		—			—		445

Balance at December 31, 2014	$	693,945	$	109,041		$	—	$	802,986


	December 31,
	2014		2013
Assets (2):
U.S. Facilities	$	1,327,563	$	1,155,813
U.K. Facilities		726,693		—
Corporate and Other		169,334		68,846

	$	2,223,590	$	1,224,659

(1)

Segment EBITDA is defined as income from continuing operations before provision for income taxes, equity-based compensation expense, debt extinguishment costs, gain on foreign currency derivatives, transaction-related expenses, interest expense and depreciation and amortization. The Company uses Segment EBITDA as an analytical indicator to measure the performance of the Company’s segments and to develop strategic objectives and operating plans for those segments. Segment EBITDA is commonly used as an analytical indicator within the health care industry, and also serves as a measure of leverage capacity and debt service ability. Segment EBITDA should not be considered as a measure of financial performance under generally accepted accounting principles, and the items excluded from Segment EBITDA are significant components in understanding and assessing financial performance. Because Segment EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, Segment EBITDA, as presented, may not be comparable to other similarly titled measures of other companies.

(2)

Assets include property and equipment for the U.S. Facilities of $478.1 million, U.K. Facilities of $578.6 million and corporate and other of $13.0 million at December 31, 2014. Assets include property and equipment for the U.S. Facilities of $358.7 million and corporate and other of $11.4 million at December 31, 2013.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

+ Details

Employee Benefit Plans

12 Months Ended

Dec. 31, 2014

Compensation and Retirement Disclosure [Abstract]

Employee Benefit Plans

16. Employee Benefit Plans

Defined Contribution Plan

The Company maintains a qualified defined contribution 401(k) plan covering substantially all of its employees in the United States. The Company may, at its discretion, make contributions to the plan. For the years ended December 31, 2014, 2013 and 2012, the Company contributed $0.1 million, $0.3 million and $0.1 million, respectively, to the 401(k) plan.

Partnerships in Care Pension Plan

As part of the acquisition of Partnerships in Care on July 1, 2014, the Company assumed a frozen contributory defined benefit retirement plan (“Partnerships in Care Pension Plan”) covering substantially all of the employees of Partnerships in Care and its subsidiaries prior to May 1, 2005. The benefits under the Partnerships in Care Pension Plan are primarily based on years of service and final average earnings.

The Company accounts for the Partnerships in Care Pension Plan in accordance with ASC 715-30 “Compensation — Defined Benefit Plans”, (“ASC 715-30”). In accordance with ASC 715-30, the Company recognizes the unfunded liability of the Partnerships in Care Pension Plan on the Company’s consolidated balance sheet and unrecognized gains (losses) and prior service credits (costs) as changes in other comprehensive income (loss). The measurement date of the Partnerships in Care Pension Plan’s assets and liabilities coincides with the Company’s year-end. The Company’s pension benefit obligation is measured using actuarial calculations that incorporate discount rates, rate of compensation increases, when applicable, expected long-term returns on plan assets and consider expected age of retirement and mortality. Expected return on plan assets is determined by using the specific asset distribution at the measurement date.

The Partnerships in Care Pension Plan pension liability was $7.6 million as of July 1, 2014. The following table summarizes the funded status of the Partnerships in Care Pension Plan based upon actuarial valuations prepared as of the most recent valuation date of December 31, 2014 (in thousands):


Reconciliation of funded status:
Projected benefit obligation	$	66,910
Fair value of plan assets		57,356

Funded status	$	9,554

The following table summarizes changes in the Partnerships in Care Pension Plan pension liability (in thousands):


Pension liability at July 1, 2014	$	7,602
Employer contributions		(825	)
Net pension benefit expense		729
Pension liability adjustment		2,758
Foreign currency translation loss		(710	)

Pension liability at December 31, 2014	$	9,554

A pension liability of $9.6 million is recorded within other liabilities on the consolidated balance sheet as of December 31, 2014. The following assumptions were used to determine the plan benefit obligation:


Discount rate	3.6	%
Compensation increase rate	3.4	%
Measurement date	December 31, 2014

A summary of the components of net pension plan expense for the six months ended December 31, 2014 is as follows (in thousands):


Interest cost on projected benefit obligation	$	1,389
Service cost on projected benefit obligation		545
Expected return on assets		(1,205	)

Total pension plan expense	$	729

Assumptions used to determine the net periodic pension plan expense for the six months ended December 31, 2014 were as follows:


Discount rate	3.6	%
Expected long-term rate of return on plan assets	4.3	%

The Company recognizes changes in the funded status of the pension plan as a direct increase or decrease to stockholders’ equity through accumulated other comprehensive income. The accumulated other comprehensive loss related to the Partnerships in Care Pension Plan for the year ended December 31, 2014 was $2.8 million ($2.2 million net of taxes).

The trustees of the Partnerships in Care Pension Plan are required to invest assets in the best interest of the Partnerships in Care Pension Plan’s members and also ensure liquid assets are available to make benefit payments as they become due. Performance of the Partnerships in Care Pension Plan’s assets are monitored quarterly, at a minimum, and asset allocations are adjusted as needed. The Partnerships in Care Pension Plan’s weighted-average asset allocations by asset category as of December 31, 2014 were as follows:


Cash and cash equivalents	1.3	%
United Kingdom government obligation	16.1	%
Equity securities	43.6	%
Debt securities	34.1	%
Other	4.9	%

As of December 31, 2014, the Partnerships in Care Pension Plan cash and cash equivalents were classified as Level 1 in the GAAP fair value hierarchy. Fair values were based on utilizing quoted prices (unadjusted) in active markets for identical assets. The United Kingdom government obligations, equity securities, debt securities and other investments were classified as Level 2 in the GAAP fair value hierarchy. Fair values were based on data points that are observable, such as quoted prices, interest rates and yield curves.

Quarterly Information (Unaudited)

12 Months Ended

Dec. 31, 2014

Quarterly Financial Information Disclosure [Abstract]

Quarterly Information (Unaudited)

17. Quarterly Information (Unaudited)

The tables below present summarized unaudited quarterly results of operations for the years ended December 31, 2014 and 2013. Management believes that all necessary adjustments have been included in the amounts stated below for a fair presentation of the results of operations for the periods presented when read in conjunction with the Company’s consolidated financial statements for the years ended December 31, 2013 and 2012. Results of operations for a particular quarter are not necessarily indicative of results of operations for an annual period and are not predictive of future periods.


	Quarter Ended
	March 31,			June 30,			September 30,			December 31,
	(In thousands except per share amounts)
2014:
Revenue	$	201,418		$	213,803		$	294,479		$	294,901
Income from continuing operations before income taxes	$	20,796		$	37,362	(1)	$	33,156	(1)	$	34,840
Net income	$	13,058		$	22,451	(1)	$	25,402	(1)	$	22,129
Basic net income per share	$	0.26		$	0.43	(1)	$	0.43	(1)	$	0.38
Diluted net income per share	$	0.26		$	0.43	(1)	$	0.43	(1)	$	0.37

2013:
Revenue	$	161,213		$	177,494		$	184,702		$	189,999
Income from continuing operations before income taxes	$	6,732	(2)	$	20,291		$	22,287		$	19,935
Net income	$	3,738	(2)	$	12,197		$	14,364		$	12,280
Basic net income per share	$	0.07	(2)	$	0.24		$	0.29		$	0.25
Diluted net income per share	$	0.07	(2)	$	0.24		$	0.29		$	0.24

(1)	Includes gain on foreign currency derivatives of $13.7 million and $1.5 million, in connection with the Partnerships in Care acquisition, for the three months ended June 30, 2014 and September 30, 2014, respectively.

(2)	Includes debt extinguishment costs of $9.4 million, or $5.8 million net of taxes, in connection with the redemption of $52.5 million of the 12.875% Senior Notes on March 12, 2013.

Subsequent Events	12 Months Ended
Subsequent Events	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events	18. Subsequent Events On February 11, 2015, the Company completed its acquisition of CRC for total consideration of approximately $1.3 billion. CRC is a leading provider of treatment services related to substance abuse and other addiction and behavioral disorders. At the acquisition date, CRC operated 35 inpatient facilities with over 2,400 beds and 81 comprehensive treatment centers located in 30 states. In connection with the CRC acquisition, on February 11, 2015, the Company issued 5,975,326 shares of its common stock to certain holders of CRC common stock, borrowed $500.0 million under its TLB Facility and $25.0 million under its revolving credit facility, and issued $375.0 million of 5.625% Senior Notes. See Note 4 – Acquisitions and Note 7 – Long-Term Debt for additional details.

Financial Information for the Company and Its Subsidiaries

12 Months Ended

Dec. 31, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Financial Information for the Company and Its Subsidiaries

19. Financial Information for the Company and Its Subsidiaries

The Company conducts substantially all of its business through its subsidiaries. The 12.875% Senior Notes, 6.125% Senior Notes, 5.125% Senior Notes and 5.625% Senior Notes are jointly and severally guaranteed on an unsecured senior basis by all of the Company’s subsidiaries that guarantee the Company’s obligations under the Amended and Restated Senior Credit Facility. Presented below is condensed consolidating financial information for the Company and its subsidiaries as of December 31, 2014 and 2013, and for the years ended December 31, 2014, 2013 and 2012. The information segregates the parent company (Acadia Healthcare Company, Inc.), the combined wholly-owned subsidiary guarantors, the combined non-guarantor subsidiaries and eliminations.

Acadia Healthcare Company, Inc.

Condensed Consolidating Balance Sheets

December 31, 2014

(In thousands)


	Parent		Combined Subsidiary Guarantors		Combined Non- Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Current assets:
Cash and cash equivalents	$	—	$	76,685	$	17,355	$	—		$	94,040
Accounts receivable, net		—		100,797		17,581		—			118,378
Deferred tax assets		—		18,395		1,760		—			20,155
Other current assets		—		36,049		5,521		—			41,570

Total current assets		—		231,926		42,217		—			274,143
Property and equipment, net		—		451,943		617,757		—			1,069,700
Goodwill		—		596,611		206,375		—			802,986
Intangible assets, net		—		19,057		2,579		—			21,636
Deferred tax assets – noncurrent		4,563		—		14,244		(5,666	)		13,141
Investment in subsidiaries		1,759,337		—		—		(1,759,337	)		—
Other assets		202,708		18,727		2,323		(181,774	)		41,984

Total assets	$	1,966,608	$	1,318,264	$	885,495	$	(1,946,777	)	$	2,223,590

Current liabilities:
Current portion of long-term debt	$	26,750	$	—	$	215	$	—		$	26,965
Accounts payable		—		39,486		9,210		—			48,696
Accrued salaries and benefits		—		47,597		11,720		—			59,317
Other accrued liabilities		13,647		7,688		9,621		—			30,956

Total current liabilities		40,397		94,771		30,766		—			165,934
Long-term debt		1,045,246		—		205,833		(181,774	)		1,069,305
Deferred tax liabilities – noncurrent		—		21,027		48,519		(5,666	)		63,880
Other liabilities		—		33,321		10,185		—			43,506

Total liabilities		1,085,643		149,119		295,303		(187,440	)		1,342,625

Total equity		880,965		1,169,145		590,192		(1,759,337	)		880,965

Total liabilities and equity	$	1,966,608	$	1,318,264	$	885,495	$	(1,946,777	)	$	2,223,590

Acadia Healthcare Company, Inc.

Condensed Consolidating Balance Sheets

December 31, 2013

(In thousands)


	Parent		Combined Subsidiary Guarantors		Combined Non- Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Current assets:
Cash and cash equivalents	$	—	$	—	$	6,494	$	(1,925	)	$	4,569
Accounts receivable, net		—		86,597		9,288		—			95,885
Deferred tax assets		—		15,284		419		—			15,703
Other current assets		—		27,886		1,083		—			28,969

Total current assets		—		129,767		17,284		(1,925	)		145,126
Property and equipment, net		—		340,175		29,934		—			370,109
Goodwill		—		564,539		97,010		—			661,549
Intangible assets, net		—		18,578		1,990		—			20,568
Investment in subsidiaries		1,034,160		—		—		(1,034,160	)		—
Other assets		46,236		11,675		8,082		(38,686	)		27,307

Total assets	$	1,080,396	$	1,064,734	$	154,300	$	(1,074,771	)	$	1,224,659

Current liabilities:
Current portion of long-term debt	$	15,000	$	—	$	195	$	—		$	15,195
Accounts payable		—		36,289		1,662		(1,925	)		36,026
Accrued salaries and benefits		—		36,027		1,694		—			37,721
Other accrued liabilities		4,876		19,982		890		—			25,748

Total current liabilities		19,876		92,298		4,441		(1,925	)		114,690
Long-term debt		577,216		—		57,650		(32,925	)		601,941
Deferred tax liabilities – noncurrent		2,594		11,138		—		(5,761	)		7,971
Other liabilities		—		19,347		—		—			19,347

Total liabilities		599,686		122,783		62,091		(40,611	)		743,949

Total equity		480,710		941,951		92,209		(1,034,160	)		480,710

Total liabilities and equity	$	1,080,396	$	1,064,734	$	154,300	$	(1,074,771	)	$	1,224,659

Acadia Healthcare Company, Inc.

Condensed Consolidating Statement of Comprehensive Income

Year Ended December 31, 2014

(In thousands)


	Parent			Combined Subsidiary Guarantors			Combined Non- Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Revenue before provision for doubtful accounts	$	—		$	826,465		$	204,319		$	—		$	1,030,784
Provision for doubtful accounts		—			(23,866	)		(2,317	)		—			(26,183	)

Revenue		—			802,599			202,002			—			1,004,601
Salaries, wages and benefits		10,058			459,297			106,057			—			575,412
Professional fees		—			38,632			13,850			—			52,482
Supplies		—			40,511			7,911			—			48,422
Rents and leases		—			10,136			2,065			—			12,201
Other operating expenses		—			83,835			26,819			—			110,654
Depreciation and amortization		—			22,990			9,677			—			32,667
Interest expense, net		27,199			6,207			14,815			—			48,221
Gain on foreign currency derivatives		(15,262	)		—			—			—			(15,262	)
Transaction-related expenses		—			12,367			1,283			—			13,650

Total expenses		21,995			673,975			182,477			—			878,447
(Loss) income from continuing operations before income taxes		(21,995	)		128,624			19,525			—			126,154
Equity in earnings of subsidiaries		97,414			—			—			(97,414	)		—
(Benefit from) provision for income taxes		(7,621	)		44,608			5,935			—			42,922

Income (loss) from continuing operations		83,040			84,016			13,590			(97,414	)		83,232
Loss from discontinued operations, net of income taxes		—			(192	)		—			—			(192	)

Net income (loss)	$	83,040		$	83,824		$	13,590		$	(97,414	)	$	83,040

Other comprehensive loss:
Foreign currency translation loss		—			—			(66,206	)		—			(66,206	)
Pension liability adjustment, net		—			—			(2,164	)		—			(2,164	)

Other comprehensive loss		—			—			(68,370	)		—			(68,370	)

Comprehensive income (loss)	$	83,040		$	83,824		$	(54,780	)	$	(97,414	)	$	14,670

Acadia Healthcare Company, Inc.

Condensed Consolidating Statement of Comprehensive Income

Year Ended December 31, 2013

(In thousands)


	Parent			Combined Subsidiary Guarantors			Combined Non- Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Revenue before provision for doubtful accounts	$	—		$	700,407		$	34,702		$	—		$	735,109
Provision for doubtful accounts		—			(20,700	)		(1,001	)		—			(21,701	)

Revenue		—			679,707			33,701			—			713,408
Salaries, wages and benefits		5,249			388,749			13,964			—			407,962
Professional fees		—			34,149			3,022			—			37,171
Supplies		—			35,686			1,883			—			37,569
Rents and leases		—			9,282			767			—			10,049
Other operating expenses		—			72,626			7,946			—			80,572
Depreciation and amortization		—			15,882			1,208			—			17,090
Interest expense, net		35,327			22			1,901			—			37,250
Debt extinguishment costs		9,350			—			—			—			9,350
Transaction-related expenses		—			6,716			434			—			7,150

Total expenses		49,926			563,112			31,125			—			644,163
(Loss) income from continuing operations before income taxes		(49,926	)		116,595			2,576			—			69,245
Equity in earnings of subsidiaries		73,538			—			—			(73,538	)		—
(Benefit from) provision for income taxes		(18,967	)		44,294			648			—			25,975

Income (loss) from continuing operations		42,579			72,301			1,928			(73,538	)		43,270
Loss from discontinued operations, net of income taxes		—			(691	)		—			—			(691	)

Net income (loss)	$	42,579		$	71,610		$	1,928		$	(73,538	)	$	42,579

Comprehensive income (loss)	$	42,579		$	71,610		$	1,928		$	(73,538	)	$	42,579

Acadia Healthcare Company, Inc.

Condensed Consolidating Statement of Comprehensive Income

Year Ended December 31, 2012

(In thousands)


	Parent			Combined Subsidiary Guarantors			Combined Non- Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Revenue before provision for doubtful accounts	$	—		$	412,161		$	1,689		$	—		$	413,850
Provision for doubtful accounts		—			(6,389	)		—			—			(6,389	)

Revenue		—			405,772			1,689			—			407,461
Salaries, wages and benefits		2,267			236,182			1,190			—			239,639
Professional fees		—			18,806			213			—			19,019
Supplies		—			19,382			114			—			19,496
Rents and leases		—			7,816			22			—			7,838
Other operating expenses		—			42,121			656			—			42,777
Depreciation and amortization		—			7,874			108			—			7,982
Interest expense, net		29,512			—			257			—			29,769
Transaction-related expenses		—			8,112			—			—			8,112

Total expenses		31,779			340,293			2,560			—			374,632
(Loss) income from continuing operations before income taxes		(31,779	)		65,479			(871	)		—			32,829
Equity in earnings of subsidiaries		40,251			—			—			(40,251	)		—
(Benefit from) provision for income taxes		(11,931	)		24,583			(327	)		—			12,325

Income (loss) from continuing operations		20,403			40,896			(544	)		(40,251	)		20,504
Loss from discontinued operations, net of income taxes		—			(101	)		—			—			(101	)

Net income (loss)	$	20,403		$	40,795		$	(544	)	$	(40,251	)	$	20,403

Comprehensive income (loss)	$	20,403		$	40,795		$	(544	)	$	(40,251	)	$	20,403

Acadia Healthcare Company, Inc.

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2014

(In thousands)


	Parent			Combined Subsidiary Guarantors			Combined Non- Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Operating activities:
Net income (loss)	$	83,040		$	83,824		$	13,590		$	(97,414	)	$	83,040
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:
Equity in earnings of subsidiaries		(97,414	)		—			—			97,414			—
Depreciation and amortization		—			22,990			9,677			—			32,667
Amortization of debt issuance costs		2,748			—			450			—			3,198
Equity-based compensation expense		10,058			—			—			—			10,058
Deferred income tax (benefit) expense		(1,969	)		5,231			3,953			—			7,215
Loss from discontinued operations, net of taxes		—			192			—			—			192
Gain on foreign currency derivatives		(15,262	)		—			—			—			(15,262	)
Other		—			449			39			—			488
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net		—			(13,636	)		(1,474	)		—			(15,110	)
Other current assets		—			(2,205	)		194			—			(2,011	)
Other assets		(1,151	)		(6,910	)		397			1,151			(6,513	)
Accounts payable and other accrued liabilities		—			(5,559	)		8,352			—			2,793
Accrued salaries and benefits		—			11,035			945			—			11,980
Other liabilities		—			1,769			980			—			2,749

Net cash (used in) provided by continuing operating activities		(19,950	)		97,180			37,103			1,151			115,484
Net cash used in discontinued operating activities		—			(198	)		—			—			(198	)

Net cash (used in) provided by operating activities		(19,950	)		96,982			37,103			1,151			115,286
Investing activities:
Cash paid for acquisitions, net of cash acquired		—			(723,064	)		(15,638	)		—			(738,702	)
Cash paid for capital expenditures		—			(83,864	)		(29,380	)		—			(113,244	)
Cash paid for real estate acquisitions		—			(23,177	)		—			—			(23,177	)
Settlement of foreign currency derivatives		15,262			—			—			—			15,262
Other		—			(913	)		—			—			(913	)

Net cash used in investing activities		15,262			(831,018	)		(45,018	)		—			(860,774	)
Financing activities:
Borrowings on long-term debt		542,500			—			—			—			542,500
Borrowings on revolving credit facility		230,500			—			—			—			230,500
Principal payments on revolving credit facility		(284,000	)		—			—			—			(284,000	)
Principal payments on long-term debt		(7,500	)		—			(1,346	)		1,151			(7,695	)
Payment of debt issuance costs		(12,993	)		—			—			—			(12,993	)
Issuance of common stock, net		374,431			—			—			—			374,431
Common stock withheld for minimum statutory taxes, net		(4,099	)		—			—			—			(4,099	)
Excess tax benefit from equity awards		4,617			—			—			—			4,617
Cash paid for contingent consideration		—			(5,000	)		—			—			(5,000	)
Other		—			(289	)		—			—			(289	)
Cash (used in) provided by intercompany activity		(838,768	)		816,010			23,135			(377	)		—

Net cash provided by financing activities		4,688			810,721			21,789			774			837,972

Effect of exchange rate changes on cash		—			—			(3,013	)		—			(3,013	)

Net increase in cash and cash equivalents		—			76,685			10,861			1,925			89,471
Cash and cash equivalents at beginning of the period		—			—			6,494			(1,925	)		4,569

Cash and cash equivalents at end of the period	$	—		$	76,685		$	17,355		$	—		$	94,040

Acadia Healthcare Company, Inc.

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2013

(In thousands)


	Parent			Combined Subsidiary Guarantors			Combined Non- Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Operating activities:
Net income (loss)	$	42,579		$	71,610		$	1,928		$	(73,538	)	$	42,579
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:
Equity in earnings of subsidiaries		(73,538	)		—			—			73,538			—
Depreciation and amortization		—			15,882			1,208			—			17,090
Amortization of debt issuance costs		2,725			—			(461	)		—			2,264
Equity-based compensation expense		5,249			—			—			—			5,249
Deferred income tax expense		(754	)		10,278			559			—			10,083
Loss from discontinued operations, net of taxes		—			691			—			—			691
Debt extinguishment costs		9,350			—			—			—			9,350
Other		—			21			—			—			21
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net		—			(22,768	)		1,526			—			(21,242	)
Other current assets		—			(3,774	)		122			—			(3,652	)
Other assets		—			(1,950	)		(289	)		—			(2,239	)
Accounts payable and other accrued liabilities		—			(287	)		(561	)		—			(848	)
Accrued salaries and benefits		—			2,161			642			—			2,803
Other liabilities		—			3,181			—			—			3,181

Net cash (used in) provided by continuing operating activities		(14,389	)		75,045			4,674			—			65,330
Net cash used in discontinued operating activities		—			232			—			—			232

Net cash (used in) provided by operating activities		(14,389	)		75,277			4,674			—			65,562
Investing activities:
Cash paid for acquisitions, net of cash acquired		—			(164,019	)		—			—			(164,019	)
Cash paid for capital expenditures		—			(68,497	)		(444	)		—			(68,941	)
Cash paid for real estate acquisitions		—			(8,092	)		—			—			(8,092	)
Other		—			(1,926	)		—			—			(1,926	)

Net cash used in investing activities		—			(242,534	)		(444	)		—			(242,978	)
Financing activities:
Borrowings on long-term debt		150,000			—			—			—			150,000
Borrowings on revolving credit facility		61,500			—			—			—			61,500
Principal payments on revolving credit facility		(8,000	)		—			—			—			(8,000	)
Principal payments on long-term debt		(7,500	)		—			(180	)		—			(7,680	)
Repayment of long-term debt		(52,500	)		—			—			—			(52,500	)
Payment of debt issuance costs		(4,307	)		—			—			—			(4,307	)
Payment of premium on note redemption		(6,759	)		—			—			—			(6,759	)
Issuance of common stock, net		(205	)		—			—			—			(205	)
Common stock withheld for minimum statutory taxes, net		(1,242	)		—			—			—			(1,242	)
Excess tax benefit from equity awards		1,779			—			—			—			1,779
Cash (used in) provided by intercompany activity		(118,377	)		117,950			2,352			(1,925	)		—

Net cash (used in) provided by financing activities		14,389			117,950			2,172			(1,925	)		132,586

Net (decrease) increase in cash and cash equivalents		—			(49,307	)		6,402			(1,925	)		(44,830	)
Cash and cash equivalents at beginning of the period		—			49,307			92			—			49,399

Cash and cash equivalents at end of the period	$	—		$	—		$	6,494		$	(1,925	)	$	4,569

Acadia Healthcare Company, Inc.

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2012

(In thousands)


	Parent			Combined Subsidiary Guarantors			Combined Non- Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Operating activities:
Net income (loss)	$	20,403		$	40,795		$	(544	)	$	(40,251	)	$	20,403
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:
Equity in earnings of subsidiaries		(40,251	)		—			—			40,251			—
Depreciation and amortization		—			7,874			108			—			7,982
Amortization of debt issuance costs		2,507			—			—			—			2,507
Equity-based compensation expense		2,267			—			—			—			2,267
Deferred income tax expense		(519	)		3,376			(10	)		—			2,847
Other		—			(3	)		—			—			(3	)
Loss from discontinued operations, net of taxes		—			101			—			—			101
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net		—			(9,283	)		(1,061	)		—			(10,344	)
Other current assets		—			1,579			4			—			1,583
Other assets		—			603			34			—			637
Accounts payable and other accrued liabilities		—			997			(512	)		—			485
Accrued salaries and benefits		—			5,121			21			—			5,142
Other liabilities		—			702			—			—			702

Net cash (used in) provided by continuing operating activities		(15,593	)		51,862			(1,960	)		—			34,309
Net cash used in discontinued operating activities		—			(411	)		—			—			(411	)

Net cash (used in) provided by operating activities		(15,593	)		51,451			(1,960	)		—			33,898
Investing activities:
Cash paid for acquisitions, net of cash acquired		—			(443,473	)		—			—			(443,473	)
Cash paid for capital expenditures		—			(27,595	)		—			—			(27,595	)
Cash paid for real estate acquisitions		—			(53,159	)		—			—			(53,159	)
Other		—			(417	)		—			—			(417	)

Net cash used in investing activities		—			(524,644	)		—			—			(524,644	)
Financing activities:
Borrowings on long-term debt		176,063			—			—			—			176,063
Borrowings on revolving credit facility		16,000			—			—			—			16,000
Principal payments on revolving credit facility		(16,000	)		—			—			—			(16,000	)
Principal payments on long-term debt		(6,000	)		—			—			—			(6,000	)
Payment of debt issuance costs		(4,551	)		—			—			—			(4,551	)
Issuance of common stock, net		311,841			—			—			—			311,841
Common stock withheld for minimum statutory taxes, net		960			—			—			—			960
Excess tax benefit from equity awards		714			—			—			—			714
Cash (used in) provided by intercompany activity		(463,434	)		461,382			2,052			—			—

Net cash (used in) provided by financing activities		15,593			461,382			2,052			—			479,027

Net (decrease) increase in cash and cash equivalents		—			(11,811	)		92			—			(11,719	)
Cash and cash equivalents at beginning of the period		—			61,118			—			—			61,118

Cash and cash equivalents at end of the period	$	—		$	49,307		$	92		$	—		$	49,399

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

Cash and Cash Equivalents

Cash and Cash Equivalents

Revenue and Accounts Receivable

Revenue and Accounts Receivable

The following table presents revenue by payor type as a percentage of revenue before provision for doubtful accounts:


	Year Ended December 31,
	2014			2013			2012
Commercial		23.0	%		24.9	%		20.1	%
Medicare		19.4			21.5			11.8
Medicaid		38.3			48.0			63.6
NHS		14.5			—			—
Self-Pay		2.5			3.4			2.5
Other		2.3			2.2			2.0

Revenue		100	%		100	%		100	%

Allowance for Contractual Discounts

Allowance for Contractual Discounts

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts

A summary of activity in the Company’s allowance for doubtful accounts is as follows (in thousands):


	Balance at Beginning of Period		Additions Charged to Costs and Expenses		Accounts Written Off, Net of Recoveries			Balance at End of Period
Year ended December 31, 2012	$	2,424	$	6,389	$	(1,329	)	$	7,484
Year ended December 31, 2013		7,484		21,701		(10,840	)		18,345
Year ended December 31, 2014		18,345		26,183		(22,079	)		22,449

Charity Care

Charity Care

Insurance

Insurance

Property and Equipment and Other Long-Lived Assets

Property and Equipment and Other Long-Lived Assets

Goodwill and Indefinite-Lived Intangible Assets

Goodwill and Indefinite-Lived Intangible Assets

Other Current Assets

Other Current Assets

Other current assets consisted of the following (in thousands):


	As of December 31,
	2014		2013

Other receivables	$	12,713	$	6,833
Prepaid expenses		11,746		6,397
Insurance receivable – current portion		3,500		3,400
Workers’ compensation deposits – current portion		4,800		4,100
Income taxes receivable		3,399		4,005
Other		5,412		4,234

Other current assets	$	41,570	$	28,969

Debt Issuance Costs

Debt Issuance Costs

Other Accrued Liabilities

Other Accrued Liabilities

Other accrued liabilities consisted of the following (in thousands):


	As of December 31,
	2014		2013

Accrued interest	$	13,013	$	5,065
Insurance liability – current portion		4,239		4,139
Contingent consideration		3,000		4,891
Accrued property taxes		2,069		1,819
Other		8,635		9,834

Other accrued liabilities	$	30,956	$	25,748

Stock Compensation

Stock Compensation

Earnings Per Share

Earnings Per Share

Income Taxes

Income Taxes

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

Revenue by Payor Type as Percentage of Revenue

The following table presents revenue by payor type as a percentage of revenue before provision for doubtful accounts:


	Year Ended December 31,
	2014			2013			2012
Commercial		23.0	%		24.9	%		20.1	%
Medicare		19.4			21.5			11.8
Medicaid		38.3			48.0			63.6
NHS		14.5			—			—
Self-Pay		2.5			3.4			2.5
Other		2.3			2.2			2.0

Revenue		100	%		100	%		100	%

Summary of Activity in the Company's Allowance for Doubtful Accounts

A summary of activity in the Company’s allowance for doubtful accounts is as follows (in thousands):


	Balance at Beginning of Period		Additions Charged to Costs and Expenses		Accounts Written Off, Net of Recoveries			Balance at End of Period
Year ended December 31, 2012	$	2,424	$	6,389	$	(1,329	)	$	7,484
Year ended December 31, 2013		7,484		21,701		(10,840	)		18,345
Year ended December 31, 2014		18,345		26,183		(22,079	)		22,449

Other Current Assets

Other current assets consisted of the following (in thousands):


	As of December 31,
	2014		2013

Other receivables	$	12,713	$	6,833
Prepaid expenses		11,746		6,397
Insurance receivable – current portion		3,500		3,400
Workers’ compensation deposits – current portion		4,800		4,100
Income taxes receivable		3,399		4,005
Other		5,412		4,234

Other current assets	$	41,570	$	28,969

Summary of Other Accrued Liabilities

Other accrued liabilities consisted of the following (in thousands):


	As of December 31,
	2014		2013

Accrued interest	$	13,013	$	5,065
Insurance liability – current portion		4,239		4,139
Contingent consideration		3,000		4,891
Accrued property taxes		2,069		1,819
Other		8,635		9,834

Other accrued liabilities	$	30,956	$	25,748

Earnings Per Share (Tables)

12 Months Ended

Dec. 31, 2014

Earnings Per Share [Abstract]

Computation of Basic and Diluted Earnings (Loss) Per Share

The following table sets forth the computation of basic and diluted earnings (loss) per share for the years ended December 31, 2014, 2013 and 2012 (in thousands except per share amounts):


	Year Ended December 31,
	2014			2013			2012
Numerator:
Basic and diluted earnings (loss) per share:
Income (loss) from continuing operations	$	83,232		$	43,270		$	20,504
(Loss) from discontinued operations		(192	)		(691	)		(101	)

Net income (loss)	$	83,040		$	42,579		$	20,403

Denominator:
Weighted average shares outstanding for basic earnings per share		55,063			50,004			38,477
Effects of dilutive instruments		264			257			219

Shares used in computing diluted earnings per common share		55,327			50,261			38,696

Basic net earnings (loss) per share:
Income (loss) from continuing operations	$	1.51		$	0.87		$	0.53
Loss from discontinued operations		—			(0.02	)		—

Net income (loss)	$	1.51		$	0.85		$	0.53

Diluted net earnings (loss) per share:
Income (loss) from continuing operations	$	1.50		$	0.86		$	0.53
Loss from discontinued operations		—			(0.01	)		—

Net income (loss)	$	1.50		$	0.85		$	0.53

Acquisitions (Tables)

12 Months Ended

Dec. 31, 2014

Preliminary Fair Values of Assets Acquired and Liabilities Assumed at Corresponding Acquisition Date


	Partnerships in Care		Other		Total
Cash	$	11,674	$	—	$	11,674
Accounts receivable		7,684		1,849		9,533
Prepaid expenses and other current assets		8,828		186		9,014
Property and equipment		610,477		27,203		637,680
Goodwill		120,364		31,951		152,315
Intangible assets		651		204		855
Other assets		6,897		3,224		10,121

Total assets acquired		766,575		64,617		831,192
Accounts payable		3,958		93		4,051
Accrued salaries and benefits		10,422		—		10,422
Other accrued expenses		6,690		732		7,422
Deferred tax liabilities – noncurrent		49,250		—		49,250
Other liabilities		7,704		—		7,704

Total liabilities assumed		78,024		825		78,849

Net assets acquired	$	688,551	$	63,792	$	752,343

The fair values of assets acquired and liabilities assumed during 2013, at the corresponding acquisition dates, were as follows (in thousands):


	UMC Facilities		Other		Total
Cash	$	52	$	873	$	925
Accounts receivable		4,961		5,840		10,801
Prepaid expenses and other current assets		691		3,039		3,730
Property and equipment		22,347		42,672		65,019
Goodwill		67,589		37,651		105,240
Intangible assets		1,505		1,910		3,415
Other assets		4,712		29		4,741

Total assets acquired		101,857		92,014		193,871
Accounts payable		1,535		7,487		9,022
Accrued salaries and benefits		588		3,079		3,667
Other accrued expenses		315		2,298		2,613
Other liabilities		—		2,360		2,360

Total liabilities assumed		2,438		15,224		17,662

Net assets acquired	$	99,419	$	76,790	$	176,209

Transaction-related expenses comprised the following costs for the years ended December 31, 2014, 2013 and 2012 (in thousands):


	Year Ended December 31,
	2014		2013		2012
Legal, accounting and other fees	$	12,836	$	5,535	$	4,161
Severance and contract termination costs		814		1,615		3,951

	$	13,650	$	7,150	$	8,112

Pro Forma Financial Information for Acquisitions Occurred

The following table provides certain pro forma financial information for the Company as if the 2013 and 2014 Acquisitions and the CRC acquisition occurred as of January 1, 2013 (in thousands):


	Year Ended December 31,
	2014		2013
Revenue	$	1,569,877	$	1,480,631

Income from continuing operations, before income taxes	$	126,263	$	18,652

CRC Health Group, Inc [Member]

Preliminary Fair Values of Assets Acquired and Liabilities Assumed at Corresponding Acquisition Date


Cash	$	15,000
Accounts receivable		50,000
Prepaid expenses and other current assets		16,000
Property and equipment		130,000
Goodwill		1,050,500
Intangible assets		15,000
Deferred tax assets - noncurrent		94,000

Total assets acquired		1,370,500
Accounts payable		6,000
Accrued salaries and benefits		23,000
Other accrued expenses		32,500
Long-term debt		895,467
Other liabilities		25,000

Total liabilities assumed		981,967

Net assets acquired	$	388,533

Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Other Identifiable Intangible Assets and Related Accumulated Amortization

Other identifiable intangible assets and related accumulated amortization consisted of the following as of December 31, 2014 and 2013 (in thousands):


	Gross Carrying Amount				Accumulated Amortization
	December 31, 2014		December 31, 2013		December 31, 2014			December 31, 2013
Intangible assets subject to amortization:
Contract intangible assets	$	2,100	$	2,100	$	(1,330	)	$	(910	)
Non-compete agreements		1,247		1,247		(1,155	)		(1,021	)

		3,347		3,347		(2,485	)		(1,931	)
Intangible assets not subject to amortization:
Licenses and accreditations		9,184		8,391		—			—
Trade names		3,000		3,000		—			—
Certificates of need		8,590		7,761		—			—

		20,774		19,152		—			—

Total	$	24,121	$	22,499	$	(2,485	)	$	(1,931	)

Discontinued Operations (Tables)

12 Months Ended

Dec. 31, 2014

Discontinued Operations and Disposal Groups [Abstract]

Summary of Results from Discontinued Operations

A summary of results from discontinued operations is as follows (in thousands):


	Year Ended December 31,
	2014			2013			2012
Revenue	$	—		$	—		$	3,576

Net loss from discontinued operations, net of income taxes	$	(192	)	$	(691	)	$	(101	)

- Definition

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

+ References + Details

Long-Term Debt (Tables)

12 Months Ended

Dec. 31, 2014

Debt Disclosure [Abstract]

Components of Long Term Debt

Long-term debt consisted of the following (in thousands):


	December 31, 2014			December 31, 2013
Amended and Restated Senior Credit Facility:
Senior Secured Term A Loans (net of discount of $1,924 and $0, respectively)	$	525,576		$	292,500
Senior Secured Revolving Line of Credit		—			53,500
12.875% Senior Notes due 2018 (net of discount of $1,080 and $1,283, respectively)		96,420			96,216
6.125% Senior Notes due 2021		150,000			150,000
5.125% Senior Notes due 2022		300,000			—
9.0% and 9.5% Revenue Bonds (net of premium of $1,649 and $2,100, respectively)		24,274			24,920

		1,096,270			617,136
Less: current portion		(26,965	)		(15,195	)

Long-term debt	$	1,069,305		$	601,941

Summary of Aggregate Maturities of Long-Term Debt

The aggregate maturities of long-term debt as of December 31, 2014 were as follows (in thousands):


2015	$	26,965
2016		40,360
2017		53,755
2018		67,155
2019		340,555
Thereafter		568,835

Total	$	1,097,625

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 22
-Article 5

+ Details

Equity-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Option Activity

Stock option activity during 2013 and 2014 was as follows (aggregate intrinsic value in thousands):


	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value
Options outstanding at January 1, 2013		555,097		$	13.13		7.53	$	5,632
Options granted		411,800			30.55		9.30		2,059
Options exercised		(126,662	)		9.36		N/A		2,803
Options cancelled		(41,426	)		23.50		N/A		N/A

Options outstanding at December 31, 2013		798,809			21.93		8.20		10,700
Options granted		226,663			49.80		9.25		209
Options exercised		(210,199	)		14.93		N/A		4,994
Options cancelled		(77,851	)		27.85		N/A		N/A

Options outstanding at December 31, 2014		737,422		$	32.19		8.09	$	14,512

Options exercisable at December 31, 2013		133,647		$	11.15		4.81	$	3,472

Options exercisable at December 31, 2014		91,947		$	28.87		6.30	$	3,326

Restricted Stock Activity

Restricted stock activity during 2013 and 2014 was as follows:


	Number of Shares			Weighted Average Grant-Date Fair Value
Unvested at January 1, 2013		318,063		$	15.73
Granted		290,845			31.31
Cancelled		(53,056	)		21.27
Vested		(94,155	)		15.52

Unvested at December 31, 2013		461,697		$	24.96
Granted		468,484			48.99
Cancelled		(75,369	)		36.36
Vested		(132,784	)		22.81

Unvested at December 31, 2014		722,028		$	39.77

Restricted Stock Unit Activity

Restricted stock unit activity during 2013 and 2014 was as follows:


	Number of Units			Weighted Average Grant-Date Fair Value
Unvested at January 1, 2013		68,628		$	16.11
Granted		72,876			29.39
Cancelled		—			—
Vested		(45,753	)		16.11

Unvested at December 31, 2013		95,751		$	23.05
Granted		108,449			50.75
Cancelled		—			—
Vested		(79,087	)		21.81

Unvested at December 31, 2014		125,113		$	38.73

Schedule of Stock Options Valuation Assumptions

The following table summarizes the grant-date fair value of options and the assumptions used to develop the fair value estimates for options granted during the year ended December 31, 2014 and 2013:


	December 31, 2014			December 31, 2013

Weighted average grant-date fair value of options	$	17.14		$	11.62
Risk-free interest rate		1.7	%		1.0	%
Expected volatility		36	%		40	%
Expected life (in years)		5.5			5.5

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2014

Income Tax Disclosure [Abstract]

Components of Provision for Income Taxes

Income tax expense (benefit) from continuing operations consists of the following for the periods presented (in thousands):


	Year Ended December 31,
	2014		2013		2012
Current:
Federal	$	30,834	$	13,202	$	7,045
State		3,959		2,513		2,553
Foreign		914		177		—

Total current		35,707		15,892		9,598
Deferred:
Federal		2,667		7,802		3,144
State		353		1,786		(417	)
Foreign		4,195		495		—

Total deferred provision		7,215		10,083		2,727

Provision for (benefit from) income taxes	$	42,922	$	25,975	$	12,325

Income Taxes Associated with Continuing Operations and Discontinued Operations

The following table presents the income taxes associated with continuing operations and discontinued operations as reflected in the consolidated statements of income (in thousands):


	Year Ended December 31,
	2014			2013			2012
Continuing operations	$	42,922		$	25,975		$	12,325
Discontinued operations		(22	)		(544	)		(197	)

Total	$	42,900		$	25,431		$	12,128

Effective Income Tax Rate

A reconciliation of the U.S. federal statutory rate, from continuing operations, to the effective tax rate is as follows for the periods presented:


	Year Ended December 31,
	2014			2013			2012
U.S. federal statutory rate on income before income taxes		35.0	%		35.0	%		35.0	%
Impact of foreign operations (1)		(4.2	)		(0.3	)		—
State income taxes, net of federal tax effect		2.3			4.9			3.8
Permanent differences		1.1			0.8			0.8
Change in valuation allowance		(0.1	)		(0.3	)		(0.9	)
Other		(0.1	)		(2.6	)		(1.2	)

Effective income tax rate		34.0	%		37.5	%		37.5	%

Deferred Tax Assets and Liabilities


	December 31,
	2014			2013
Deferred tax assets:
Net operating losses and tax credit carryforwards – federal and state	$	5,082		$	905
Fixed asset basis difference		—			1,141
Bad debt allowance		9,028			7,490
Accrued compensation and severance		11,517			7,669
Pension reserves		1,975			—
Insurance reserves		4,621			2,680
Leases		850			1,083
Accrued expenses		41			91
Other assets		1,989			1,553

Total gross deferred tax assets		35,103			22,612
Less: valuation allowance		(4,734	)		(124	)

Deferred tax assets		30,369			22,488

Deferred tax liabilities:
Fixed asset basis difference		(38,147	)		—
Prepaid items		(1,705	)		(1,560	)
Intangible assets		(21,094	)		(13,196	)
Other liabilities		(7	)		—

Total deferred tax liabilities		(60,953	)		(14,756	)

Total net deferred tax (liability) asset	$	(30,584	)	$	7,732

Unrecognized Income Tax Benefits

A reconciliation of the beginning and ending amount of unrecognized income tax benefits is as follows (in thousands):


	2014		2013		2012
Balance at January 1	$	1,893	$	1,195	$	1,050
Additions based on tax positions related to the current year		—		321		262
Additions for tax positions of prior years		1,030		377		—
Reductions as a result of the lapse of applicable statutes of limitations		—		—		(117	)

Balance at December 31	$	2,923	$	1,893	$	1,195

Fair Value Measurements (Tables)

12 Months Ended

Dec. 31, 2014

Fair Value Disclosures [Abstract]

Carrying Amounts and Fair Values of Company's Amended and Restated Senior Credit Facilities and Contingent Consideration Liability


	Carrying Amount				Fair Value
	December 31,				December 31,
	2014		2013		2014		2013
Amended and Restated Senior Credit Facility	$	525,576	$	346,000	$	525,576	$	346,000

12.875% Senior Notes due 2018	$	96,420	$	96,216	$	109,688	$	118,706

6.125% Senior Notes due 2021	$	150,000	$	150,000	$	153,000	$	155,625

5.125% Senior Notes due 2022	$	300,000		—	$	295,500		—

9.0% and 9.5% Revenue Bonds	$	24,274	$	24,920	$	24,274	$	24,920

Contingent consideration liabilities	$	3,000	$	6,500	$	3,000	$	6,500

Leases (Tables)

12 Months Ended

Dec. 31, 2014

Leases [Abstract]

Schedule of Aggregate Minimum Lease Payments under Non-cancelable Operating Leases

Aggregate minimum lease payments under non-cancelable operating leases with original or remaining lease terms in excess of one year were as follows as of December 31, 2014 (in thousands):


2015	$	9,951
2016		8,976
2017		6,439
2018		4,118
2019		2,678
Thereafter		18,551

Total minimum rental obligations	$	50,713

Segment Information (Tables)

12 Months Ended

Dec. 31, 2014

Assets [Member]

Summary of Financial Information by Operating Segment


	December 31,
	2014		2013
Assets (2):
U.S. Facilities	$	1,327,563	$	1,155,813
U.K. Facilities		726,693		—
Corporate and Other		169,334		68,846

	$	2,223,590	$	1,224,659

Goodwill [Member]

Summary of Financial Information by Operating Segment


	U.S. Facilities		U.K. Facilities			Corporate and Other		Consolidated
Goodwill:
Balance at January 1, 2014	$	661,549	$	—		$	—	$	661,549
Increase from 2014 acquisitions		31,951		120,364			—		152,315
Foreign currency translation loss		—		(11,323	)		—		(11,323	)
Other		445		—			—		445

Balance at December 31, 2014	$	693,945	$	109,041		$	—	$	802,986

Operating Income (Loss) [Member]

Summary of Financial Information by Operating Segment

The following tables set forth the financial information by operating segment, including a reconciliation of Segment EBITDA to income from continuing operations before income taxes (in thousands):


	Year Ended December 31,
	2014			2013			2012

Revenue:
U.S. Facilities	$	850,625		$	710,695		$	406,718
U.K. Facilities		151,127			—			—
Corporate and Other		2,849			2,713			743

	$	1,004,601		$	713,408		$	407,461


Segment EBITDA (1):
U.S. Facilities	$	209,668		$	172,625		$	102,443
U.K. Facilities		39,832			—			—
Corporate and Other		(34,012	)		(27,291	)		(21,484	)

	$	215,488		$	145,334		$	80,959


	Year Ended December 31,
	2014			2013			2012

Segment EBITDA (1)	$	215,488		$	145,334		$	80,959
Plus (less):
Equity-based compensation expense		(10,058	)		(5,249	)		(2,267	)
Gain on foreign currency derivatives		15,262			—			—
Debt extinguishment costs		—			(9,350	)		—
Transaction-related expenses		(13,650	)		(7,150	)		(8,112	)
Interest expense, net		(48,221	)		(37,250	)		(29,769	)
Depreciation and amortization		(32,667	)		(17,090	)		(7,982	)

Income (loss) from continuing operations before income taxes	$	126,154		$	69,245		$	32,829

(1)

Employee Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2014

Compensation and Retirement Disclosure [Abstract]

Summary of Funded Status of Partnerships in Care Pension Plan Based Upon Actuarial Valuations


Reconciliation of funded status:
Projected benefit obligation	$	66,910
Fair value of plan assets		57,356

Funded status	$	9,554

Summary of Changes in Partnerships in Care Pension Plan Pension Liability

The following table summarizes changes in the Partnerships in Care Pension Plan pension liability (in thousands):


Pension liability at July 1, 2014	$	7,602
Employer contributions		(825	)
Net pension benefit expense		729
Pension liability adjustment		2,758
Foreign currency translation loss		(710	)

Pension liability at December 31, 2014	$	9,554

Summary of Assumptions Used to Determine Plan Benefit obligation

The following assumptions were used to determine the plan benefit obligation:


Discount rate	3.6	%
Compensation increase rate	3.4	%
Measurement date	December 31, 2014

Assumptions used to determine the net periodic pension plan expense for the six months ended December 31, 2014 were as follows:


Discount rate	3.6	%
Expected long-term rate of return on plan assets	4.3	%

Summary of Components of Net Pension Plan Expense

A summary of the components of net pension plan expense for the six months ended December 31, 2014 is as follows (in thousands):


Interest cost on projected benefit obligation	$	1,389
Service cost on projected benefit obligation		545
Expected return on assets		(1,205	)

Total pension plan expense	$	729

Schedule of Weighted-Average Asset Allocation by Asset Category in Partnerships in Care Pension Plan

The Partnerships in Care Pension Plan’s weighted-average asset allocations by asset category as of December 31, 2014 were as follows:


Cash and cash equivalents	1.3	%
United Kingdom government obligation	16.1	%
Equity securities	43.6	%
Debt securities	34.1	%
Other	4.9	%

Quarterly Information (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2014

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information


	Quarter Ended
	March 31,			June 30,			September 30,			December 31,
	(In thousands except per share amounts)
2014:
Revenue	$	201,418		$	213,803		$	294,479		$	294,901
Income from continuing operations before income taxes	$	20,796		$	37,362	(1)	$	33,156	(1)	$	34,840
Net income	$	13,058		$	22,451	(1)	$	25,402	(1)	$	22,129
Basic net income per share	$	0.26		$	0.43	(1)	$	0.43	(1)	$	0.38
Diluted net income per share	$	0.26		$	0.43	(1)	$	0.43	(1)	$	0.37

2013:
Revenue	$	161,213		$	177,494		$	184,702		$	189,999
Income from continuing operations before income taxes	$	6,732	(2)	$	20,291		$	22,287		$	19,935
Net income	$	3,738	(2)	$	12,197		$	14,364		$	12,280
Basic net income per share	$	0.07	(2)	$	0.24		$	0.29		$	0.25
Diluted net income per share	$	0.07	(2)	$	0.24		$	0.29		$	0.24

(1)	Includes gain on foreign currency derivatives of $13.7 million and $1.5 million, in connection with the Partnerships in Care acquisition, for the three months ended June 30, 2014 and September 30, 2014, respectively.

(2)	Includes debt extinguishment costs of $9.4 million, or $5.8 million net of taxes, in connection with the redemption of $52.5 million of the 12.875% Senior Notes on March 12, 2013.

Financial Information for the Company and Its Subsidiaries (Tables)

12 Months Ended

Dec. 31, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Summary of Condensed Consolidating Balance Sheets

Acadia Healthcare Company, Inc.

Condensed Consolidating Balance Sheets

December 31, 2014

(In thousands)


	Parent		Combined Subsidiary Guarantors		Combined Non- Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Current assets:
Cash and cash equivalents	$	—	$	76,685	$	17,355	$	—		$	94,040
Accounts receivable, net		—		100,797		17,581		—			118,378
Deferred tax assets		—		18,395		1,760		—			20,155
Other current assets		—		36,049		5,521		—			41,570

Total current assets		—		231,926		42,217		—			274,143
Property and equipment, net		—		451,943		617,757		—			1,069,700
Goodwill		—		596,611		206,375		—			802,986
Intangible assets, net		—		19,057		2,579		—			21,636
Deferred tax assets – noncurrent		4,563		—		14,244		(5,666	)		13,141
Investment in subsidiaries		1,759,337		—		—		(1,759,337	)		—
Other assets		202,708		18,727		2,323		(181,774	)		41,984

Total assets	$	1,966,608	$	1,318,264	$	885,495	$	(1,946,777	)	$	2,223,590

Current liabilities:
Current portion of long-term debt	$	26,750	$	—	$	215	$	—		$	26,965
Accounts payable		—		39,486		9,210		—			48,696
Accrued salaries and benefits		—		47,597		11,720		—			59,317
Other accrued liabilities		13,647		7,688		9,621		—			30,956

Total current liabilities		40,397		94,771		30,766		—			165,934
Long-term debt		1,045,246		—		205,833		(181,774	)		1,069,305
Deferred tax liabilities – noncurrent		—		21,027		48,519		(5,666	)		63,880
Other liabilities		—		33,321		10,185		—			43,506

Total liabilities		1,085,643		149,119		295,303		(187,440	)		1,342,625

Total equity		880,965		1,169,145		590,192		(1,759,337	)		880,965

Total liabilities and equity	$	1,966,608	$	1,318,264	$	885,495	$	(1,946,777	)	$	2,223,590

Acadia Healthcare Company, Inc.

Condensed Consolidating Balance Sheets

December 31, 2013

(In thousands)


	Parent		Combined Subsidiary Guarantors		Combined Non- Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Current assets:
Cash and cash equivalents	$	—	$	—	$	6,494	$	(1,925	)	$	4,569
Accounts receivable, net		—		86,597		9,288		—			95,885
Deferred tax assets		—		15,284		419		—			15,703
Other current assets		—		27,886		1,083		—			28,969

Total current assets		—		129,767		17,284		(1,925	)		145,126
Property and equipment, net		—		340,175		29,934		—			370,109
Goodwill		—		564,539		97,010		—			661,549
Intangible assets, net		—		18,578		1,990		—			20,568
Investment in subsidiaries		1,034,160		—		—		(1,034,160	)		—
Other assets		46,236		11,675		8,082		(38,686	)		27,307

Total assets	$	1,080,396	$	1,064,734	$	154,300	$	(1,074,771	)	$	1,224,659

Current liabilities:
Current portion of long-term debt	$	15,000	$	—	$	195	$	—		$	15,195
Accounts payable		—		36,289		1,662		(1,925	)		36,026
Accrued salaries and benefits		—		36,027		1,694		—			37,721
Other accrued liabilities		4,876		19,982		890		—			25,748

Total current liabilities		19,876		92,298		4,441		(1,925	)		114,690
Long-term debt		577,216		—		57,650		(32,925	)		601,941
Deferred tax liabilities – noncurrent		2,594		11,138		—		(5,761	)		7,971
Other liabilities		—		19,347		—		—			19,347

Total liabilities		599,686		122,783		62,091		(40,611	)		743,949

Total equity		480,710		941,951		92,209		(1,034,160	)		480,710

Total liabilities and equity	$	1,080,396	$	1,064,734	$	154,300	$	(1,074,771	)	$	1,224,659

Summary of Condensed Consolidating Statement of Comprehensive Loss

Acadia Healthcare Company, Inc.

Condensed Consolidating Statement of Comprehensive Income

Year Ended December 31, 2014

(In thousands)


	Parent			Combined Subsidiary Guarantors			Combined Non- Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Revenue before provision for doubtful accounts	$	—		$	826,465		$	204,319		$	—		$	1,030,784
Provision for doubtful accounts		—			(23,866	)		(2,317	)		—			(26,183	)

Revenue		—			802,599			202,002			—			1,004,601
Salaries, wages and benefits		10,058			459,297			106,057			—			575,412
Professional fees		—			38,632			13,850			—			52,482
Supplies		—			40,511			7,911			—			48,422
Rents and leases		—			10,136			2,065			—			12,201
Other operating expenses		—			83,835			26,819			—			110,654
Depreciation and amortization		—			22,990			9,677			—			32,667
Interest expense, net		27,199			6,207			14,815			—			48,221
Gain on foreign currency derivatives		(15,262	)		—			—			—			(15,262	)
Transaction-related expenses		—			12,367			1,283			—			13,650

Total expenses		21,995			673,975			182,477			—			878,447
(Loss) income from continuing operations before income taxes		(21,995	)		128,624			19,525			—			126,154
Equity in earnings of subsidiaries		97,414			—			—			(97,414	)		—
(Benefit from) provision for income taxes		(7,621	)		44,608			5,935			—			42,922

Income (loss) from continuing operations		83,040			84,016			13,590			(97,414	)		83,232
Loss from discontinued operations, net of income taxes		—			(192	)		—			—			(192	)

Net income (loss)	$	83,040		$	83,824		$	13,590		$	(97,414	)	$	83,040

Other comprehensive loss:
Foreign currency translation loss		—			—			(66,206	)		—			(66,206	)
Pension liability adjustment, net		—			—			(2,164	)		—			(2,164	)

Other comprehensive loss		—			—			(68,370	)		—			(68,370	)

Comprehensive income (loss)	$	83,040		$	83,824		$	(54,780	)	$	(97,414	)	$	14,670

Acadia Healthcare Company, Inc.

Condensed Consolidating Statement of Comprehensive Income

Year Ended December 31, 2013

(In thousands)


	Parent			Combined Subsidiary Guarantors			Combined Non- Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Revenue before provision for doubtful accounts	$	—		$	700,407		$	34,702		$	—		$	735,109
Provision for doubtful accounts		—			(20,700	)		(1,001	)		—			(21,701	)

Revenue		—			679,707			33,701			—			713,408
Salaries, wages and benefits		5,249			388,749			13,964			—			407,962
Professional fees		—			34,149			3,022			—			37,171
Supplies		—			35,686			1,883			—			37,569
Rents and leases		—			9,282			767			—			10,049
Other operating expenses		—			72,626			7,946			—			80,572
Depreciation and amortization		—			15,882			1,208			—			17,090
Interest expense, net		35,327			22			1,901			—			37,250
Debt extinguishment costs		9,350			—			—			—			9,350
Transaction-related expenses		—			6,716			434			—			7,150

Total expenses		49,926			563,112			31,125			—			644,163
(Loss) income from continuing operations before income taxes		(49,926	)		116,595			2,576			—			69,245
Equity in earnings of subsidiaries		73,538			—			—			(73,538	)		—
(Benefit from) provision for income taxes		(18,967	)		44,294			648			—			25,975

Income (loss) from continuing operations		42,579			72,301			1,928			(73,538	)		43,270
Loss from discontinued operations, net of income taxes		—			(691	)		—			—			(691	)

Net income (loss)	$	42,579		$	71,610		$	1,928		$	(73,538	)	$	42,579

Comprehensive income (loss)	$	42,579		$	71,610		$	1,928		$	(73,538	)	$	42,579

Acadia Healthcare Company, Inc.

Condensed Consolidating Statement of Comprehensive Income

Year Ended December 31, 2012

(In thousands)


	Parent			Combined Subsidiary Guarantors			Combined Non- Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Revenue before provision for doubtful accounts	$	—		$	412,161		$	1,689		$	—		$	413,850
Provision for doubtful accounts		—			(6,389	)		—			—			(6,389	)

Revenue		—			405,772			1,689			—			407,461
Salaries, wages and benefits		2,267			236,182			1,190			—			239,639
Professional fees		—			18,806			213			—			19,019
Supplies		—			19,382			114			—			19,496
Rents and leases		—			7,816			22			—			7,838
Other operating expenses		—			42,121			656			—			42,777
Depreciation and amortization		—			7,874			108			—			7,982
Interest expense, net		29,512			—			257			—			29,769
Transaction-related expenses		—			8,112			—			—			8,112

Total expenses		31,779			340,293			2,560			—			374,632
(Loss) income from continuing operations before income taxes		(31,779	)		65,479			(871	)		—			32,829
Equity in earnings of subsidiaries		40,251			—			—			(40,251	)		—
(Benefit from) provision for income taxes		(11,931	)		24,583			(327	)		—			12,325

Income (loss) from continuing operations		20,403			40,896			(544	)		(40,251	)		20,504
Loss from discontinued operations, net of income taxes		—			(101	)		—			—			(101	)

Net income (loss)	$	20,403		$	40,795		$	(544	)	$	(40,251	)	$	20,403

Comprehensive income (loss)	$	20,403		$	40,795		$	(544	)	$	(40,251	)	$	20,403

Summary of Condensed Consolidating Statement of Cash Flows

Acadia Healthcare Company, Inc.

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2014

(In thousands)


	Parent			Combined Subsidiary Guarantors			Combined Non- Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Operating activities:
Net income (loss)	$	83,040		$	83,824		$	13,590		$	(97,414	)	$	83,040
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:
Equity in earnings of subsidiaries		(97,414	)		—			—			97,414			—
Depreciation and amortization		—			22,990			9,677			—			32,667
Amortization of debt issuance costs		2,748			—			450			—			3,198
Equity-based compensation expense		10,058			—			—			—			10,058
Deferred income tax (benefit) expense		(1,969	)		5,231			3,953			—			7,215
Loss from discontinued operations, net of taxes		—			192			—			—			192
Gain on foreign currency derivatives		(15,262	)		—			—			—			(15,262	)
Other		—			449			39			—			488
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net		—			(13,636	)		(1,474	)		—			(15,110	)
Other current assets		—			(2,205	)		194			—			(2,011	)
Other assets		(1,151	)		(6,910	)		397			1,151			(6,513	)
Accounts payable and other accrued liabilities		—			(5,559	)		8,352			—			2,793
Accrued salaries and benefits		—			11,035			945			—			11,980
Other liabilities		—			1,769			980			—			2,749

Net cash (used in) provided by continuing operating activities		(19,950	)		97,180			37,103			1,151			115,484
Net cash used in discontinued operating activities		—			(198	)		—			—			(198	)

Net cash (used in) provided by operating activities		(19,950	)		96,982			37,103			1,151			115,286
Investing activities:
Cash paid for acquisitions, net of cash acquired		—			(723,064	)		(15,638	)		—			(738,702	)
Cash paid for capital expenditures		—			(83,864	)		(29,380	)		—			(113,244	)
Cash paid for real estate acquisitions		—			(23,177	)		—			—			(23,177	)
Settlement of foreign currency derivatives		15,262			—			—			—			15,262
Other		—			(913	)		—			—			(913	)

Net cash used in investing activities		15,262			(831,018	)		(45,018	)		—			(860,774	)
Financing activities:
Borrowings on long-term debt		542,500			—			—			—			542,500
Borrowings on revolving credit facility		230,500			—			—			—			230,500
Principal payments on revolving credit facility		(284,000	)		—			—			—			(284,000	)
Principal payments on long-term debt		(7,500	)		—			(1,346	)		1,151			(7,695	)
Payment of debt issuance costs		(12,993	)		—			—			—			(12,993	)
Issuance of common stock, net		374,431			—			—			—			374,431
Common stock withheld for minimum statutory taxes, net		(4,099	)		—			—			—			(4,099	)
Excess tax benefit from equity awards		4,617			—			—			—			4,617
Cash paid for contingent consideration		—			(5,000	)		—			—			(5,000	)
Other		—			(289	)		—			—			(289	)
Cash (used in) provided by intercompany activity		(838,768	)		816,010			23,135			(377	)		—

Net cash provided by financing activities		4,688			810,721			21,789			774			837,972

Effect of exchange rate changes on cash		—			—			(3,013	)		—			(3,013	)

Net increase in cash and cash equivalents		—			76,685			10,861			1,925			89,471
Cash and cash equivalents at beginning of the period		—			—			6,494			(1,925	)		4,569

Cash and cash equivalents at end of the period	$	—		$	76,685		$	17,355		$	—		$	94,040

Acadia Healthcare Company, Inc.

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2013

(In thousands)


	Parent			Combined Subsidiary Guarantors			Combined Non- Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Operating activities:
Net income (loss)	$	42,579		$	71,610		$	1,928		$	(73,538	)	$	42,579
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:
Equity in earnings of subsidiaries		(73,538	)		—			—			73,538			—
Depreciation and amortization		—			15,882			1,208			—			17,090
Amortization of debt issuance costs		2,725			—			(461	)		—			2,264
Equity-based compensation expense		5,249			—			—			—			5,249
Deferred income tax expense		(754	)		10,278			559			—			10,083
Loss from discontinued operations, net of taxes		—			691			—			—			691
Debt extinguishment costs		9,350			—			—			—			9,350
Other		—			21			—			—			21
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net		—			(22,768	)		1,526			—			(21,242	)
Other current assets		—			(3,774	)		122			—			(3,652	)
Other assets		—			(1,950	)		(289	)		—			(2,239	)
Accounts payable and other accrued liabilities		—			(287	)		(561	)		—			(848	)
Accrued salaries and benefits		—			2,161			642			—			2,803
Other liabilities		—			3,181			—			—			3,181

Net cash (used in) provided by continuing operating activities		(14,389	)		75,045			4,674			—			65,330
Net cash used in discontinued operating activities		—			232			—			—			232

Net cash (used in) provided by operating activities		(14,389	)		75,277			4,674			—			65,562
Investing activities:
Cash paid for acquisitions, net of cash acquired		—			(164,019	)		—			—			(164,019	)
Cash paid for capital expenditures		—			(68,497	)		(444	)		—			(68,941	)
Cash paid for real estate acquisitions		—			(8,092	)		—			—			(8,092	)
Other		—			(1,926	)		—			—			(1,926	)

Net cash used in investing activities		—			(242,534	)		(444	)		—			(242,978	)
Financing activities:
Borrowings on long-term debt		150,000			—			—			—			150,000
Borrowings on revolving credit facility		61,500			—			—			—			61,500
Principal payments on revolving credit facility		(8,000	)		—			—			—			(8,000	)
Principal payments on long-term debt		(7,500	)		—			(180	)		—			(7,680	)
Repayment of long-term debt		(52,500	)		—			—			—			(52,500	)
Payment of debt issuance costs		(4,307	)		—			—			—			(4,307	)
Payment of premium on note redemption		(6,759	)		—			—			—			(6,759	)
Issuance of common stock, net		(205	)		—			—			—			(205	)
Common stock withheld for minimum statutory taxes, net		(1,242	)		—			—			—			(1,242	)
Excess tax benefit from equity awards		1,779			—			—			—			1,779
Cash (used in) provided by intercompany activity		(118,377	)		117,950			2,352			(1,925	)		—

Net cash (used in) provided by financing activities		14,389			117,950			2,172			(1,925	)		132,586

Net (decrease) increase in cash and cash equivalents		—			(49,307	)		6,402			(1,925	)		(44,830	)
Cash and cash equivalents at beginning of the period		—			49,307			92			—			49,399

Cash and cash equivalents at end of the period	$	—		$	—		$	6,494		$	(1,925	)	$	4,569

Acadia Healthcare Company, Inc.

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2012

(In thousands)


	Parent			Combined Subsidiary Guarantors			Combined Non- Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Operating activities:
Net income (loss)	$	20,403		$	40,795		$	(544	)	$	(40,251	)	$	20,403
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:
Equity in earnings of subsidiaries		(40,251	)		—			—			40,251			—
Depreciation and amortization		—			7,874			108			—			7,982
Amortization of debt issuance costs		2,507			—			—			—			2,507
Equity-based compensation expense		2,267			—			—			—			2,267
Deferred income tax expense		(519	)		3,376			(10	)		—			2,847
Other		—			(3	)		—			—			(3	)
Loss from discontinued operations, net of taxes		—			101			—			—			101
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net		—			(9,283	)		(1,061	)		—			(10,344	)
Other current assets		—			1,579			4			—			1,583
Other assets		—			603			34			—			637
Accounts payable and other accrued liabilities		—			997			(512	)		—			485
Accrued salaries and benefits		—			5,121			21			—			5,142
Other liabilities		—			702			—			—			702

Net cash (used in) provided by continuing operating activities		(15,593	)		51,862			(1,960	)		—			34,309
Net cash used in discontinued operating activities		—			(411	)		—			—			(411	)

Net cash (used in) provided by operating activities		(15,593	)		51,451			(1,960	)		—			33,898
Investing activities:
Cash paid for acquisitions, net of cash acquired		—			(443,473	)		—			—			(443,473	)
Cash paid for capital expenditures		—			(27,595	)		—			—			(27,595	)
Cash paid for real estate acquisitions		—			(53,159	)		—			—			(53,159	)
Other		—			(417	)		—			—			(417	)

Net cash used in investing activities		—			(524,644	)		—			—			(524,644	)
Financing activities:
Borrowings on long-term debt		176,063			—			—			—			176,063
Borrowings on revolving credit facility		16,000			—			—			—			16,000
Principal payments on revolving credit facility		(16,000	)		—			—			—			(16,000	)
Principal payments on long-term debt		(6,000	)		—			—			—			(6,000	)
Payment of debt issuance costs		(4,551	)		—			—			—			(4,551	)
Issuance of common stock, net		311,841			—			—			—			311,841
Common stock withheld for minimum statutory taxes, net		960			—			—			—			960
Excess tax benefit from equity awards		714			—			—			—			714
Cash (used in) provided by intercompany activity		(463,434	)		461,382			2,052			—			—

Net cash (used in) provided by financing activities		15,593			461,382			2,052			—			479,027

Net (decrease) increase in cash and cash equivalents		—			(11,811	)		92			—			(11,719	)
Cash and cash equivalents at beginning of the period		—			61,118			—			—			61,118

Cash and cash equivalents at end of the period	$	—		$	49,307		$	92		$	—		$	49,399

Description of Business and Basis of Presentation - Additional Information (Detail) $ in Millions		12 Months Ended
	Feb. 11, 2015 USD ($) Beds State Center Facilities	Dec. 31, 2014 USD ($) Beds State Center Facilities	Dec. 31, 2013 USD ($)	Dec. 31, 2012 USD ($)
Business And Basis Of Presentation [Line Items]
Number of facilities		78
Number beds \| Beds		5,800
Number of states covered under inpatient psychiatric facilities \| State		24
Percentage of ownership in subsidiaries		100.00%
General and administrative expenses \| $		$ 36.9	$ 29.0	$ 21.6
CRC Health Group, Inc [Member]
Business And Basis Of Presentation [Line Items]
Number of states covered under inpatient psychiatric facilities \| State		30
Number of beds \| Beds		2,400
Acquisition completion date		Feb. 11, 2015
CRC Health Group, Inc [Member] \| Comprehensive Treatment Centers [Member]
Business And Basis Of Presentation [Line Items]
Number of facilities acquired \| Center		81
CRC Health Group, Inc [Member] \| Minimum [Member]
Business And Basis Of Presentation [Line Items]
Number of inpatient		35
Subsequent Event [Member] \| CRC Health Group, Inc [Member]
Business And Basis Of Presentation [Line Items]
Number of facilities	35
Number of states covered under inpatient psychiatric facilities \| State	30
Number of inpatient	35
Number of beds \| Beds	2,400
Total consideration related to acquisition \| $	$ 1,300.0
Acquisition completion date	Feb. 11, 2015
Subsequent Event [Member] \| CRC Health Group, Inc [Member] \| Comprehensive Treatment Centers [Member]
Business And Basis Of Presentation [Line Items]
Number of facilities acquired \| Center	81

Summary of Significant Accounting Policies - Revenue by Payor Type as Percentage of Revenue (Detail)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Percentage of revenue	100.00%	100.00%	100.00%
Commercial [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Percentage of revenue	23.00%	24.90%	20.10%
Medicare [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Percentage of revenue	19.40%	21.50%	11.80%
Medicaid [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Percentage of revenue	38.30%	48.00%	63.60%
NHS [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Percentage of revenue	14.50%
Self-Pay [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Percentage of revenue	2.50%	3.40%	2.50%
Other [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Percentage of revenue	2.30%	2.20%	2.00%

Summary of Significant Accounting Policies - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2014 USD ($) Segment	Dec. 31, 2013 USD ($)	Dec. 31, 2012 USD ($)
Summary Of Significant Policies [Line Items]
Percentage of revenue	100.00%	100.00%	100.00%
Cost report receivables	$ 1,900,000	$ 800,000
Net adjustments to estimated cost report settlements resulted in increases to revenue	300,000	200,000
Costs of providing charity care services	2,500,000	2,600,000	$ 1,200,000
Insurance claims in excess of deductible	250,000
Insured excess limit	36,000,000
Professional and general liability reserve	16,300,000	14,000,000
Professional and general liability reserve current	4,200,000	4,100,000
Professional and general liability reserve noncurrent	12,100,000	9,900,000
Insurance receivable	12,000,000	11,200,000
Insurance receivable current	3,500,000	3,400,000
Insurance receivable noncurrent	8,500,000	7,800,000
Workers compensation insurance claims deductible per accident	500,000
Reserve for workers compensation liability	8,400,000	6,200,000
Accrued salaries and benefits	4,800,000	4,100,000
Other long-term liabilities	3,600,000	2,100,000
Depreciation expense	$ 32,100,000	16,300,000	$ 7,400,000
Number of operating segment \| Segment	2
Number of reporting unit \| Segment	1
Intangible assets impairment charges	$ 0
Debt issuance costs	20,900,000	13,300,000
Accumulated amortization	9,500,000	6,100,000
Amortization expenses reported as interest expense	3,200,000	$ 2,300,000
Estimated amortization of debt issuance costs year one	4,500,000
Estimated amortization of debt issuance costs year two	4,600,000
Estimated amortization of debt issuance costs year three	4,700,000
Estimated amortization of debt issuance costs year four	4,500,000
Estimated amortization of debt issuance costs year five	$ 1,600,000
Minimum [Member] \| Buildings and Improvements [Member]
Summary Of Significant Policies [Line Items]
Property plant and equipment estimated useful life	10 years
Minimum [Member] \| Equipment [Member]
Summary Of Significant Policies [Line Items]
Property plant and equipment estimated useful life	3 years
Maximum [Member] \| Buildings and Improvements [Member]
Summary Of Significant Policies [Line Items]
Property plant and equipment estimated useful life	40 years
Maximum [Member] \| Equipment [Member]
Summary Of Significant Policies [Line Items]
Property plant and equipment estimated useful life	7 years
United Kingdom [Member]
Summary Of Significant Policies [Line Items]
Percentage of revenue generated by facility	15.00%
Arkansas [Member]
Summary Of Significant Policies [Line Items]
Percentage of revenue generated by facility	12.00%	17.00%
Mississippi [Member]
Summary Of Significant Policies [Line Items]
Percentage of revenue generated by facility		8.00%
Medicare and Medicaid [Member]
Summary Of Significant Policies [Line Items]
Percentage of revenue	58.00%	70.00%	75.00%

Summary of Significant Accounting Policies - Summary of Activity in Company's Allowance for Doubtful Accounts (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Receivables [Abstract]
Balance at Beginning of Period	$ 18,345	$ 7,484	$ 2,424
Additions Charged to Costs and Expenses	26,183	21,701	6,389
Accounts Written Off, Net of Recoveries	(22,079)	(10,840)	(1,329)
Balance at End of Period	$ 22,449	$ 18,345	$ 7,484

Summary of Significant Accounting Policies - Other Current Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other receivables	$ 12,713	$ 6,833
Prepaid expenses	11,746	6,397
Insurance receivable - current portion	3,500	3,400
Workers' compensation deposits - current portion	4,800	4,100
Income taxes receivable	3,399	4,005
Other	5,412	4,234
Other current assets	$ 41,570	$ 28,969

Summary of Significant Accounting Policies - Summary of Other Accrued Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Accounts Payable and Accrued Liabilities, Current [Abstract]
Accrued interest	$ 13,013	$ 5,065
Insurance liability - current portion	4,239	4,139
Contingent consideration	3,000	4,891
Accrued property taxes	2,069	1,819
Other	8,635	9,834
Other accrued liabilities	$ 30,956	$ 25,748

Earnings Per Share - Computation of Basic and Diluted Earnings (Loss) Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Basic and diluted earnings (loss) per share:
Income (loss) from continuing operations									$ 83,232	$ 43,270	$ 20,504
(Loss) from discontinued operations									(192)	(691)	(101)
Net income (loss)	$ 22,129	$ 25,402	$ 22,451	$ 13,058	$ 12,280	$ 14,364	$ 12,197	$ 3,738	$ 83,040	$ 42,579	$ 20,403
Denominator:
Weighted average shares outstanding for basic earnings per share									55,063	50,004	38,477
Effects of dilutive instruments									264	257	219
Shares used in computing diluted earnings per common share									55,327	50,261	38,696
Basic net earnings (loss) per share:
Income (loss) from continuing operations									$ 1.51	$ 0.87	$ 0.53
Loss from discontinued operations										(0.02)
Net income (loss)	$ 0.38	$ 0.43	$ 0.43	$ 0.26	$ 0.25	$ 0.29	$ 0.24	$ 0.07	1.51	0.85	0.53
Diluted net earnings (loss) per share:
Income (loss) from continuing operations									1.50	0.86	0.53
Loss from discontinued operations										(0.01)
Net income (loss)	$ 0.37	$ 0.43	$ 0.43	$ 0.26	$ 0.24	$ 0.29	$ 0.24	$ 0.07	$ 1.50	$ 0.85	$ 0.53

Earnings Per Share - Additional Information (Detail) - shares shares in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Earnings Per Share [Abstract]
Excluded common stock for computation of diluted earnings per share	0.7	0.6	0.4

Acquisitions - Recent Acquisitions (Detail) $ in Thousands						12 Months Ended
Acquisitions - Recent Acquisitions (Detail) $ in Thousands	Dec. 01, 2014 USD ($) Beds	Sep. 03, 2014 USD ($) Beds	Jul. 01, 2014 USD ($) Beds Facilities	Jun. 17, 2014 USD ($)	Jan. 01, 2014 USD ($) Beds	Dec. 31, 2014 USD ($) Beds
Business Acquisition [Line Items]
Gain on foreign currency derivatives						$ 15,262
Net proceeds from sale of shares				$ 374,400
5.125% Senior Notes due 2022 [Member]
Business Acquisition [Line Items]
Senior notes interest percentage						5.125%
Partnerships In Care [Member]
Business Acquisition [Line Items]
Acquisition completion date			Jul. 01, 2014
Total consideration related to acquisition			$ 661,700
Cash from consideration related to acquisition			12,000
Gain on foreign currency derivatives			$ 15,300
Net proceeds from sale of shares				$ 374,400
Number of inpatient psychiatric facilities \| Facilities			23
Partnerships In Care [Member] \| Minimum [Member]
Business Acquisition [Line Items]
Number of beds \| Beds			1,200
Partnerships In Care [Member] \| 5.125% Senior Notes due 2022 [Member]
Business Acquisition [Line Items]
Proceeds from issuance of debt			$ 300,000
Debt instrument maturity date			Jul. 01, 2022
Senior notes interest percentage			5.125%
Pacific Grove [Member]
Business Acquisition [Line Items]
Business acquisition cash paid					$ 10,500
Number of beds \| Beds					68
McCallum [Member]
Business Acquisition [Line Items]
Business acquisition cash paid		$ 37,400
Number of beds \| Beds		85
Cash payments for earn-out agreement		$ 6,000				$ 6,000
Croxton [Member]
Business Acquisition [Line Items]
Business acquisition cash paid	$ 15,600
Number of beds \| Beds	24
Skyway [Member]
Business Acquisition [Line Items]
Business acquisition cash paid						$ 300
Number of beds \| Beds						28
Acquisition completion date						Dec. 31, 2014

Acquisitions - 2013 Acquisitions (Detail) - Facility		12 Months Ended
Acquisitions - 2013 Acquisitions (Detail) - Facility	May 01, 2013	Dec. 31, 2014
Cascade [Member]
Business Acquisition [Line Items]
Acquisition completion date		Dec. 01, 2013
Longleaf [Member]
Business Acquisition [Line Items]
Acquisition completion date		Oct. 01, 2013
The Refuge [Member]
Business Acquisition [Line Items]
Acquisition completion date		Aug. 01, 2013
UMC Facilities [Member]
Business Acquisition [Line Items]
Acquisition completion date	May 01, 2013	May 01, 2013
Number of facilities acquired	2
Delta [Member]
Business Acquisition [Line Items]
Acquisition completion date		Jan. 31, 2013
Greenleaf [Member]
Business Acquisition [Line Items]
Acquisition completion date		Jan. 01, 2013

Acquisitions - Summary of Acquisitions (Detail) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Business Acquisition [Line Items]
Goodwill	$ 802,986	$ 661,549
2014 Acquisitions [Member]
Business Acquisition [Line Items]
Cash	11,674
Accounts receivable	9,533
Prepaid expenses and other current assets	9,014
Property and equipment	637,680
Goodwill	152,315
Intangible assets	855
Other assets	10,121
Total assets acquired	831,192
Accounts payable	4,051
Accrued salaries and benefits	10,422
Other accrued expenses	7,422
Deferred tax liabilities - noncurrent	49,250
Other liabilities	7,704
Total liabilities assumed	78,849
Net assets acquired	752,343
2013 Acquisitions [Member]
Business Acquisition [Line Items]
Cash		925
Accounts receivable		10,801
Prepaid expenses and other current assets		3,730
Property and equipment		65,019
Goodwill		105,240
Intangible assets		3,415
Other assets		4,741
Total assets acquired		193,871
Accounts payable		9,022
Accrued salaries and benefits		3,667
Other accrued expenses		2,613
Other liabilities		2,360
Total liabilities assumed		17,662
Net assets acquired		176,209
Partnerships In Care [Member] \| 2014 Acquisitions [Member]
Business Acquisition [Line Items]
Cash	11,674
Accounts receivable	7,684
Prepaid expenses and other current assets	8,828
Property and equipment	610,477
Goodwill	120,364
Intangible assets	651
Other assets	6,897
Total assets acquired	766,575
Accounts payable	3,958
Accrued salaries and benefits	10,422
Other accrued expenses	6,690
Deferred tax liabilities - noncurrent	49,250
Other liabilities	7,704
Total liabilities assumed	78,024
Net assets acquired	688,551
Other [Member] \| 2014 Acquisitions [Member]
Business Acquisition [Line Items]
Accounts receivable	1,849
Prepaid expenses and other current assets	186
Property and equipment	27,203
Goodwill	31,951
Intangible assets	204
Other assets	3,224
Total assets acquired	64,617
Accounts payable	93
Other accrued expenses	732
Total liabilities assumed	825
Net assets acquired	$ 63,792
Other [Member] \| 2013 Acquisitions [Member]
Business Acquisition [Line Items]
Cash		873
Accounts receivable		5,840
Prepaid expenses and other current assets		3,039
Property and equipment		42,672
Goodwill		37,651
Intangible assets		1,910
Other assets		29
Total assets acquired		92,014
Accounts payable		7,487
Accrued salaries and benefits		3,079
Other accrued expenses		2,298
Other liabilities		2,360
Total liabilities assumed		15,224
Net assets acquired		76,790
UMC Facilities [Member] \| 2013 Acquisitions [Member]
Business Acquisition [Line Items]
Cash		52
Accounts receivable		4,961
Prepaid expenses and other current assets		691
Property and equipment		22,347
Goodwill		67,589
Intangible assets		1,505
Other assets		4,712
Total assets acquired		101,857
Accounts payable		1,535
Accrued salaries and benefits		588
Other accrued expenses		315
Total liabilities assumed		2,438
Net assets acquired		$ 99,419

Acquisitions - Other (Detail) - USD ($) $ in Thousands	12 Months Ended
Acquisitions - Other (Detail) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Business Combinations [Abstract]
Legal, accounting and other fees	$ 12,836	$ 5,535	$ 4,161
Severance and contract termination costs	814	1,615	3,951
Transaction-related expenses	$ 13,650	$ 7,150	$ 8,112

Acquisitions - CRC Acquisition (Detail) $ in Thousands		12 Months Ended
Acquisitions - CRC Acquisition (Detail) $ in Thousands	Feb. 11, 2015 USD ($) Beds State Center Facilities shares	Dec. 31, 2014 USD ($) Beds State Center	Dec. 31, 2013 USD ($)
Business Acquisition [Line Items]
Number of states covered \| State		24
Goodwill		$ 802,986	$ 661,549
CRC Health Group, Inc [Member]
Business Acquisition [Line Items]
Number of states covered \| State		30
Number of beds \| Beds		2,400
CRC Health Group, Inc [Member] \| Comprehensive Treatment Centers [Member]
Business Acquisition [Line Items]
Number of facilities acquired \| Center		81
Subsequent Event [Member] \| CRC Health Group, Inc [Member]
Business Acquisition [Line Items]
Total consideration related to acquisition	$ 1,300,000
Shares issued for acquisition \| shares	5,975,326
Number of inpatient facilities \| Facilities	35
Number of states covered \| State	30
Number of beds \| Beds	2,400
Cash	$ 15,000
Accounts receivable	50,000
Prepaid expenses and other current assets	16,000
Property and equipment	130,000
Goodwill	1,050,500
Intangible assets	15,000
Deferred tax assets - noncurrent	94,000
Total assets acquired	1,370,500
Accounts payable	6,000
Accrued salaries and benefits	23,000
Other accrued expenses	32,500
Long-term debt	895,467
Other liabilities	25,000
Total liabilities assumed	981,967
Net assets acquired	$ 388,533
Subsequent Event [Member] \| CRC Health Group, Inc [Member] \| Comprehensive Treatment Centers [Member]
Business Acquisition [Line Items]
Number of facilities acquired \| Center	81

Acquisitions - Pro Forma Information (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Revenue									$ 1,004,601	$ 713,408	$ 407,461
Income (loss) from continuing operations	$ 34,840	$ 33,156	$ 37,362	$ 20,796	$ 19,935	$ 22,287	$ 20,291	$ 6,732	126,154	69,245	$ 32,829
Revenue									1,569,877	1,480,631
Income from continuing operations, before income taxes									126,263	18,652
Acquisitions Completed in 2013 and 2014 [Member]
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Revenue									300,400
Income (loss) from continuing operations									$ 23,900
Acquisitions Completed in 2013 [Member]
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Revenue										80,800
Income (loss) from continuing operations										$ (300)

Other Intangible Assets - Other Identifiable Intangible Assets and Related Accumulated Amortization (Detail) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Schedule Of Finite and Indefinite Lived Other Intangible Assets [Line Items]
Intangible assets subject to amortization, Gross Carrying Amount	$ 3,347	$ 3,347
Intangible assets not subject to amortization, Gross Carrying Amount	20,774	19,152
Total	24,121	22,499
Intangible assets subject to amortization, Accumulated Amortization	(2,485)	(1,931)
Contract Intangible Assets [Member]
Schedule Of Finite and Indefinite Lived Other Intangible Assets [Line Items]
Intangible assets subject to amortization, Gross Carrying Amount	2,100	2,100
Intangible assets subject to amortization, Accumulated Amortization	(1,330)	(910)
Non-Compete Agreements [Member]
Schedule Of Finite and Indefinite Lived Other Intangible Assets [Line Items]
Intangible assets subject to amortization, Gross Carrying Amount	1,247	1,247
Intangible assets subject to amortization, Accumulated Amortization	(1,155)	(1,021)
Licenses and Accreditations [Member]
Schedule Of Finite and Indefinite Lived Other Intangible Assets [Line Items]
Intangible assets not subject to amortization, Gross Carrying Amount	9,184	8,391
Trade Names [Member]
Schedule Of Finite and Indefinite Lived Other Intangible Assets [Line Items]
Intangible assets not subject to amortization, Gross Carrying Amount	3,000	3,000
Certificates of Need [Member]
Schedule Of Finite and Indefinite Lived Other Intangible Assets [Line Items]
Intangible assets not subject to amortization, Gross Carrying Amount	$ 8,590	$ 7,761

Other Intangible Assets - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 0.6	$ 0.8	$ 0.6
Estimated amortization expense, 2014	0.5
Estimated amortization expense, 2015	0.4
Estimated amortization expense, 2016	0.0
Estimated amortization expense, 2017	0.0
Estimated amortization expense, 2018	$ 0.0

Discontinued Operations - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2012 USD ($)
Discontinued Operations and Disposal Groups [Abstract]
Loss on disposal of entity	$ 0.2

Discontinued Operations - Summary of Results from Discontinued Operations (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Discontinued Operations and Disposal Groups [Abstract]
Revenue			$ 3,576
Net loss from discontinued operations, net of income taxes	$ (192)	$ (691)	$ (101)

Long-Term Debt - Components of Long-Term Debt (Detail) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
Long-term debt	$ 1,096,270	$ 617,136
Long-term debt	1,096,270	617,136
Less: current portion	(26,965)	(15,195)
Long-term debt	1,069,305	601,941
Amended and Restated Credit Facility [Member] \| Senior Secured Term A Loans [Member]
Debt Instrument [Line Items]
Senior Secured	525,576	292,500
Amended and Restated Credit Facility [Member] \| Senior Secured Revolving Line of Credit [Member]
Debt Instrument [Line Items]
Senior Secured		53,500
12.875% Senior Notes Due 2018 [Member]
Debt Instrument [Line Items]
Senior Notes	96,420	96,216
6.125% Senior Notes Due 2021 [Member]
Debt Instrument [Line Items]
Senior Notes	150,000	150,000
5.125% Senior Notes due 2022 [Member]
Debt Instrument [Line Items]
Senior Notes	300,000
9.0% and 9.5% Revenue Bonds [Member]
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds	$ 24,274	$ 24,920

Long-Term Debt - Components of Long-Term Debt (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Mar. 12, 2013	Nov. 01, 2011
12.875% Senior Notes Due 2018 [Member]
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds	12.875%	12.875%	12.875%
Senior Notes	2018	2018
Debt instrument discount	$ 1,080	$ 1,283		$ 2,500
6.125% Senior Notes Due 2021 [Member]
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds	6.125%	6.125%
Senior Notes	2021	2021
5.125% Senior Notes due 2022 [Member]
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds	5.125%	5.125%
Senior Notes	2022	2022
9.0% and 9.5% Revenue Bonds [Member]
Debt Instrument [Line Items]
Debt instrument premium	$ 1,649	$ 2,100
9.0% Revenue Bonds [Member]
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds	9.00%	9.00%
9.5% Revenue Bonds [Member]
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds	9.50%	9.50%
Senior Secured Term A Loans [Member] \| Amended and Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt instrument discount	$ 1,924	$ 0

Long-Term Debt (Amended and Restated Senior Credit Facility) - Additional Information (Detail) - USD ($)							3 Months Ended			11 Months Ended	12 Months Ended			13 Months Ended
	Dec. 31, 2014	Dec. 15, 2014	Jun. 16, 2014	Feb. 13, 2014	Dec. 31, 2012	Jan. 04, 2011	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Feb. 12, 2013	Feb. 11, 2015	Feb. 06, 2015
Debt Instrument [Line Items]
Quarterly term loan principal payment											$ 284,000,000	$ 8,000,000	$ 16,000,000
Amended and Restated Credit Facility [Member]
Debt Instrument [Line Items]
Date entered into an agreement		Dec. 15, 2014		Feb. 13, 2014	Dec. 31, 2012	Apr. 01, 2011
Amount available under revolving line of credit	$ 299,600,000						$ 299,600,000			$ 299,600,000	$ 299,600,000
Debt instrument maturity date		Feb. 13, 2019									Feb. 11, 2022
Quarterly term loan principal payment		$ 1,900,000
Term loan repayments											$ 1,300,000
Consolidated funded debt, unrestricted and unencumbered cash to consolidated EBITDA		40,000,000
Commitment fee for undrawn amounts										0.40%				0.50%
Amended and Restated Credit Facility [Member] \| Miscellaneous Investments [Member]
Debt Instrument [Line Items]
Date entered into an agreement			Jun. 16, 2014
Restrictive covenants on investments, Description											The Company may now invest, in any given fiscal year, up to five percent (5%) of its total assets in both joint ventures and foreign subsidiaries, respectively; provided that the aggregate amount of investments in both joint ventures and foreign subsidiaries, respectively, may not exceed ten percent (10%) of its total assets over the life of the Amended and Restated Senior Credit Facility; provided further that the aggregate amount of investments made in both joint ventures and foreign subsidiaries collectively pursuant to the foregoing may not exceed fifteen percent (15%) of its total assets.
Amended and Restated Credit Facility [Member] \| Scenario, Plan [Member]
Debt Instrument [Line Items]
Additional term loans				$ 150,000,000
Line of Credit Facility, Increase (Decrease) for Period, Description											The Fourth Amendment also provides for a $150.0 million incremental credit facility, with the potential for unlimited additional incremental amounts, provided the Company meets certain financial ratios, in each case subject to customary conditions precedent to borrowing.
Amended and Restated Credit Facility [Member] \| March 31, 2015 to December 31, 2015 [Member]
Debt Instrument [Line Items]
Term loan principal repayments		6,700,000
Term loan repayments									$ 1,300,000
Amended and Restated Credit Facility [Member] \| March 31, 2016 to December 31, 2016 [Member]
Debt Instrument [Line Items]
Term loan principal repayments		10,000,000
Term loan repayments								$ 1,300,000
Amended and Restated Credit Facility [Member] \| March 31, 2017 to December 31, 2017 [Member]
Debt Instrument [Line Items]
Term loan principal repayments		13,400,000
Term loan repayments							$ 1,300,000
Amended and Restated Credit Facility [Member] \| March 31, 2018 to December 31, 2018 [Member]
Debt Instrument [Line Items]
Term loan principal repayments		16,700,000
Amended and Restated Credit Facility [Member] \| Senior Secured Term A Loans [Member]
Debt Instrument [Line Items]
Line of credit				300,000,000
Additional term loans		235,000,000
Amended and Restated Credit Facility [Member] \| Senior Secured Revolving Line of Credit [Member]
Debt Instrument [Line Items]
Line of credit				$ 300,000,000
Amended and Restated Credit Facility [Member] \| Seventh Amendment [Member]
Debt Instrument [Line Items]
Date entered into an agreement											Feb. 06, 2015
Amended and Restated Credit Facility [Member] \| Letter of Credit [Member] \| Seventh Amendment [Member] \| Subsequent Event [Member]
Debt Instrument [Line Items]
Line of credit																$ 20,000,000
Amended and Restated Credit Facility [Member] \| Swing Line Sublimit [Member] \| Seventh Amendment [Member] \| Subsequent Event [Member]
Debt Instrument [Line Items]
Line of credit																$ 20,000,000
Amended and Restated Credit Facility [Member] \| CRC Health Group, Inc [Member] \| Senior Secured Revolving Line of Credit [Member]
Debt Instrument [Line Items]
Temporary reserve		$ 110,000,000
Amended and Restated Credit Facility [Member] \| Eurodollar [Member]
Debt Instrument [Line Items]
Interest on borrowings	2.75%
Basis spread on variable rate	1.00%
Amended and Restated Credit Facility [Member] \| Base Rate Loans [Member]
Debt Instrument [Line Items]
Interest on borrowings	1.75%
Basis spread on variable rate	0.50%
Amended and Restated Credit Facility [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Interest on borrowings	2.75%
Amended and Restated Credit Facility [Member] \| Senior Debt Obligations [Member] \| First Incremental Amendment [Member]
Debt Instrument [Line Items]
Date entered into an agreement											Feb. 11, 2015
Amended and Restated Credit Facility [Member] \| Senior Debt Obligations [Member] \| First Incremental Amendment [Member] \| Subsequent Event [Member]
Debt Instrument [Line Items]
Line of credit															$ 500,000,000

Long-Term Debt (12.875% Senior Notes due 2018) - Additional Information (Detail) - USD ($) $ in Thousands		12 Months Ended
	Mar. 12, 2013	Dec. 31, 2014	Dec. 31, 2013	Nov. 01, 2011
Debt Instrument [Line Items]
Debt extinguishment charge			$ (9,350)
12.875% Senior Notes Due 2018 [Member]
Debt Instrument [Line Items]
Issued Senior Notes				$ 150,000
Issue rate of senior notes				98.323%
Debt instrument discount		$ 1,080	$ 1,283	$ 2,500
Interest on the notes		Semi-annually, in arrears, on November 1 and May 1 of each year
Debt instrument, maximum redemption amount	$ 52,500
Debt instrument, redemption price percentage	112.875%
Senior notes interest percentage	12.875%	12.875%	12.875%
Redemption percentage of senior notes	35.00%
Debt extinguishment charge	$ (9,350)

Long-Term Debt (6.125% Senior Notes due 2021) - Additional Information (Detail) - 6.125% Senior Notes Due 2021 [Member] - USD ($) $ in Millions		12 Months Ended
	Mar. 12, 2013	Dec. 31, 2014
Debt Instrument [Line Items]
Issued Senior Notes	$ 150.0
Debt instrument maturity date	Mar. 15, 2021
Interest on the notes		Payable semi-annually in arrears on March 15 and September 15 of each year.
Senior notes terms		The Company may redeem the 6.125% Senior Notes at its option, in whole or part, at any time prior to March 15, 2016, at a price equal to 100% of the principal amount of the 6.125% Senior Notes redeemed, plus accrued and unpaid interest to the redemption date and plus an applicable premium. The Company may redeem the 6.125% Senior Notes, in whole or in part, on or after March 15, 2016, at the redemption prices set forth in the indenture governing the 6.125% Senior Notes plus accrued and unpaid interest to the redemption date. At any time on or before March 15, 2016, the Company may elect to redeem up to 35% of the aggregate principal amount of the 6.125% Senior Notes at a redemption price equal to 106.125% of the principal amount thereof, plus accrued and unpaid interest to the redemption date, with the net proceeds of one or more equity offerings.
Redemption percentage of senior notes		35.00%
Prior to March 15, 2016 [Member]
Debt Instrument [Line Items]
Debt instrument, redemption price percentage		100.00%
Prior to March 15, 2016, 35% Redemption [Member]
Debt Instrument [Line Items]
Debt instrument, redemption price percentage		106.125%

Long-Term Debt (5.125% Senior Notes due 2022) - Additional Information (Detail) - 5.125% Senior Notes due 2022 [Member] - USD ($) $ in Millions		12 Months Ended
	Jul. 01, 2014	Dec. 31, 2014
Debt Instrument [Line Items]
Issued Senior Notes	$ 300.0
Debt instrument maturity date	Jul. 01, 2022
Interest on the notes		Payable semi-annually in arrears on January 1 and July 1 of each year, beginning on January 1, 2015.
Senior notes terms		The Company may redeem the 5.125% Senior Notes at its option, in whole or part, at any time prior to July 1, 2017, at a price equal to 100% of the principal amount of the 5.125% Senior Notes redeemed, plus accrued and unpaid interest to the redemption date and plus an applicable premium. The Company may redeem the 5.125% Senior Notes, in whole or in part, on or after July 1, 2017, at the redemption prices set forth in the indenture governing the 5.125% Senior Notes plus accrued and unpaid interest to the redemption date. At any time on or before July 1, 2017, the Company may elect to redeem up to 35% of the aggregate principal amount of the 5.125% Senior Notes at a redemption price equal to 105.125% of the principal amount thereof, plus accrued and unpaid interest to the redemption date, with the net proceeds of one or more equity offerings.
Redemption percentage of senior notes		35.00%
Prior to July 1, 2017 [Member]
Debt Instrument [Line Items]
Debt instrument, redemption price percentage		100.00%
Prior to July 1, 2017, 35% Redemption [Member]
Debt Instrument [Line Items]
Debt instrument, redemption price percentage		105.125%

Long-Term Debt (5.625% Senior Notes due 2023) - Additional Information (Detail) - 5.625% Senior Notes due 2023 [Member ] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Feb. 11, 2015
Debt Instrument [Line Items]
Debt instrument maturity date	Feb. 15, 2023
Date of initial payments on senior notes	Aug. 15, 2015
Redemption percentage of senior notes	35.00%
Prior to February 15, 2018 [Member]
Debt Instrument [Line Items]
Debt instrument, redemption price percentage	100.00%
Prior to February 15, 2018, 35% Redemption [Member]
Debt Instrument [Line Items]
Debt instrument, redemption price percentage	105.625%
Subsequent Event [Member]
Debt Instrument [Line Items]
Issued Senior Notes		$ 375.0
Debt instrument interest rate		5.625%

Long-Term Debt (9.0% and 9.5% Revenue Bonds) - Additional Information (Detail) - 9.0% and 9.5% Revenue Bonds [Member] - USD ($) $ in Thousands	Nov. 11, 2011	Dec. 31, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds		$ 24,274	$ 24,920
Debt instrument premium		1,649	2,100
Park Royal [Member]
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds	$ 23,000
Debt service reserve fund within other assets		$ 2,300	$ 2,300
Debt instrument premium	2,600
Fair Value Measurement [Member] \| Park Royal [Member]
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds	25,600
9.0% Revenue Bonds [Member] \| Park Royal [Member]
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds	$ 7,500
Debt instrument maturity date	Dec. 01, 2030
9.5% Revenue Bonds [Member] \| Park Royal [Member]
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds	$ 15,500
Debt instrument maturity date	Dec. 01, 2040

Long-Term Debt (Other) - Schedule of Aggregate Maturities of Long-Term Debt (Detail) $ in Thousands	Dec. 31, 2014 USD ($)
Debt Disclosure [Abstract]
2015	$ 26,965
2016	40,360
2017	53,755
2018	67,155
2019	340,555
Thereafter	568,835
Total	$ 1,097,625

Equity - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions			12 Months Ended
	Feb. 11, 2015	Jun. 17, 2014	Dec. 31, 2014	Dec. 31, 2013
Equity [Line Items]
Preferred stock, number of shares proposed to be issued			10,000,000	10,000,000
Common stock, number of shares proposed to be issued			90,000,000	90,000,000
Common stock voting rights			One vote for each share
Common stock offered		8,881,794	59,211,859	50,070,980
Common stock offer price		$ 44.00	$ 0.01	$ 0.01
Underwriting discount amount		$ 15.6
Additional offering-related expenses		0.8
Net proceeds from sale of shares		$ 374.4
Subsequent Event [Member] \| CRC Health Group, Inc [Member]
Equity [Line Items]
Total consideration related to acquisition	$ 1,300.0
Common stock shares, issued	5,975,326
Maximum [Member]
Equity [Line Items]
Preferred stock, number of shares proposed to be issued			10,000,000
Common stock, number of shares proposed to be issued			90,000,000

Equity-Based Compensation - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Authorized common stock	4,700,000
Equity incentive plan available for future grant	2,671,030
Annual increments in employee grants	25.00%
Stock options, contractual term	10 years
Equity-based compensation expense	$ 10,058,000	$ 5,249,000	$ 2,267,000
Unrecognized compensation expense related to unvested options	$ 31,300,000
Vesting period	1 year 6 months
Warrants outstanding and exercisable	0
Deferred income tax benefit	$ 7,215,000	10,083,000	2,727,000
Tax realized from stock options exercised	4,600,000	1,800,000	$ 0
Stock Compensation Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Deferred income tax benefit	$ 4,100,000	$ 2,100,000

Equity-Based Compensation - Stock Option Activity (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Options outstanding, Beginning balance	798,809	555,097
Options granted	226,663	411,800
Options exercised	(210,199)	(126,662)
Options cancelled	(77,851)	(41,426)
Options outstanding, Ending balance	737,422	798,809	555,097
Options outstanding, Weighted Average Exercise Price, Beginning balance	$ 21.93	$ 13.13
Options exercisable, Ending balance	91,947	133,647
Options granted, Weighted Average Exercise Price	$ 49.80	$ 30.55
Options exercised, Weighted Average Exercise Price	14.93	9.36
Options cancelled, Weighted Average Exercise Price	27.85	23.50
Options outstanding, Weighted Average Exercise Price, Ending balance	$ 32.19	$ 21.93	$ 13.13
Options outstanding, Aggregate Intrinsic Value, Beginning balance	$ 10,700	$ 5,632
Options exercisable, Weighted Average Exercise Price, Ending balance	$ 28.87	$ 11.15
Options granted, Aggregate Intrinsic Value	$ 209	$ 2,059
Options granted, Weighted Average Remaining Contractual Term	9 years 3 months	9 years 3 months 18 days
Options exercised, Aggregate Intrinsic Value	$ 4,994	$ 2,803
Options outstanding, Weighted Average Remaining Contractual Term	8 years 1 month 2 days	8 years 2 months 12 days	7 years 6 months 11 days
Options cancelled, Aggregate Intrinsic Value	$ 0	$ 0
Options exercisable, Weighted Average Remaining Contractual Term, Ending balance	6 years 3 months 18 days	4 years 9 months 22 days
Options outstanding, Aggregate Intrinsic Value, Ending balance	$ 14,512	$ 10,700	$ 5,632
Options exercisable, Aggregate Intrinsic Value, Ending balance	$ 3,326	$ 3,472

Equity-Based Compensation - Restricted Stock Activity (Detail) - Restricted Stock Award [Member] - $ / shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested, Number of Shares/Units, Beginning balance	461,697	318,063
Granted, Number of Shares	468,484	290,845
Cancelled, Number of Shares	(75,369)	(53,056)
Vested, Number of Shares	(132,784)	(94,155)
Unvested, Number of Shares/Units, Ending balance	722,028	461,697
Unvested, Weighted Average Grant-Date Fair Value, Beginning balance	$ 24.96	$ 15.73
Granted, Weighted Average Grant-Date Fair Value	48.99	31.31
Cancelled, Weighted Average Grant-Date Fair Value	36.36	21.27
Vested, Weighted Average Grant-Date Fair Value	22.81	15.52
Unvested , Weighted Average Grant-Date Fair Value, Ending balance	$ 39.77	$ 24.96

Equity-Based Compensation - Restricted Stock Unit Activity (Detail) - Restricted Stock Units [Member] - $ / shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested, Number of Shares/Units, Beginning balance	95,751	68,628
Granted, Number of Units	108,449	72,876
Cancelled, Number of Units	0	0
Vested, Number of Units	(79,087)	(45,753)
Unvested, Number of Shares/Units, Ending balance	125,113	95,751
Unvested, Weighted Average Grant-Date Fair Value, Beginning balance	$ 23.05	$ 16.11
Granted, Weighted Average Grant-Date Fair Value	50.75	29.39
Cancelled, Weighted Average Grant-Date Fair Value	0	0
Vested, Weighted Average Grant-Date Fair Value	21.81	16.11
Unvested , Weighted Average Grant-Date Fair Value, Ending balance	$ 38.73	$ 23.05

Equity-Based Compensation - Schedule of Stock Options Valuation Assumptions (Detail) - $ / shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Weighted average grant-date fair value of options	$ 17.14	$ 11.62
Risk-free interest rate	1.70%	1.00%
Expected volatility	36.00%	40.00%
Expected life (in years)	5 years 6 months	5 years 6 months

Income Taxes - Components of Provision for Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Current:
Federal	$ 30,834	$ 13,202	$ 7,045
State	3,959	2,513	2,553
Foreign	914	177
Total current	35,707	15,892	9,598
Deferred:
Federal	2,667	7,802	3,144
State	353	1,786	(417)
Foreign	4,195	495
Total deferred provision	7,215	10,083	2,727
Provision for (benefit from) income taxes	$ 42,922	$ 25,975	$ 12,325

Income Taxes - Income Taxes Associated with Continuing Operations and Discontinued Operations (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Continuing operations	$ 42,922	$ 25,975	$ 12,325
Discontinued operations	(22)	(544)	(197)
Total	$ 42,900	$ 25,431	$ 12,128

Income Taxes - Effective Income Tax Rate (Detail)	12 Months Ended
Income Taxes - Effective Income Tax Rate (Detail)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
U.S. federal statutory rate on income before income taxes	35.00%	35.00%	35.00%
Impact of foreign operations	(4.20%)	(0.30%)
State income taxes, net of federal tax effect	2.30%	4.90%	3.80%
Permanent differences	1.10%	0.80%	0.80%
Change in valuation allowance	(0.10%)	(0.30%)	(0.90%)
Other	(0.10%)	(2.60%)	(1.20%)
Effective income tax rate	34.00%	37.50%	37.50%

Income Taxes - Deferred Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Deferred tax assets:
Net operating losses and tax credit carryforwards - federal and state	$ 5,082	$ 905
Fixed asset basis difference		1,141
Bad debt allowance	9,028	7,490
Accrued compensation and severance	11,517	7,669
Pension reserves	1,975
Insurance reserves	4,621	2,680
Leases	850	1,083
Accrued expenses	41	91
Other assets	1,989	1,553
Total gross deferred tax assets	35,103	22,612
Less: valuation allowance	(4,734)	(124)
Deferred tax assets	30,369	22,488
Deferred tax liabilities:
Fixed asset basis difference	(38,147)
Prepaid items	(1,705)	(1,560)
Intangible assets	(21,094)	(13,196)
Other liabilities	(7)
Total deferred tax liabilities	(60,953)	(14,756)
Total net deferred tax (liability) asset	$ (30,584)	$ 7,732

Income Taxes - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Examination [Line Items]
Current deferred tax assets	$ 20,200,000	$ 15,700,000
Non-current deferred tax assets	13,100,000
Non-current deferred tax liabilities	63,900,000	8,000,000
Valuation allowance against deferred tax assets	4,734,000	124,000
Foreign net operating loss carryforward	23,700,000
State net operating loss carry forwards	$ 7,100,000	18,500,000
Operating loss carryforwards expiration start year	2031
Operating loss carryforwards expiration end year	2033
Expiration of State tax credits	2026
Income taxes receivable	$ 3,399,000	4,005,000
Income tax payable included in other accrued liabilities	100,000
Interest and penalties recognized	$ 300,000	100,000	$ 0.0
Maximum [Member]
Income Tax Examination [Line Items]
Exemption of tax credit	50.00%
Internal Revenue Service (IRS) [Member] \| Earliest Tax Year [Member]
Income Tax Examination [Line Items]
Period of examination by internal revenue service	2011
Internal Revenue Service (IRS) [Member] \| Latest Tax Year [Member]
Income Tax Examination [Line Items]
Period of examination by internal revenue service	2014
Payroll [Member] \| Maximum [Member]
Income Tax Examination [Line Items]
Exemption of tax credit	15.00%
Foreign Tax Authority [Member]
Income Tax Examination [Line Items]
Period of examination by internal revenue service minimum	2010
Period of examination by internal revenue service maximum	2014
State and Local Jurisdiction [Member]
Income Tax Examination [Line Items]
Period of examination by internal revenue service minimum	2010
Period of examination by internal revenue service maximum	2014
Other Liabilities [Member]
Income Tax Examination [Line Items]
Income tax payable included in other accrued liabilities	$ 2,400,000	$ 1,300,000
Non US Subsidiaries [Member]
Income Tax Examination [Line Items]
Undistributed earnings of the foreign subsidiaries	$ 20,700,000

Income Taxes - Unrecognized Income Tax Benefits (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Balance at January 1	$ 1,893	$ 1,195	$ 1,050
Additions based on tax positions related to the current year		321	262
Additions for tax positions of prior years	1,030	377
Reductions as a result of the lapse of applicable statutes of limitations			(117)
Balance at December 31	$ 2,923	$ 1,893	$ 1,195

Derivatives - Additional Information (Detail) $ in Millions	12 Months Ended
Derivatives - Additional Information (Detail) $ in Millions	Dec. 31, 2014 USD ($)	Jun. 30, 2014 Contract
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Number of foreign currency forward contracts \| Contract		2
Gain associated with changes in fair value of the foreign currency forward contracts \| $	$ 15.3

Fair Value Measurements - Carrying Amounts and Fair Values of Long-Term Debt and Contingent Consideration Liability (Detail) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
12.875% Senior Notes Due 2018 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	$ 96,420	$ 96,216
6.125% Senior Notes Due 2021 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	150,000	150,000
5.125% Senior Notes due 2022 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	300,000
9.0% and 9.5% Revenue Bonds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
9.0% and 9.5% Revenue Bonds	24,274	24,920
Fair Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Contingent consideration liabilities	3,000	6,500
Fair Value [Member] \| Amended and Restated Credit Facility [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amended and Restated Senior Credit Facility	525,576	346,000
Fair Value [Member] \| 12.875% Senior Notes Due 2018 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	109,688	118,706
Fair Value [Member] \| 6.125% Senior Notes Due 2021 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	153,000	155,625
Fair Value [Member] \| 5.125% Senior Notes due 2022 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	295,500
Fair Value [Member] \| 9.0% and 9.5% Revenue Bonds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
9.0% and 9.5% Revenue Bonds	24,274	24,920
Carrying Amounts [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Contingent consideration liabilities	3,000	6,500
Carrying Amounts [Member] \| Amended and Restated Credit Facility [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amended and Restated Senior Credit Facility	525,576	346,000
Carrying Amounts [Member] \| 12.875% Senior Notes Due 2018 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	96,420	96,216
Carrying Amounts [Member] \| 6.125% Senior Notes Due 2021 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	150,000	150,000
Carrying Amounts [Member] \| 5.125% Senior Notes due 2022 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	300,000
Carrying Amounts [Member] \| 9.0% and 9.5% Revenue Bonds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
9.0% and 9.5% Revenue Bonds	$ 24,274	$ 24,920

Fair Value Measurements - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Sep. 03, 2014	Dec. 31, 2013	Mar. 12, 2013
Disclosures Regarding Financial Instruments [Line Items]
Contingent consideration, Paid	$ 5,000
Park Royal [Member]
Disclosures Regarding Financial Instruments [Line Items]
Increase (Decrease) in fair value of contingent consideration liability	500
Contingent consideration, Paid	5,000
Contingent consideration liability	7,000
McCallum [Member]
Disclosures Regarding Financial Instruments [Line Items]
Increase (Decrease) in fair value of contingent consideration liability	(500)
Cash payments for earn-out agreement	$ 6,000	$ 6,000
12.875% Senior Notes Due 2018 [Member]
Disclosures Regarding Financial Instruments [Line Items]
Debt instrument interest rate	12.875%		12.875%	12.875%
6.125% Senior Notes Due 2021 [Member]
Disclosures Regarding Financial Instruments [Line Items]
Debt instrument interest rate	6.125%		6.125%
5.125% Senior Notes due 2022 [Member]
Disclosures Regarding Financial Instruments [Line Items]
Debt instrument interest rate	5.125%		5.125%
9.0% Revenue Bonds [Member]
Disclosures Regarding Financial Instruments [Line Items]
Debt instrument interest rate	9.00%		9.00%
9.5% Revenue Bonds [Member]
Disclosures Regarding Financial Instruments [Line Items]
Debt instrument interest rate	9.50%		9.50%

Leases - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Operating Leased Assets [Line Items]
Rent expense	$ 12,201	$ 10,049	$ 7,838
Minimum [Member]
Operating Leased Assets [Line Items]
Original terms of the leases	5 years
Maximum [Member]
Operating Leased Assets [Line Items]
Original terms of the leases	10 years

Leases - Schedule of Aggregate Minimum Lease Payments under Non-cancelable Operating Leases (Detail) $ in Thousands	Dec. 31, 2014 USD ($)
Leases [Abstract]
2015	$ 9,951
2016	8,976
2017	6,439
2018	4,118
2019	2,678
Thereafter	18,551
Total minimum rental obligations	$ 50,713

Segment Information - Additional Information (Detail)	12 Months Ended
Segment Information - Additional Information (Detail)	Dec. 31, 2014 Beds State Facilities
Segment Reporting Information [Line Items]
Number of facilities \| Facilities	78
Number beds \| Beds	5,800
Number of operating states \| State	24
U.S. Facilities [Member]
Segment Reporting Information [Line Items]
Number of facilities \| Facilities	54
Number of operating states \| State	24
U.S. Facilities [Member] \| Minimum [Member]
Segment Reporting Information [Line Items]
Number beds \| Beds	4,600
U.K. Facilities [Member]
Segment Reporting Information [Line Items]
Number of facilities \| Facilities	24
U.K. Facilities [Member] \| Minimum [Member]
Segment Reporting Information [Line Items]
Number beds \| Beds	1,300

Segment Information - Summary of Financial Information by Operating Segment (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting Information [Line Items]
Revenue									$ 1,004,601	$ 713,408	$ 407,461
Segment EBITDA									215,488	145,334	80,959
Equity-based compensation expense									(10,058)	(5,249)	(2,267)
Gain on foreign currency derivatives									15,262
Debt extinguishment costs										(9,350)
Transaction-related expenses									(13,650)	(7,150)	(8,112)
Interest expense, net									(48,221)	(37,250)	(29,769)
Depreciation and amortization									(32,667)	(17,090)	(7,982)
Income (loss) from continuing operations before income taxes	$ 34,840	$ 33,156	$ 37,362	$ 20,796	$ 19,935	$ 22,287	$ 20,291	$ 6,732	126,154	69,245	32,829
U.S. Facilities [Member]
Segment Reporting Information [Line Items]
Revenue									850,625	710,695	406,718
Segment EBITDA									209,668	172,625	102,443
U.K. Facilities [Member]
Segment Reporting Information [Line Items]
Revenue									151,127
Segment EBITDA									39,832
Corporate and Other [Member]
Segment Reporting Information [Line Items]
Revenue									2,849	2,713	743
Segment EBITDA									$ (34,012)	$ (27,291)	$ (21,484)

Segment Information - Summary of Financial Information by Operating Segment, Goodwill (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2014 USD ($)
Goodwill:
Beginning balance	$ 661,549
Increase from 2014 acquisitions	152,315
Foreign currency translation loss	(11,323)
Other	445
Ending balance	802,986
U.S. Facilities [Member]
Goodwill:
Beginning balance	661,549
Increase from 2014 acquisitions	31,951
Other	445
Ending balance	693,945
U.K. Facilities [Member]
Goodwill:
Increase from 2014 acquisitions	120,364
Foreign currency translation loss	(11,323)
Ending balance	$ 109,041

Segment Information - Summary of Financial Information by Operating Segment, Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Assets:
Assets	$ 2,223,590	$ 1,224,659
U.S. Facilities [Member]
Assets:
Assets	1,327,563	1,155,813
U.K. Facilities [Member]
Assets:
Assets	726,693
Corporate and Other [Member]
Assets:
Assets	$ 169,334	$ 68,846

Segment Information - Summary of Financial Information by Operating Segment, Assets (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	$ 1,069,700	$ 370,109
U.S. Facilities [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	478,100	358,700
U.K. Facilities [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	578,600
Corporate and Other [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	$ 13,000	$ 11,400

Employee Benefit Plans - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jul. 01, 2014
Defined Benefit Plan, Funded Status of Plan [Abstract]
Defined contribution plan, employer discretionary contribution amount	$ 100	$ 300	$ 100
Pension liability under defined benefit pension plan	9,554			$ 7,602
Employee benefit plan, Accumulated other comprehensive income Loss	2,800
Employee benefit plan, Accumulated other comprehensive income Loss , Net	$ 2,200

Employee Benefit Plans - Summary of Funded Status of Partnerships in Care Pension Plan Based Upon Actuarial Valuations (Detail) - USD ($) $ in Thousands	Dec. 31, 2014	Jul. 01, 2014
Reconciliation of funded status:
Projected benefit obligation	$ 66,910
Fair value of plan assets	57,356
Funded status	$ 9,554	$ 7,602

Employee Benefit Plans - Summary of Changes in Partnerships in Care Pension Plan Pension Liability (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2014 USD ($)
Defined Benefit Plan, Funded Status of Plan [Abstract]
Employer contributions	$ (825)
Net pension benefit expense	729
Pension liability adjustment	2,758
Foreign currency translation loss	(710)
Pension liability at December 31, 2014	$ 9,554

Employee Benefit Plans - Summary of Assumptions Used to Determine Plan Benefit Obligation (Detail)	12 Months Ended
	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Discount rate	3.60%
Compensation increase rate	3.40%
Measurement date	Dec. 31, 2014

Employee Benefit Plans - Summary of Components of Net Pension Plan Expense (Detail) $ in Thousands	6 Months Ended
	Dec. 31, 2014 USD ($)
Compensation and Retirement Disclosure [Abstract]
Interest cost on projected benefit obligation	$ 1,389
Service cost on projected benefit obligation	545
Expected return on assets	(1,205)
Total pension plan expense	$ 729

Employee Benefit Plans - Summary of Assumptions Used to Determine Net Periodic Pension Plan Expense (Detail)	6 Months Ended
	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Discount rate	3.60%
Expected long-term rate of return on plan assets	4.30%

Employee Benefit Plans - Schedule of Weighted-Average Asset Allocation by Asset Category in Partnerships in Care Pension Plan (Detail)	12 Months Ended
	Dec. 31, 2014
Cash and Cash Equivalents [Member]
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation	1.30%
United Kingdom Government Obligation [Member]
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation	16.10%
Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation	43.60%
Debt Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation	34.10%
Other [Member]
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation	4.90%

Quarterly Information (Unaudited) - Schedule of Quarterly Financial Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Quarterly Financial Information Disclosure [Abstract]
Revenue	$ 294,901	$ 294,479	$ 213,803	$ 201,418	$ 189,999	$ 184,702	$ 177,494	$ 161,213	$ 1,030,784	$ 735,109	$ 413,850
Income from continuing operations before income taxes	34,840	33,156	37,362	20,796	19,935	22,287	20,291	6,732	126,154	69,245	32,829
Net income	$ 22,129	$ 25,402	$ 22,451	$ 13,058	$ 12,280	$ 14,364	$ 12,197	$ 3,738	$ 83,040	$ 42,579	$ 20,403
Basic net income per share	$ 0.38	$ 0.43	$ 0.43	$ 0.26	$ 0.25	$ 0.29	$ 0.24	$ 0.07	$ 1.51	$ 0.85	$ 0.53
Diluted net income per share	$ 0.37	$ 0.43	$ 0.43	$ 0.26	$ 0.24	$ 0.29	$ 0.24	$ 0.07	$ 1.50	$ 0.85	$ 0.53

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Quarterly Information (Unaudited) - Schedule of Quarterly Financial Information (Parenthetical) (Detail) - USD ($) $ in Thousands	3 Months Ended			12 Months Ended
	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2014
Quarterly Financial Information [Line Items]
Debt extinguishment costs				$ (9,350)
Partnerships in Care and CRC [Member]
Quarterly Financial Information [Line Items]
Gain on foreign currency derivatives	$ 1,500	$ 13,700
12.875% Senior Notes Due 2018 [Member]
Quarterly Financial Information [Line Items]
Debt extinguishment costs			$ (9,350)
Debt extinguishment costs, net of taxes			(5,800)
Redemption amount			$ 52,500
Debt instrument interest rate			12.875%		12.875%

Subsequent Events - Additional Information (Detail) $ in Millions		12 Months Ended
	Feb. 11, 2015 USD ($) State Facilities shares	Dec. 31, 2014 State Facilities
Subsequent Event [Line Items]
Number of facilities operated by CRC \| Facilities		78
Number of states covered under treatment services CRC \| State		24
CRC Health Group, Inc [Member]
Subsequent Event [Line Items]
Number of states covered under treatment services CRC \| State		30
Acquisition completion date		Feb. 11, 2015
Subsequent Event [Member] \| CRC Health Group, Inc [Member]
Subsequent Event [Line Items]
Business acquisition cash paid	$ 1,300.0
Number of facilities operated by CRC \| Facilities	35
Number of states covered under treatment services CRC \| State	30
Acquisition completion date	Feb. 11, 2015
Shares issued for acquisition \| shares	5,975,326
Subsequent Event [Member] \| TLB Facility [Member] \| CRC Health Group, Inc [Member]
Subsequent Event [Line Items]
Amended and Restated Senior Credit Facility	$ 500.0
Subsequent Event [Member] \| 5.625% Senior Notes Due 2023 [Member] \| CRC Health Group, Inc [Member]
Subsequent Event [Line Items]
Issued Senior Notes	$ 375.0
Issue rate of senior notes	5.625%
Subsequent Event [Member] \| Senior Secured Revolving Line of Credit [Member] \| CRC Health Group, Inc [Member]
Subsequent Event [Line Items]
Amended and Restated Senior Credit Facility	$ 25.0

Financial Information for the Company and Its Subsidiaries - Additional Information (Detail)	Dec. 31, 2014	Mar. 31, 2013
12.875% Senior Notes Due 2018 [Member]
Line of Credit Facility [Line Items]
Debt instrument interest rate	12.875%	12.875%
6.125% Senior Notes Due 2021 [Member]
Line of Credit Facility [Line Items]
Debt instrument interest rate	6.125%
5.125% Senior Notes due 2022 [Member]
Line of Credit Facility [Line Items]
Debt instrument interest rate	5.125%
5.625% Senior Notes Due 2023 [Member]
Line of Credit Facility [Line Items]
Debt instrument interest rate	5.625%

Financial Information for the Company and Its Subsidiaries - Summary of Condensed Consolidating Balance Sheets (Detail) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 94,040	$ 4,569	$ 49,399	$ 61,118
Accounts receivable, net	118,378	95,885
Deferred tax assets	20,155	15,703
Other current assets	41,570	28,969
Total current assets	274,143	145,126
Property and equipment, net	1,069,700	370,109
Goodwill	802,986	661,549
Intangible assets, net	21,636	20,568
Deferred tax assets - noncurrent	13,141
Other assets	41,984	27,307
Total assets	2,223,590	1,224,659
Current liabilities:
Current portion of long-term debt	26,965	15,195
Accounts payable	48,696	36,026
Accrued salaries and benefits	59,317	37,721
Other accrued liabilities	30,956	25,748
Total current liabilities	165,934	114,690
Long-term debt	1,069,305	601,941
Deferred tax liabilities - noncurrent	63,880	7,971
Other liabilities	43,506	19,347
Total liabilities	1,342,625	743,949
Total equity	880,965	480,710	432,550	96,365
Total liabilities and equity	2,223,590	1,224,659
Consolidation, Eliminations [Member]
Current assets:
Cash and cash equivalents		(1,925)
Total current assets		(1,925)
Deferred tax assets - noncurrent	(5,666)
Investment in subsidiaries	(1,759,337)	(1,034,160)
Other assets	(181,774)	(38,686)
Total assets	(1,946,777)	(1,074,771)
Current liabilities:
Accounts payable		(1,925)
Total current liabilities		(1,925)
Long-term debt	(181,774)	(32,925)
Deferred tax liabilities - noncurrent	(5,666)	(5,761)
Total liabilities	(187,440)	(40,611)
Total equity	(1,759,337)	(1,034,160)
Total liabilities and equity	(1,946,777)	(1,074,771)
Parent [Member]
Current assets:
Deferred tax assets - noncurrent	4,563
Investment in subsidiaries	1,759,337	1,034,160
Other assets	202,708	46,236
Total assets	1,966,608	1,080,396
Current liabilities:
Current portion of long-term debt	26,750	15,000
Other accrued liabilities	13,647	4,876
Total current liabilities	40,397	19,876
Long-term debt	1,045,246	577,216
Deferred tax liabilities - noncurrent		2,594
Total liabilities	1,085,643	599,686
Total equity	880,965	480,710
Total liabilities and equity	1,966,608	1,080,396
Combined Subsidiary Guarantors [Member]
Current assets:
Cash and cash equivalents	76,685		49,307	$ 61,118
Accounts receivable, net	100,797	86,597
Deferred tax assets	18,395	15,284
Other current assets	36,049	27,886
Total current assets	231,926	129,767
Property and equipment, net	451,943	340,175
Goodwill	596,611	564,539
Intangible assets, net	19,057	18,578
Other assets	18,727	11,675
Total assets	1,318,264	1,064,734
Current liabilities:
Accounts payable	39,486	36,289
Accrued salaries and benefits	47,597	36,027
Other accrued liabilities	7,688	19,982
Total current liabilities	94,771	92,298
Deferred tax liabilities - noncurrent	21,027	11,138
Other liabilities	33,321	19,347
Total liabilities	149,119	122,783
Total equity	1,169,145	941,951
Total liabilities and equity	1,318,264	1,064,734
Combined Non-Guarantors [Member]
Current assets:
Cash and cash equivalents	17,355	6,494	$ 92
Accounts receivable, net	17,581	9,288
Deferred tax assets	1,760	419
Other current assets	5,521	1,083
Total current assets	42,217	17,284
Property and equipment, net	617,757	29,934
Goodwill	206,375	97,010
Intangible assets, net	2,579	1,990
Deferred tax assets - noncurrent	14,244
Other assets	2,323	8,082
Total assets	885,495	154,300
Current liabilities:
Current portion of long-term debt	215	195
Accounts payable	9,210	1,662
Accrued salaries and benefits	11,720	1,694
Other accrued liabilities	9,621	890
Total current liabilities	30,766	4,441
Long-term debt	205,833	57,650
Deferred tax liabilities - noncurrent	48,519
Other liabilities	10,185
Total liabilities	295,303	62,091
Total equity	590,192	92,209
Total liabilities and equity	$ 885,495	$ 154,300

Financial Information for the Company and Its Subsidiaries - Summary of Condensed Consolidating Statement of Statement of Comprehensive Income (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Condensed Financial Statements, Captions [Line Items]
Revenue before provision for doubtful accounts	$ 294,901	$ 294,479	$ 213,803	$ 201,418	$ 189,999	$ 184,702	$ 177,494	$ 161,213	$ 1,030,784	$ 735,109	$ 413,850
Provision for doubtful accounts									(26,183)	(21,701)	(6,389)
Revenue									1,004,601	713,408	407,461
Salaries, wages and benefits									575,412	407,962	239,639
Professional fees									52,482	37,171	19,019
Supplies									48,422	37,569	19,496
Rents and leases									12,201	10,049	7,838
Other operating expenses									110,654	80,572	42,777
Depreciation and amortization									32,667	17,090	7,982
Interest expense, net									48,221	37,250	29,769
Gain on foreign currency derivatives									(15,262)
Debt extinguishment costs										9,350
Transaction-related expenses									13,650	7,150	8,112
Total expenses									878,447	644,163	374,632
(Loss) income from continuing operations before income taxes	34,840	33,156	37,362	20,796	19,935	22,287	20,291	6,732	126,154	69,245	32,829
(Benefit from) provision for income taxes									42,922	25,975	12,325
Income (loss) from continuing operations									83,232	43,270	20,504
Loss from discontinued operations, net of income taxes									(192)	(691)	(101)
Net income (loss)	$ 22,129	$ 25,402	$ 22,451	$ 13,058	$ 12,280	$ 14,364	$ 12,197	$ 3,738	83,040	42,579	20,403
Other comprehensive loss:
Foreign currency translation loss									(66,206)
Pension liability adjustment, net									(2,164)
Other comprehensive loss									(68,370)
Comprehensive income (loss)									14,670	42,579	20,403
Consolidation, Eliminations [Member]
Condensed Financial Statements, Captions [Line Items]
Equity in earnings of subsidiaries									(97,414)	(73,538)	(40,251)
Income (loss) from continuing operations									(97,414)	(73,538)	(40,251)
Net income (loss)									(97,414)	(73,538)	(40,251)
Other comprehensive loss:
Comprehensive income (loss)									(97,414)	(73,538)	(40,251)
Parent [Member]
Condensed Financial Statements, Captions [Line Items]
Salaries, wages and benefits									10,058	5,249	2,267
Interest expense, net									27,199	35,327	29,512
Gain on foreign currency derivatives									(15,262)
Debt extinguishment costs										9,350
Total expenses									21,995	49,926	31,779
(Loss) income from continuing operations before income taxes									(21,995)	(49,926)	(31,779)
Equity in earnings of subsidiaries									97,414	73,538	40,251
(Benefit from) provision for income taxes									(7,621)	(18,967)	(11,931)
Income (loss) from continuing operations									83,040	42,579	20,403
Net income (loss)									83,040	42,579	20,403
Other comprehensive loss:
Comprehensive income (loss)									83,040	42,579	20,403
Combined Subsidiary Guarantors [Member]
Condensed Financial Statements, Captions [Line Items]
Revenue before provision for doubtful accounts									826,465	700,407	412,161
Provision for doubtful accounts									(23,866)	(20,700)	(6,389)
Revenue									802,599	679,707	405,772
Salaries, wages and benefits									459,297	388,749	236,182
Professional fees									38,632	34,149	18,806
Supplies									40,511	35,686	19,382
Rents and leases									10,136	9,282	7,816
Other operating expenses									83,835	72,626	42,121
Depreciation and amortization									22,990	15,882	7,874
Interest expense, net									6,207	22
Transaction-related expenses									12,367	6,716	8,112
Total expenses									673,975	563,112	340,293
(Loss) income from continuing operations before income taxes									128,624	116,595	65,479
(Benefit from) provision for income taxes									44,608	44,294	24,583
Income (loss) from continuing operations									84,016	72,301	40,896
Loss from discontinued operations, net of income taxes									(192)	(691)	(101)
Net income (loss)									83,824	71,610	40,795
Other comprehensive loss:
Comprehensive income (loss)									83,824	71,610	40,795
Combined Non-Guarantors [Member]
Condensed Financial Statements, Captions [Line Items]
Revenue before provision for doubtful accounts									204,319	34,702	1,689
Provision for doubtful accounts									(2,317)	(1,001)
Revenue									202,002	33,701	1,689
Salaries, wages and benefits									106,057	13,964	1,190
Professional fees									13,850	3,022	213
Supplies									7,911	1,883	114
Rents and leases									2,065	767	22
Other operating expenses									26,819	7,946	656
Depreciation and amortization									9,677	1,208	108
Interest expense, net									14,815	1,901	257
Transaction-related expenses									1,283	434
Total expenses									182,477	31,125	2,560
(Loss) income from continuing operations before income taxes									19,525	2,576	(871)
(Benefit from) provision for income taxes									5,935	648	(327)
Income (loss) from continuing operations									13,590	1,928	(544)
Net income (loss)									13,590	1,928	(544)
Other comprehensive loss:
Foreign currency translation loss									(66,206)
Pension liability adjustment, net									(2,164)
Other comprehensive loss									(68,370)
Comprehensive income (loss)									$ (54,780)	$ 1,928	$ (544)

Financial Information for the Company and Its Subsidiaries - Summary of Condensed Consolidating Statement of Cash Flows (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Operating activities:
Net income (loss)	$ 22,129	$ 25,402	$ 22,451	$ 13,058	$ 12,280	$ 14,364	$ 12,197	$ 3,738	$ 83,040	$ 42,579	$ 20,403
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:
Depreciation and amortization									32,667	17,090	7,982
Amortization of debt issuance costs									3,198	2,264	2,507
Equity-based compensation expense									10,058	5,249	2,267
Deferred income tax (benefit) expense									7,215	10,083	2,847
Loss from discontinued operations, net of taxes									192	691	101
Gain on foreign currency derivatives									(15,262)
Debt extinguishment costs										9,350
Other									488	21	(3)
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net									(15,110)	(21,242)	(10,344)
Other current assets									(2,011)	(3,652)	1,583
Other assets									(6,513)	(2,239)	637
Accounts payable and other accrued liabilities									2,793	(848)	485
Accrued salaries and benefits									11,980	2,803	5,142
Other liabilities									2,749	3,181	702
Net cash (used in) provided by continuing operating activities									115,484	65,330	34,309
Net cash used in discontinued operating activities									(198)	232	(411)
Net cash (used in) provided by operating activities									115,286	65,562	33,898
Investing activities:
Cash paid for acquisitions, net of cash acquired									(738,702)	(164,019)	(443,473)
Cash paid for capital expenditures									(113,244)	(68,941)	(27,595)
Cash paid for real estate acquisitions									(23,177)	(8,092)	(53,159)
Settlement of foreign currency derivatives									15,262
Other									(913)	(1,926)	(417)
Net cash used in investing activities									(860,774)	(242,978)	(524,644)
Financing activities:
Borrowings on long-term debt									542,500	150,000	176,063
Borrowings on revolving credit facility									230,500	61,500	16,000
Principal payments on revolving credit facility									(284,000)	(8,000)	(16,000)
Principal payments on long-term debt									(7,695)	(7,680)	(6,000)
Repayment of long-term debt										(52,500)
Payment of debt issuance costs									(12,993)	(4,307)	(4,551)
Payment of premium on note redemption										(6,759)
Issuance of common stock, net									374,431	(205)	311,841
Common stock withheld for minimum statutory taxes, net									(4,099)	(1,242)	960
Excess tax benefit from equity awards									4,617	1,779	714
Cash paid for contingent consideration									(5,000)
Other									(289)
Net cash provided by financing activities									837,972	132,586	479,027
Effect of exchange rate changes on cash									(3,013)
Net increase (decrease) in cash and cash equivalents									89,471	(44,830)	(11,719)
Cash and cash equivalents at beginning of the period				4,569				49,399	4,569	49,399	61,118
Cash and cash equivalents at end of the period	94,040				4,569				94,040	4,569	49,399
Consolidation, Eliminations [Member]
Operating activities:
Net income (loss)									(97,414)	(73,538)	(40,251)
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:
Equity in earnings of subsidiaries									97,414	73,538	40,251
Change in operating assets and liabilities, net of effect of acquisitions:
Other assets									1,151
Net cash (used in) provided by continuing operating activities									1,151
Net cash (used in) provided by operating activities									1,151
Financing activities:
Principal payments on long-term debt									1,151
Cash (used in) provided by intercompany activity									(377)	(1,925)
Net cash provided by financing activities									774	(1,925)
Net increase (decrease) in cash and cash equivalents									1,925	(1,925)
Cash and cash equivalents at beginning of the period				(1,925)					(1,925)
Cash and cash equivalents at end of the period					(1,925)					(1,925)
Parent [Member]
Operating activities:
Net income (loss)									83,040	42,579	20,403
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:
Equity in earnings of subsidiaries									(97,414)	(73,538)	(40,251)
Amortization of debt issuance costs									2,748	2,725	2,507
Equity-based compensation expense									10,058	5,249	2,267
Deferred income tax (benefit) expense									(1,969)	(754)	(519)
Gain on foreign currency derivatives									(15,262)
Debt extinguishment costs										9,350
Change in operating assets and liabilities, net of effect of acquisitions:
Other assets									(1,151)
Net cash (used in) provided by continuing operating activities									(19,950)	(14,389)	(15,593)
Net cash (used in) provided by operating activities									(19,950)	(14,389)	(15,593)
Investing activities:
Settlement of foreign currency derivatives									15,262
Net cash used in investing activities									15,262
Financing activities:
Borrowings on long-term debt									542,500	150,000	176,063
Borrowings on revolving credit facility									230,500	61,500	16,000
Principal payments on revolving credit facility									(284,000)	(8,000)	(16,000)
Principal payments on long-term debt									(7,500)	(7,500)	(6,000)
Repayment of long-term debt										(52,500)
Payment of debt issuance costs									(12,993)	(4,307)	(4,551)
Payment of premium on note redemption										(6,759)
Issuance of common stock, net									374,431	(205)	311,841
Common stock withheld for minimum statutory taxes, net									(4,099)	(1,242)	960
Excess tax benefit from equity awards									4,617	1,779	714
Cash (used in) provided by intercompany activity									(838,768)	(118,377)	(463,434)
Net cash provided by financing activities									4,688	14,389	15,593
Combined Subsidiary Guarantors [Member]
Operating activities:
Net income (loss)									83,824	71,610	40,795
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:
Depreciation and amortization									22,990	15,882	7,874
Deferred income tax (benefit) expense									5,231	10,278	3,376
Loss from discontinued operations, net of taxes									192	691	101
Other									449	21	(3)
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net									(13,636)	(22,768)	(9,283)
Other current assets									(2,205)	(3,774)	1,579
Other assets									(6,910)	(1,950)	603
Accounts payable and other accrued liabilities									(5,559)	(287)	997
Accrued salaries and benefits									11,035	2,161	5,121
Other liabilities									1,769	3,181	702
Net cash (used in) provided by continuing operating activities									97,180	75,045	51,862
Net cash used in discontinued operating activities									(198)	232	(411)
Net cash (used in) provided by operating activities									96,982	75,277	51,451
Investing activities:
Cash paid for acquisitions, net of cash acquired									(723,064)	(164,019)	(443,473)
Cash paid for capital expenditures									(83,864)	(68,497)	(27,595)
Cash paid for real estate acquisitions									(23,177)	(8,092)	(53,159)
Other									(913)	(1,926)	(417)
Net cash used in investing activities									(831,018)	(242,534)	(524,644)
Financing activities:
Cash paid for contingent consideration									(5,000)
Other									(289)
Cash (used in) provided by intercompany activity									816,010	117,950	461,382
Net cash provided by financing activities									810,721	117,950	461,382
Net increase (decrease) in cash and cash equivalents									76,685	(49,307)	(11,811)
Cash and cash equivalents at beginning of the period								49,307		49,307	61,118
Cash and cash equivalents at end of the period	76,685								76,685		49,307
Combined Non-Guarantors [Member]
Operating activities:
Net income (loss)									13,590	1,928	(544)
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:
Depreciation and amortization									9,677	1,208	108
Amortization of debt issuance costs									450	(461)
Deferred income tax (benefit) expense									3,953	559	(10)
Other									39
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net									(1,474)	1,526	(1,061)
Other current assets									194	122	4
Other assets									397	(289)	34
Accounts payable and other accrued liabilities									8,352	(561)	(512)
Accrued salaries and benefits									945	642	21
Other liabilities									980
Net cash (used in) provided by continuing operating activities									37,103	4,674	(1,960)
Net cash (used in) provided by operating activities									37,103	4,674	(1,960)
Investing activities:
Cash paid for acquisitions, net of cash acquired									(15,638)
Cash paid for capital expenditures									(29,380)	(444)
Net cash used in investing activities									(45,018)	(444)
Financing activities:
Principal payments on long-term debt									(1,346)	(180)
Cash (used in) provided by intercompany activity									23,135	2,352	2,052
Net cash provided by financing activities									21,789	2,172	2,052
Effect of exchange rate changes on cash									(3,013)
Net increase (decrease) in cash and cash equivalents									10,861	6,402	92
Cash and cash equivalents at beginning of the period				$ 6,494				$ 92	6,494	92
Cash and cash equivalents at end of the period	$ 17,355				$ 6,494				$ 17,355	$ 6,494	$ 92